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Summary 
My work was focussed on the development of a drug-free, antibacterial, multilayer 
honey-mimetic wound dressing, composed of: (1) a loaded antibacterial reactive 
oxygen species (ROS)-producing, injectable hydrogel, (2) an antibacterial glucose 
oxidase (GO) surface-functionalized electrospun polyurethane fibre patch 
protecting the hydrogel layer, and  (3) a glucose-loaded hydrogel on top of the 
electrospun fibre wound dressing. Assembled all together, these materials would be 
applied on the wound site to facilitate healing and prevent bacterial infections. 
 
In the development of the Layer (1) - wound dressing hydrogel -, an in situ quick 
forming, water absorbing hydrogel was developed, mimicking the antibacterial 
mechanism of honey. Within honey, antibacterial ROS such as hydrogen peroxide 
(H2O2) are continuously formed from the reaction of GO enzyme and glucose. The 
hydrogel was prepared by the Michael addition thiol-ene click chemistry between 
a synthesised hyperbranched polyethylene glycol diacrylate (HB PEGDA) and a 
commercially available thiolated hyaluronic acid (HA-SH). This reaction occurs 
rapidly in a physiological pH environment and causes a quick sol to gel transition 
of the mixed polymer solutions.  
 
Four different HB PEGDA/HA-SH hydrogels were obtained by mixing HB 
PEGDA polymer solution (10-20 w/w %) with an equal volume of HA-SH solution 
(0.5-2 w/w %). Produced hydrogels differed for the relative content of the polymers 
(HB PEGDA dry weight: from 83.3 % w. to 90.9 % w.) and overall hydrogel 
concentration (from 6 to 12 % w./w.). 
 
The hydrogel was screened based on its gelation time, water absorption profile, and 
degradation rate. Based on the results, HB PEGDA/HA-SH 10-1.0 was selected. 
Mouldable and injectable HB PEGDA/HA-SH 10-1.0 hydrogels, prepared from HB 
PEGDA (10  w/w %) and HA-SH (1.0 w/w %) (dry weight composition: 90.9 wt.% 
HB PEGDA; 9.1 wt.% HA-SH; overall hydrogel concentration: 11 wt.%) were 
selected as their gelation time (63 s) may potentially allow in vivo injection.  They 
displayed high water absorption (130%) after six weeks incubation in phosphate 
buffered saline solution. After 64 days, they showed no signs of degradation in 
terms of decreasing hydrogel mass. 
 
A range of glucose oxidase concentrations (0-500 U/L) were tested with 2.5 w/w% 
glucose within the HB PEGDA/HA-SH 10-1.0 hydrogel. One final GO 
concentration was selected based on the amount of H2O2 produced (target range 
was 10-20 mM H2O2 per day) in 24 hours and cytocompatibility. 
 
This HB PEGDA/HA-SH 10-1.0 hydrogel containing 250 U/L glucose oxidase and 
2.5 w/w% glucose produced 9.11±0.92 mM H2O2 in static conditions after 24 hours 
by pertitanic acid assay, and displayed cytocompatibility when tested in the 
presence of NIH/3T3 mouse fibroblast cells for 24 hours. Antibacterial ability was 
also measured against relevant Gram-positive bacteria and Gram-negative bacteria: 
E. coli, S. aureus, P. aeurginosa, MRSA, MRSE, etc.: the hydrogel had a higher 
antibacterial response to Gram-positive bacteria, which were more receptive to 
H2O2 due to their structural characteristics (they lack an outer membrane). 
 
Layer (2) was made of Lubrizol Tecophilic SP60D60, a commercially available 
medical-grade thermoplastic polyurethane (TPU). This was coated with a 
polyDOPA (PDA) film to facilitate immobilization of GO enzyme as it grafts itself 
on PDA quinone functional groups. PDA coating by spontaneous oxidation of L-
dihydroxyphenylalanine (L-DOPA) and self-polymerisation has been previously 
optimized at Politecnico di Torino to get a well-distributed coating layer using 7 
hour time. To reduce oxidation/polymerisation time in PDA-coating, a novel 
protocol was developed by adding an oxidizing enzyme, lactoperoxidase (LPO) at 
various concentrations (0-1.4 U/mL). Furthermore, self-polymerisation approach 
was also tested at shorter times than 7 hours. PDA coating using 1.4 U/mL LPO 
was achieved in 3 hours. As a comparison, PDA coating was also prepared by self-
polymerisation in 3 hours.  
Glucose oxidase was successfully grafted into TPU-PDA fibre patches (with and 
without the use of LPO). One of the modified fibre patches of interest was TPU-
PDA-GO-0-3, obtained by grafting GO to PDA deriving from DOPA self-
polymerization in 3 hours. Such coating had an enzyme activity of 7.9±1.9 U/g 
glucose oxidase. This was used as GO enzyme assay results showed that the 
addition of LPO did not play a significant role on increasing the amount of GO that 
can be grafted onto a PDA-coated substrate 
 
For the top glucose-replenishing hydrogel (3), the material was prepared from UV-
cured gelatin methacrylate (GelMA) loaded with 10 w/v glucose. GelMA was 
synthesized by following a literature protocol by Nichol, et al., 2010 (Cell-laden 
microengineered gelatin methacrylate hydrogels). GelMA was dissolved at a 
concentration of 15 w/v% into a PBS solution at pH 7.4 that contained 10 w/v% 
glucose and 1 w/v% Irgacure 2959. Hydrogels were formed by UV crosslinking 
under a UV lamp with an intensity of 4 mW/cm2 at a wavelength of 365 nm. The 
bilayer device formed by glucose-loaded GelMA in combination with TPU-PDA-
GO patches (obtained at different coating times and DOPA-oxidizing conditions) 
resulted cytocompatible in indirect contact tests with NIH/3T3 mouse fibroblast 
cells for 24 hours. 
 
The image below (Figure 10.1) shows the schematic representation of the 
assembled multilayer wound healing device with the specific materials used for 
each layer. 
 
 
Figure 10.1 Multilayer wound healing device 
 
 
The highest overall cytocompatibility of the multilayer device was 58.3±8.5% with 
the use of TPU-PDA-GO-0-3 and glucose-loaded (10 w/v%) UV-crosslinked 
GelMA hydrogel. The obtained cytocompatibility for the multilayer was not 
considerably ideal: the GO/glucose concentrations in HB PEGDA/HA-SH 10-1.0 
should be reduced when used with the TPU-PDA-GO fibre patch and glucose-
loaded GelMA, as to reduce the amount of produced H2O2. An alternative would 
be to apply the TPU-PDA-GO system to protect the in situ HB PEGDA/HA-SH 10-
1.0 wound dressing from exposure and once the glucose from the HB PEGDA/HA-
SH 10.1 hydrogel has almost depleted itself, the glucose-loaded GelMA hydrogel 
could be applied as an additional glucose source. 
 
In future studies, the potential of drug-free GO enzyme/glucose ROS-producing 
systems to act on various bacterial strains, particularly Gram-positive antibiotic-
resistant ones should be explored more in-depth, especially given concerns on the 
increasing antimicrobial resistance of bacteria. Further optimization of the overall 
H2O2 output will be required and be the subject of future studies. 
 
Scope and Limitations of the Study 
This Ph.D thesis focused on the use of a range of materials to produce drug-free 
antibacterial polymers as part of the objectives set by the EU Horizon 2020 Project 
HyMedPoly. To achieve this, the general concept of the study was to develop 
wound healing materials that are embedded with glucose oxidase and glucose that 
produce antibacterial hydrogen peroxide continuously until the glucose source is 
depleted. Several areas of research were involved:  
• Polymer synthesis and characterization  
• Material processing and modification by novel techniques 
• Characterization of physicochemical properties of materials 
• ROS-producing parameters and assay methods 
• Assembly of multilayer wound healing device 
• Cytocompatibility testing 
• Antibacterial activity testing 
 
The synthesis and characterization of two new types of hyperbranched polymers 
(hyperbranched polyethylene glycol diacrylate, HB PEGDA and hyperbranched 
polyethylene glycol diacrylate-co-glycidyl methacrylate, HB PEGDA-co-GMA) 
using free radical polymerization techniques was investigated. On the other hand, a 
known literature protocol was applied for the synthesis of gelatin methacrylate 
(GelMA). Additionally commercially available polymers, such as Vornia Ltd.’s 
thiolated hyaluronic acid (HA-SH) and Lubrizol Tecophilic SP60D60 
thermoplastic polyurethane (TPU A or TPU) were used in this work. 
 
Material processing and modification was addressed to the development of 
functional hydrogels and electrospun fiber patches. Techniques investigated for 
material processing included: 
• Hydrogel formation by crosslinking methods: Michael-addition thiol-ene 
crosslinking and UV-mediated crosslinking 
• Electrospinning of thermoplastic polymers in solution (TPU) to form 
electrospun patches 
• Use of enzymes for different applications: Glucose oxidase (GO) for 
hydrogen peroxide production in combination with glucose, and use of 
Lactoperoxidase (LPO) for increased oxidation rate of DOPA  
• Enzyme immobilization methods: enzyme physical encapsulation in 
hydrogels, and its covalent-grafting to hydrogel polymers or solid substrates 
[via reacting with an epoxide group (HB PEGDA-co-GMA) or quinone 
group (polyDOPA)] 
• Surface functionalization of a TPU fibre patch by polyDOPA coating 
methods 
 
Table 0.1 lists the general characterization experiments of the materials and whether 
or not they were performed for a specific material. For example, HB PEGDA/HA-
SH has a “Yes” under gelation time meaning that this was measured while it has 
“No” for static contact angle meaning that it was not analysed for this materials. 
 
 
 
 
 
  
Table 0.1. List of characterization experiments performed on the materials 
(excluding GO-grafting and ROS-relevant experiments). 
Characterization 
experiments HB PEGDA/HA-SH 
HBPEGDA-co-
GMA/HA-SH TPU 
GelMA 
hydrogel 
Gelation time Yes Yes No Yes 
Rheological 
properties Yes Yes No No 
Water absorption 
profile Yes Yes Yes No 
Degradation 
profile Yes Yes Yes No 
Tensile properties No No Yes No 
Static contact 
angle No No Yes No 
SEM analysis No No Yes No 
FTIR analysis No No Yes Yes 
 
 
Another important aim was to tailor GO and glucose contents within materials, to 
produce antibacterial H2O2 avoiding cytotoxic effects on cells. In this study, the 
final concentration of GO ranged from 0-1,000 U/L for hydrogel applications. A 
solution of 10,000 U/L of GO was used for GO-grafting the polyDOPA-coated 
TPU.  
 
These concentrations define the amount of H2O2 that can be produced per unit of 
time from a glucose source. In this study, glucose amount was limited to a 
concentration range of 2.5-10 w/w% in hydrogels and 10 w/v% in phosphate buffer 
solution (PBS) pH 7.4 used to immerse TPU-PDA-GO fibre patches. 
 
The method used for measuring H2O2 concentrations was a colorimetric pertitanic 
acid assay with a measurement range of 0-20 mM H2O2 based on the prepared 
hydrogen peroxide standards as the protocol stated that measurements beyond 20 
mM H2O2 become more inaccurate. 
  
Another aim was to fabricate a multilayer device composed of different layers, each 
with a specific function related to the production of antibacterial ROS: 
 
• Layer 1: The bottom most layer was intended to be an injectable hydrogel 
that would be introduced as a liquid polymer solution and gel in in situ on 
the wound surface. This material would be capable of producing 
antibacterial ROS on its own. 
• Layer 2: The intermediate layer was intended to be a functionalized 
protective layer with GO-grafted enzymes on its surface for additional 
antibacterial activity. This material would require a glucose source to 
produce antibacterial ROS. 
• Layer 3: A glucose-loaded hydrogel that can be place on top of Layer 2 and 
be removed and replaced to provide a glucose source for Layers 2 (and 
possibly Layer 1). This material would not have any antibacterial properties 
in and of itself but can be used for producing antibacterial ROS when 
combined with Layer 2. 
 
A combination of [Layers 1 with 2], [Layer 2 with 3], and [Layer 1, 2, and 3] were 
intended to be used for wound healing applications.  The multilayer wound healing 
device was intended only for preventing infections in common bacterial strains and 
some antibiotic resistant Gram-positive bacteria like (Methicillin-resistant S. 
aureus) MRSA and (Methicillin-resistant S. epidermidis) MRSE. Figure 10.2 below 
(taken from Chapter 10) illustrate the different proposed combinations that could 
be done with the materials developed. 
 
Figure 10.2: Possible configurations for assembling the materials developed in 
this thesis for an antibacterial wound healing patch using Layers 1 to 3. 
 
 
In the assembly of the final multilayer wound healing device, Layer 1 (HB 
PEGDA/HA-SH 10-1.0 hydrogel) was limited to one GO/glucose concentration, 
which was 250 U/L glucose oxidase and 2.5 w/w% glucose. Layer 2 (TPU-PDA-
GO-0-3 fibre patch) was selected from the material that would give an ideal H2O2 
release and have cytocompatible properties. Layer 3 (glucose-loaded GelMA 
hydrogel) utilized one glucose composition of 10 w/v% glucose. 
 
Preliminary cytocompatibility tests (CT 1)were performed using NIH/3T3 mouse 
fibroblast cells and an indirect, non-contact method. A different cytocompatibility 
test protocol (CT 2)however was for the testing of the multilayer device developed 
from ISO 10993 standards using eluates collected from the multilayer wound 
healing device.  
 
Single and combined components of the wound healing device were tested, as 
summarized in Table 0.2 based on the cytocompatibility protocol used (CT1 or 
CT2),  if ROS-production tests were performed on the material (Yes or No), or if 
antibacterial tests have been performed (Yes or No).  
 
Table 0.2. List of experiments performed on the materials relevant to wound-
healing applications. 
Layer and 
combination 
Cytocompatibility 
tested 
ROS 
measurements 
Antibacterial tests 
Layer 1 CT 1 Yes Yes 
Layer 2 CT 1 Yes No 
Layer 3 CT 1 No No 
Layer 2+3 CT 1 Yes No 
Layer 1+2+3 CT 2 No No 
 
Antibacterial activity in nine bacterial strains (4 Gram-positive and 5 Gram-
negative) was preliminarily tested on HB PEGDA/HA-SH hydrogels. The method 
used for assessing antibacterial activity was based on an agar diffusion test and the 
data gathered was reported in terms of zone of inhibition. Indeed such hydrogel can 
be used alone to treat infected wounds, while the other components can prolong the 
antibacterial activity. The complete device will be subject of future investigations.  
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Chapter 1  Wounds 
1.1. Abstract 
 
This chapter, introduces the foundation of the study by providing the background 
information relevant to the research project such as the structure of skin, the 
definition of wounds, the complications that might occur such as wound infections 
with antibacterial resistance and current methods of treating antibacterial infections. 
The design for a drug-free multilayer wound healing device is presented with the 
aim to protect injured tissue, stimulate healing, and prevent infections. 
 
 
1.2. Introduction 
 
Wounds are defined as injury to living tissue caused by a blow, sting, or cut, that 
breaks the skin. However, different sources have varying definitions, sometimes 
including lacerations, ulcers and burns as types of wounds1,2. 
Sales are driven by emerging technologies for wound treatment, particularly for 
chronic wounds, and traditional wound care will only account for 30% of the total 
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wound care market by 20243. Market research forecasts that by 2024, traditional 
wound care devices (adhesives, gauzes, and nonadherents) will only comprise 30% 
of the market while more advanced wound care devices such as bioengineered skin, 
skin substitutes, foams, hydrogels will dominate the industry3.  
  
 
1.2.1. Structure of skin 
 
Skin consists of three layers: the epidermis, dermis, and deep subcutaneous 
tissue/hypodermis. The epidermis serves as the waterproof covering of the skin that 
also serves as a natural barrier against bacterial infections. Wounds often differ in 
depth and area, but generally they involve damaging the epidermal layer. The 
epidermis itself has no blood vessels but is nourished by the dermis. When wounds 
bleed, this usually indicates damage to the dermis at the very least4. 
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Figure 1.1: Structure of the skin. 
 
1.2.2. Types of wounds 
 
The most common types of wounds are punctures, ulcers, skin tears, and 
contusions5. A study on the global prevalence of wound types that occurred in 2015,  
indicates that surgical wounds, lacerations, and ulcers (diabetic, venous, and 
pressure) have the highest prevalence6. 
 
In this Doctorate Thesis, the design of an antibacterial material for skin lesions of 
both wounds and ulcers will be focused upon. Normally, wounds are differentiated 
from ulcers in that wounds are physically inflicted by an external source, such as a 
jagged surface or surgical incision.  
 
A skin ulcer is an open wound on the skin, which can be caused by a health problem 
such as infection, by a pressure sore, or by vein problems (venous skin ulcers)7. 
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These normally are much harder to heal and can occur chronically, particularly 
when a patient has a compromised immune system8. 
 
 
1.3. Wound healing and treatment 
 
 
Figure 1.2. Phases of wound healing. 
 
Wound healing is a natural process performed by the body. It is comprised of four 
phases as shown in Figure 1.2: hemostasis, inflammation, proliferation, and 
maturation9. The use of dressings and other wound care materials supports this 
healing process by protecting the wound from exposure, preventing infection and 
complications, and preserving skin function10. 
 
 
 
1.3.1. Wound healing mechanism 
 
The first event in wound healing is hemostasis consisting of the following factors 
that aim at decreasing blood loss:  Platelets’ aggregation and activation, blood clot 
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formation, vasoconstriction, and platelet release of chemokines as chemo-
attractants to inflammatory cells at the wound site9. 
 
During the inflammatory phase, the blood vessels dilate to allow cells, antibodies, 
growth factors, etc., to enter the wound area. This involves the actions of 
neutrophils, macrophages, and lymphocytes. Neutrophils are responsible for 
cleaning the wound from bacteria and necrotic tissues, while releasing 
inflammatory mediators and bactericidal oxygen free radicals9. Macrophages have 
many functions during wound healing such as providing host defense, controlling 
the inflammatory response as well as breaking down and removing dead cells11. 
Lymphocytes are a type of white blood cells that are also responsible for the body’s 
defense system against foreign particles12. Also, by the time this stage takes place, 
the blood on the outermost surface will have formed into a scab to protect foreign 
objects from entering the body. This phase lasts four to six days. 
 
During proliferation phase, the granulation tissue starts to form9. This tissue is 
comprised of collagen and extracellular matrices like hyaluronic acid13. Within this 
tissue new blood vessels are regenerated in a process called angiogenesis and the 
quality and health of the granulation tissue is dependent on the availability of 
oxygen and nutrients supplied to it by the blood vessels9.Wound contraction also 
occurs at this stage, with decrease in wound size9. Proliferation takes place 
anywhere between four to twenty-four days. 
 
The last phase is maturation. Here, the newly deposited collagen forms crosslinks, 
increasing the tensile strength of the scar tissue9. Scars that have a raised appearance 
are called hypertrophic scars or keloid scars and occur when too much collagen has 
been produced14. Scars are made of the same type of collagen in normal skin but 
differ in fibre composition15. The collagen of normal skin’s fibres is more randomly 
weaved while scar tissue’s collagen is crosslinked and aligned in a single 
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direction15. Thus, scar tissue is more rigid and lacks the natural elasticity of skin15. 
This phase can take between 21 days to 2 years. 
 
 
1.3.2. Complications in wound healing 
 
Frequently not healing chronic wounds form because of the presence of bacterial 
biofilms and antibiotic-resistant bacteria in the wound bed, although there are other 
contributing factors such as foreign debris, diabetes, and inadequate nutrition8. 
 
For example, Pseudomonas aeruginosa is a bacterial strain found in many chronic 
wounds that has a strong resistance to standard antibiotics, affecting people with 
compromised immune systems8. Wounds infected with P. aeruginosa may have a 
bluish tinge to them due to bacteria consuming fluids in the wound and then 
releasing waste back into the wound tissue8.  
 
Some bacteria are also capable of quorum sensing. This ability lets them release 
chemical signals, often called autoinducers, to control their cell density before 
expressing a gene to release byproducts into the media they occupy such as 
extracellular matrices or virulent proteins16. These materials aggregate and lead to 
the formations of biofilms. 
 
Biofilms are composites of bacterial or fungal cells, encased in extracellular matrix 
composed of hydrated polymers and debris, like polysaccharides, proteins, and 
DNA that are excreted by bacteria17. Bacteria in biofilms behave differently with 
respect to their planktonic status, in terms of structure, gene expression, antibiotic 
resistance, and interaction with the host17. Bacterial biofilm can be found on the 
surface of the skin, in the wound tissue, and in some cases deeper in the apparently 
normal tissue 18.  
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Bacterial infections that involve biofilm formation are harder to recover from as the 
biofilm protects the bacteria from the host’s immune response17. They also impede 
fibroblast development and inflammatory responses. Thus, it is unlikely that a 
wound can fully heal until the bacterial infection or biofilm is eliminated. 
 
 
1.3.3. Role of Reactive Oxygen Species (ROS) in wound healing 
 
The roles ROS play in wound healing differ at various stages in the wound healing 
process. This is briefly summarized and illustrated by Figure 1.3. 
 
Figure 1.3: Reactive oxygen species (ROS) and their role in wound healing19. 
(Reproduced with permission from Dunill, et al. 2015. Full access). 
 
Reactive oxygen species (ROS), such as hydrogen peroxide, play a pivotal role in 
the orchestration of the normal wound-healing response. They are responsible for 
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killing bacteria during inflammation and are involved in the repair process by acting 
as secondary messengers to many immunocytes and non-lymphoid cells19. 
Harnessing the potential of ROS to be used within wound care devices provides the 
potential to accelerate the healing process and to prevent bacterial infections. 
 
 
 
1.4. Antibiotic resistance 
 
One of the pressing challenges in the biomedical sector is to fight antibiotic resistant 
bacteria. A study from the United Kingdom estimates that failure to address this 
issue could result in 10 million deaths per year by 2050 and cost 60 trillion GBP20. 
 
On 27th Feb 2017 the World Health Organization (WHO) published a list of 
bacteria that require new antibiotics to be developed21. 
 
Priority 1: CRITICAL 
• Acinetobacter baumannii, carbapenem-resistant 
• Pseudomonas aeruginosa, carbapenem-resistant 
• Enterobacteriaceae, carbapenem-resistant, Extended Spectrum β-
Lactamase (ESBL)-producing 
 Priority 2: HIGH 
• Enterococcus faecium, vancomycin-resistant 
• Staphylococcus aureus, methicillin-resistant, vancomycin-intermediate 
and resistant 
• Helicobacter pylori, clarithromycin-resistant 
• Campylobacter spp., fluoroquinolone-resistant 
• Salmonellae, fluoroquinolone-resistant 
• Neisseria gonorrhoeae, cephalosporin-resistant, fluoroquinolone-resistant 
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Priority 3: MEDIUM 
• Streptococcus pneumoniae, penicillin-non-susceptible 
• Haemophilus influenzae, ampicillin-resistant 
• Shigella spp., fluoroquinolone-resistant 
 
 
1.4.1.  Bacterial resistance in wounds 
 
Antibiotic resistant species that can be found in wounds and ulcers include 
Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Enterococcus 
faecalis and Acinetobacter baumannii, that occur in WHO's 2017 priority research 
list22,23. 
  
Given how the use of antibiotics lead to the risky development of antibacterial-
resistant bacteria, especially in the case of patients overusing antibiotics, it is worth 
looking into alternative antibacterial methods that do not require the use of 
antibiotics and decrease the reliance on them24. In developing an antibacterial 
wound healing device, the material efficiency against these species should be tested 
and proved to kill or prevent proliferation of some of these bacteria. 
 
 
1.4.2. Current antibacterial methods 
 
Antimicrobial intervention in wounds today are grouped as antibiotic and non-
antibiotic based treatments. Antibiotics are drugs that are made (either naturally or 
synthetically) from fungi, molds, and other living organisms that can kill bacteria.  
 
Non-antibiotic methods include the use of antiseptics such as silver, iodine, 
potassium permanganate (KMnO4) topically applied on the wound tissue or 
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embedded in a wound dressing or gel as the most common method25. Emerging 
non-antibiotic methods are being devised from more equipment intensive 
techniques such as cold plasma, ozone, phototherapy, and bacteriophage therapy26–
28.  
 
Polymers used for biomedical applications such as implants are often imbued with 
antibacterial properties in order to prevent possible infections from occurring. This 
can be accomplished by: i) adding an intrinsic antibacterial activity to the polymer, 
ii) conjugation of the polymer with an antibacterial agent, or iii) loading an 
antibacterial agent into the polymer matrix29. 
 
Meanwhile, many researchers are investigating ancient natural remedies to evaluate 
which antimicrobial strategies can be developed from them. Today’s scientists have 
the advantage of being able to analyze the specific antibacterial mechanisms of 
these ancient remedies. 
 
 
1.4.3. Research on natural sources for wound healing 
 
As far back as 2000 BC, in ancient empires such as those of the Egyptians, Chinese, 
and Assyrians, healing of wounds sustained from war and combat was the concern 
of many healers30,31. As they have been tasked to devise effective wound healing 
and antibacterial strategies, they looked to sources derived from plants and 
animals30,32. 
 
Today, several naturally occurring substances have been verified to display 
antibacterial properties such as honey, ginger, garlic, echinacaea33. 
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Research has been conducted on Manuka (L. scoparium) honey, which has been 
demonstrated to be effective against several human pathogens, including 
Escherichia coli (E. coli), Enterobacter aerogenes, Salmonella typhimurium, 
Staphylococcus aureus (S. aureus), β-haemolytic streptococci and vancomycin- 
resistant Enterococci (VRE) and Pseudomonas aeruginosa (P. aeruginosa)31,34. 
 
Honey has been noted in several studies to have a bactericidal effect34,35. Its 
antibacterial effects are attributed to many factors, which include its phytochemical 
components, osmotic effect of sugar on bacterial cells, acidic pH that aids 
macrophages in destroying bacteria, and the enzymatic activity of Glucose Oxidase 
(GO) to produce hydrogen peroxide (H2O2) from glucose35–39. In this Doctorate 
thesis the effect of glucose oxidase in producing Reactive Oxygen Species (ROS) 
as an antibacterial agent will be analysed. 
 
 
1.5. Role of enzymes in wound healing 
  
Other enzymes have different functions in the wound healing process such as: 
-Proteolytic enzymes produced endogenously (i.e. by the body cells) degrade 
necrotic tissue in the wound by hydrolysing peptide bonds40.  
- Anti-quorum sensing enzymes are used to prevent biofilm formation41.  
 
The complete list of enzymes involved in wound healing can be found in Table 1.1. 
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Table 1.1.  Examples of enzymes used for antimicrobial and antibiofilm strategies41 
Proteolytic 
Enzymes 
Polysaccharide-
degrading 
Enzymes 
Oxidative Enzymes 
• Subtilins 
• Lysostaphin 
• Bacteriophages 
lysin 
• Lysozyme 
• Amylases 
• Dispersin B 
• Alginate 
lyase 
• Myeloperoxidase 
• Cellobiose 
dehydrogenase 
• Glucose oxidase 
• Horseradish 
peroxidase 
 
 
 
1.5.1. Glucose oxidase and ROS 
 
Glucose oxidase is an enzyme first identified in 1929 which was observed to form 
H2O2 from glucose and oxygen42. Its side product, D-gluconolactone is a common 
ingredient in most skin creams and anti-aging formulas, thus it is unlikely that it 
will demonstrate any adverse effects when it is produced in wound healing. Figure 
1.4 illustrates the reaction of glucose oxidase on glucose in the presence of oxygen. 
 
 
Figure 1.4: ROS formation of H2O2 from glucose catalyzed by glucose oxidase (GO). 
However, topical application of GO directly on the wound site in the form of a 
solution results in its rapid diffusion and becomes toxic to the wound by causing 
sudden glucose deprivation and burst release of ROS43. Additionally, GO may be 
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quickly degraded due to the presence of endoproteases and peptidases in the healing 
tissue, even before exerting any antimicrobial effect43.  
 
To circumvent the problems associated with topical application of GO, in this work 
controlled release of hydrogen peroxide was obtained by incorporating GO and 
glucose in a two-component hydrogel.  
 
 
1.6. Hydrogels in regenerative medicine 
 
Hydrogels are water-swollen polymeric materials that maintain a distinct three-
dimensional structure and were the first biomaterials designed for use in the human 
body as their resemblance to living tissue opens up many opportunities for 
applications in biomedical areas 44,45. They have been used for drug delivery, tissue 
scaffolds, wound healing, and bioprinting46–50. 
 
 
1.6.1. Hydrogels for wound care 
 
An ideal type of wound dressing is based on a material that can maintain a warm 
and moist environment around the wound as well as absorb exudates from the 
wound surface and reduce dehydration51. Other important characteristics that a 
wound dressing should have are: 1) composed of of biocompatible materials, 2) 
permeability for oxygen and carbon dioxide, 3) prevent or inhibit bacterial growth 
4) enhance growth factor activity52. To meet this challenge, a wound dressing 
system by using the versatile group of materials called hydrogels has been 
developed in this project. 
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1.6.1.1. Properties relevant to wound care 
 
Hydrogels are formed when long chain polymers crosslink to form a three-
dimensional network. This crosslinking can be made physically (polymer chain 
entanglements, ionic or hydrophobic interactions, hydrogen bonding, etc.) or 
chemically (functional groups of one polymer chain covalently bonded with other 
functional groups in other chains) by introducing a kind of stimuli, such as change 
in pH, temperature, or exposure to UV light53,54. Hydrogel hydrophilic groups allow 
water absorption while hydrophobic groups prevent dissolution 54. Hence hydrogels 
are capable of absorbing high water contents when hydrated. This water absorption 
property, which ranges from 10-1000 wt%, satisfies one of the properties required 
for a wound dressing55. 
 
 
 
Figure 1.5: Swelling of hydrogel by absorbing water. 
Hydrogels can be made of synthetic or natural polymers or  their combination.  
While cells can easily attach to natural polymers that are part of the extracellular 
matrix (e.g. hyaluronic acid, collagen), due to the presence of ligands for cell 
receptors, the properties of natural polymers  (such as molecular weight, molecular 
number, chemical groups that can be functionalized) can vary too widely and 
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despite the cytocompatible advantages of natural polymers, their physical and 
mechanical properties can be difficult to replicate and predict. 
 
On the other hand, synthetic polymers have reproducible properties and  can be 
easily tailored to have suitable mechanical properties and degradation rates for the 
application, as well as hydrophilic composition. Tailor-made synthesis allows the 
incorporation of  a variety of functional groups into the polymer chain56. Synthetic 
polymers generally suffer from poor cell attachment. 
 
As hydrogels have porous crosslinked structure, this allows the material to be 
oxygen permeable, which aids in wound healing. In some applications, hydrogels 
have been used as contact lenses for this purpose57,58. 
 
Hydrogels can be embedded with antibacterial and wound healing agents that can 
diffuse into the wound tissue. Examples include silver nanoparticles, enzymes, and 
bioactive compounds (e.g. allicin and cinnamon aldehyde) 43,49,59,60. Hydrogels can 
also provide a scaffold for new cells to grow, as is the case with adipose-derived 
stem cells48,61. 
 
Additional properties that can be conferred to hydrogels for wound dressing are: 
quick forming ability, wound area coverage, adequate mechanical properties for 
handling and adhesive properties to the wound site. 
 
 
1.6.1.2. Click-chemistry thiol-ene hydrogels 
 
In order to design a hydrogel that is quick forming from a polymer solution 
(typically dissolved in water or phosphate buffer solution (PBS), a rapid 
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crosslinking is required. One possibility is to exploit the thiol-Michael addition 
reactions, specifically the thiol-ene click chemistry reaction. 
 
First described in the 1960s, it is defined as an enolate-type carbonyl (e.g. a polymer 
with a thiol functional group) reacting in the presence of a catalyst to an α,β-
unsaturated carbonyl (e.g. a polymer with an acrylate functional group)62. Figure 
1.6 shows this reaction . 
 
 
Figure 1.6: Thiol-Ene click chemistry reaction. 
 
This thiol-ene click chemistry can either be base- or nucleophile-catalyzed62. For 
instance, a polymer, such as thiolated hyaluronic acid (HA-SH) dissolved in water 
at 1 w/v% concentration results in a solution with a pH of 3.5 . The introduction of 
a base such as sodium hydroxide (NaOH) to the acidic HA-SH solution to reach a 
pH of 7.4 allows the base-catalyzed reaction to occur in mild, physiological 
conditions. 
 
Hyaluronic acid was chosen as the thiolated component for this research for a 
variety of reasons: it has previously shown cytocompatible properties, it is part of 
the extracellular matrix of skin tissue, and it has been proven to crosslink by click-
chemistry with a wide range of acrylated polymers at physiological conditions 
49,59,63. 
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1.6.1.3. Hyperbranched hydrogels 
 
HB polymers are characterized to have abundant functional groups, an irregular 3D 
topology, low viscosity, and high solubility64.   
 
 
Figure 1.7: Hyperbranched polymer structure. 
 
 
Such properties make them ideal to be used as components in an in situ formed 
hydrogel system. Their high solubility into low viscosity solutions allow them to be  
easily and rapidly dissolved in aqueous solution as a pre-hydrogel polymer solution. 
Their 3D topology and abundant functional groups allow rapid crosslinking with 
other polymer components, such as HA-SH thiol groups, forming a hydrogel with 
adequate stiffness. 
 
Hyperbranched polymers can be characterized by their degree of branching (DB). 
DB DB is the ratio of the molar fraction of branched and terminal units relative to 
that of the total possible branching sites64. For the polymerization of an AB2 type 
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monomer, such as a diacrylate polymer illustrated in Figure 1.8, DB can be 
calculated from the equation64: 
𝐷𝐵 =
𝐷 + 𝑇
𝐷 + 𝑇 + 𝐿
          (𝑒𝑞. 1) 
 
When a hyperbranched polymerization is assumed to have a high degree of 
polymerization (DP), the number of T approximates that of D, and the equation is 
reduced as follows: 
𝐷𝐵 =
1
1 +
𝐿
2𝐷
          (𝑒𝑞. 2) 
 
 
 
Figure 1.8: Description of the polymer units a hyperbranched polymer is composed of. 
 
As a calculation example to obtain the DB, from Figure 1.9, there are 18 terminal 
units, 1 initial unit, 16 dendritic units, and 74 polymer units. Using equation 1, the 
DB is: 
𝐷𝐵 =
𝐷 + 𝑇
𝐷 + 𝑇 + 𝐿
=
16 + 18
16 + 18 + 74
= 0.31 
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This means that for 1 mol of the hyperbranched polymer, there are 0.31 mol of 
dendritic and terminal functional groups. 
 
Adding to this, the vinyl content (VC) for acrylate hyperbranched polymers can be 
calculated as: 
𝑉𝐶 =
𝑇
𝐷 + 𝑇 + 𝐿
          (𝑒𝑞. 3) 
This equation will be useful when calculating the stoichiometry of the minimum 
amount of crosslinking material (such as HA-SH). This data can be obtained from 
analysis of a polymer's Nuclear Magnetic Resonance (NMR) spectra. 
 
Hyperbranched polymers made from biocompatible materials such as polyethylene 
glycol (PEG)-based have been used as hydrogel components for biomedical 
applications48,49,59,65–67. When crosslinked via Michael addition thiol-ene click 
chemistry, enzymes, cells, and bioactive compounds can be encapsulated in the 
hydrogel matrix48. 
 
For this study, the synthesis of a hyperbranched polyethylene glycol (PEG)-based 
hydrogel containing acrylate functional groups will be prepared to develop a quick 
forming, antibacterial wound dressing hydrogel.  
 
 
1.7. State of the art in antibacterial wound care 
 
Wound care devices can be sorted as traditional (gauze, adhesive, foams) and 
advanced (skin substitutes, stem cells, cold plasma treatment), with advanced 
wound care products growing each year, as observed from 2012 until the present 
day by market researchers27,68. In Figure 1.9, the market size of the traditional 
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wound dressings remains approximately constant, while the market size for 
advanced wound dressings has been continuously increasing reaching 
approximately 60% of the entire market in 2018.  Thus, with the rising threat of 
antimicrobial resistance (AMR) and the growth of elderly population percentage, 
there is a demand for effective drug-free antibacterial wound dressings. 
 
 
 
 
Figure 1.9: Market size of traditional and advanced wound dressings in North America68. 
 
A mechanism for killing bacteria in wounds that is often applied is through reactive 
oxygen species (ROS). The simplest of these methods is the application of a 
solution of hydrogen peroxide on the wound site for cleaning and disinfection. ROS 
can be formed in a variety of ways, ranging from chemical reactions to enzymatic 
reactions.  
 
There are several ROS-based technologies that are currently in the market or 
applied in research. One of these commercial products is Surgihoney, an 
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antibacterial soft gel that can be applied on wounds36. Surgihoney produces a 
maximum  of  2.25 mM H2O2 after 24 hours of applications 36.  
 
A second ROS-based commercially available wound dressing is Oxyzyme69,70. It 
consists of one hydrogel patch embedded with glucose that is called the  'wound 
contact patch' while a smaller hydrogel patch, called the 'secondary wound patch', 
is embedded with glucose oxidase enzyme71. These hydrogels are stacked on top of 
each other, then a cover dressing is applied to protect the wound from exposure. 
 
In the literature, a quick forming, in situ H2O2 releasing hydrogel (based on gelatin-
hydroxyphenyl propionic acid) has been developed exploiting the mechanism of 
horseradish peroxidase enzyme (HRP)  to produce an in situ gelling hydrogel with 
the help of the H2O2, ; the remaining H2O2 serves as the antibacterial component72. 
While H2O2 is being released into the wound, it is not continuously produced, like 
in the case of devices containing glucose oxidase enzyme + glucose antibacterial 
system. 
 
From studies done by Loo, et al, 2012, topically applying 2.5 µmol of H2O2 in 
solutions with varying concentrations (10-166 mM) daily over a span of 10 days, it 
was found that a solution at a concentration of 10 mM enhances angiogenesis while 
166 mM solution retards the wound closure73. Thus, 10 mM per day is considered 
here as the target concentration to be achieved. 
 
Based on the current state of the art, this research aims at producing a durable, 
mouldable, quick forming (transitioning from liquid state to a solid gel state) 
antibacterial hydrogel for wound dressing improving the current technologies 
mimicking the antibacterial properties of honey. The hydrogel will have higher 
mechanical stiffness than Surgihoney (a viscous solution) and higher GO/glucose 
content within the hydrogel compared to Oxyzyme. 
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This hydrogel will be formed when a hyperbranched polymer solution (containing 
GO enzyme) is mixed with a thiolated hyaluronic acid solution (containing 
glucose). As the two solutions are mixed and start to crosslink via thiol-ene click 
chemistry, the GO and glucose also interact and form antibacterial ROS ( H2O2) as 
seen in Figure 1.10. Within the hydrogel matrix, glucose (molecular weight 180 
g/mol) diffuses, while GO (molecular weight 160 kDa) is less mobile and is 
considered physically encapsulated74. This potentially addresses the issue that 
topical application of GO may be quickly degraded due to the presence of 
endoproteases and peptidases in the healing tissue, even before exerting any 
antimicrobial effect43.  
  
 
 
 
Figure 1.10: Formation of antibacterial H2O2 . 
 
 
The mixed liquid that is subsequently becoming a gel can be extruded into a wound 
surface and give full coverage of the wound tissue even in irregular surfaces, as 
seen in Figure 1.11, compared to a layer of hydrogel or bandage. Gelation time is 
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targeted to be under two minutes, and when the material is completely crosslinked, 
a semi-rigid gel forms.  
 
Figure 1.11: Illustration of the hydrogel filling irregular shaped wound crevices. 
 
The rate of H2O2 formed can be tailored by manipulating the enzyme and glucose 
concentrations within the polymer solutions. This hydrogel should also have good 
swelling properties in order to absorb wound exudates as its secondary function. 
Due to its water absorbent properties, it can be possible to “recharge” the hydrogel 
with more glucose solution during the in vivo application, to allow continuous 
production of H2O2 once the original glucose has been depleted and to rehydrate 
the wound bed. 
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Chapter 2 Preparation and 
Characterization of 
Hyperbranched PEGDA/HA-SH 
Hydrogels 
  
2.1. Abstract 
 
This work was aimed at the preparation of a hyperbranched PEG-based acrylate 
polymer that could crosslink with thiolated hyaluronic acid. In order to synthesize 
this polymer, Reversible Atom Chain-Transfer Fragmentation (RAFT) 
polymerization was applied. Hyperbranched polyethylene glycol diacrylate (HB 
PEGDA) was successfully synthesized, with a molecular weight of 16,656 Da and 
vinyl content of 57% under a reaction time of 2 hours and 40 minutes. Hydrogels 
were obtained by mixing HB PEGDA polymer solutions (10-20 w/w%) with an 
equal volume of thiolated hyaluronic acid (HA-SH, 0.5-2 w/w%), based on the 
mechanism of thiol-ene click chemistry. Gelation time of 1000 μL volume of 
hydrogels, obtained by the by the vial-tilt method, ranged from 42 to 585 seconds, 
depending on the HB PEGDA/HA-SH composition. The rheological properties, 
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swelling and water uptake, and degradation profile of hydrogels were obtained. 
Based on the physical criteria that a wound dressing hydrogel should be quick 
forming, mouldable, have high water absorption properties, have a minimum 
degradation time of one week, HB PEGDA/HA-SH hydrogel has potentiality for 
further studies in this application. This part of the activity was carried out at Wenxin 
Wang's Wound Healing and Skin Research Laboratory in Charles Institute of 
Dermatology, School of Medicine, University College Dublin, Ireland. 
 
 
2.2. Introduction 
 
2.2.1. Free Radical Polymerization 
 
The Michael addition thiol-ene reaction has been exploited for a wide variety of 
material science applications. Given that reaction can occur in mild conditions and 
at fast reaction rates, it is the objective of this chapter to synthesize a PEG-based 
acrylate hyperbranched polymer that can react with a thiolated polymer, namely 
thiolated hyaluronic acid (HA-SH) to form a quick forming hydrogel with good 
mechanical properties, retaining large amounts of water1.  
 
There are two methods for synthesizing polymers: chain reaction (addition) 
polymerization and step reaction (condensation) polymerization2. For monomers 
with vinyl groups, chain reaction polymerization is generally the method of choice.  
 
For chain reaction polymerization, a catalyst such as a free radical from a peroxide 
molecule is required. In this reaction, the double bond of the vinyl group is attacked 
and opens up to bond with other monomers (initiation). The polymer chain 
continues to grow with the free electron from the radical passing into the outermost 
carbon. (propagation). The polymer chain then ends when one chain containing a 
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free radical reacts with another chain containing a free radical (termination by 
combination). Other alternative termination reactions that occur are termination by 
disproportionation and termination by transfer reaction3,4.  Figure 2.1 shows as an 
example the polymerization of polyethylene from ethylene occurring through three 
steps of initiation, propagation, and termination by combination. 
 
 
Figure 2.1: Representation of chain growth polymerization. 
 
2.2.2. Reversible-deactivation Radical Polymerization 
 
A drawback of conventional Free Radical Polymerization is the termination 
reaction between radicals is difficult to be controlled, thus it is challenging to obtain 
a specific polymer structure, molecular weight and polydispersity index5. 
 
On the contrary, Reversible-deactivation radical polymerization, RDRP (also 
known as "Controlled/Living polymerization, CRP" and variations like Living 
Radical Polymerization, or Living Free Radical Polymerization), are defined as a 
form of chain growth polymerization where chain transfer and chain termination 
are absent5. This method allows a more controllable synthesis of polymers with 
different compositions, functionalities and architectures as shown in Figure 2.2.  
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Figure 2.2: Examples of molecular structures obtained by RDRP or CRP. 
 
The three most promising CRP methods of polymerizations are: 1) stable free 
radical polymerization (SFRP) or nitroxide mediated polymerization (NMP); 2) 
transition-metal-catalyzed atom transfer radical polymerization (ATRP), 3) 
reversible addition- fragmentation chain transfer (RAFT) polymerization5. 
 
Within CRP, the most versatile method for synthesizing hyperbranched polymers 
for biomedical applications is RAFT polymerization. Compared to ATRP methods, 
it does not require a metal catalyst like copper chloride. This can often interfere 
with the biocompatibility of the material, when trace elements still exist in the end 
product of the reaction even after extensive purification methods. Synthesis in 
RAFT polymerization occurs much faster compared to SFRP, which requires 30-
70 hours6. 
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RAFT agents are typically carbonylthio compounds as shown in Figure 2.3. In 
RAFT polymerization, the components for the reaction are: 1) monomer, 2) a 
radical source (eg. azobisisobutyronitrile or AIBN), 3) the RAFT agent (see Figure 
2.3), 4) solvent7 
 
Figure 2.3: Structure and examples of RAFT agents7,8. 
 
In the RAFT polymerization mechanism, initiation and radical-radical termination 
occur similar to that of conventional polymerization, described in Figure 2.1. The 
detailed mechanism of RAFT polymerization and how it differs from conventional 
polymerization is illustrated below in Figure 2.4 
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Figure 2.4: RAFT reaction mechanism with thiolcarbonylthiol agent. 
 
During the reversible chain transfer phase, which is in the early stage of 
polymerization, the propagating radical (Pn●) reacts to the thiocarbonylthio 
compound, which then fragments off the intermediate radical (R●), and a polymeric 
carbonylthio compound is formed.  
In the re-initiation stage, R● reacts with other monomers and forms a new 
propagating radical polymer (Pm●). 
 
Due to rapid equilibrium between the active propagating radicals, (Pn● and Pm●) and 
the dormant polymeric thiocarbonylthio compounds, there is equal probability for 
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all chains to grow and this results in polymers with narrow polydispersity index. 
When the polymerization is completed, most of the polymer chains retain the 
thiocarbonylthio end group and can be isolated as stable materials. The stability of 
the polymer formed via RAFT was proven, synthesizing two hyperbranched 
polymers with close molecular weights and polydispersity index, using both RAFT 
and DEATRP methods. For example, a hyperbranched PEG-based polymer was 
synthesized in Wenxin Wang’s research group using the two methods: RAFT 
synthesis gave a weight-average molecular weight (Mw) of 16,656 Da and 
DEATRP gave a Mw of 19,881 Da. Upon collection of the polymers via 
lyophilization, the DEATRP-synthesized polymer self crosslinked while the 
RAFT-synthesized polymer maintained its initial chemical characteristics. A 
possible explanation is that some of the DE-ATRP polymers became activated as 
radicals and reacted with the other vinyl groups in the polymer chains.  
 
In this chapter, the synthesis of a hyperbranched (HB) polymer to be used for the 
preparation of an antibacterial hydrogel is described. The methods and results of 
the chemical characterization of this material are also detailed in this chapter. 
Afterwards, this HB polymer was crosslinked with thiolated hyaluronic acid to form 
a hydrogel. The physical and chemical characteristics of the hydrogel were then 
determined and described in this chapter. 
 
 
2.3. Materials and methods 
 
2,2'-Azobis(isobutyronitrile) (AIBN), Tetraethylthiuram disulfide (DSDA), 
Polyethylene glycol Diacrylate, MW = 575 Da (PEGDA), Butanone, Hexane, 
Diethyl Ether, Acetone, Glucose, Glucose Oxidase enzyme (E.C. 1.1.3.4), 
Phosphate Buffer Solution pH 7.4 (PBS) were bought from Sigma Aldrich, UK. 
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Thiolated Hyaluronic acid (HA-SH, 80% degree of thiolation, 400 kDa) was 
provided by Vornia  Ltd., Ireland. 
 
Experiments were performed in Professor Wenxin Wang's Wound Healing and 
Skin Research Laboratory in Charles Institute of Dermatology, School of Medicine, 
University College Dublin, Ireland. 
 
 
2.3.1. Polyethylene diacrylate (PEGDA) 
 
 
Figure 2.5: Chemical structure of PEGDA. 
 
PEGDA has been used as a monomer to synthesize polymers for biomedical 
applications. Its acrylate functional groups allow it to polymerize with itself or other 
monomers to form a hyperbranched copolymer9–11. 
 
 
2.3.2. Thiolated hyaluronic acid (HA-SH) 
 
Figure 2.6: Chemical structure of HA-SH. 
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The synthesis protocol of HA-SH was described by Shu, et al., 200212. HA-SH is 
highly likely to form disulfide bonds with itself when exposed to oxygen, and forms 
a gel with itself if left in a solution in open air after several hours. This is due to the 
formation of disulfide bonds in oxidative environment. 
 
In this research, the limitations of handling HA-SH were taken into consideration 
when developing industrial applications for this product. 
 
 
2.3.3. Reversible addition fragmentation chain transfer (RAFT) 
polymerization of HB PEGDA 
 
HB PEGDA was synthesized via Reversible Atom Chain-Transfer Fragmentation 
(RAFT) polymerization. Briefly, in a 250 mL double-neck flask, the following 
reagents were dissolved in 160 mL butanone: 46 g PEGDA, 948.92 mg DSDA 
(chain transfer agent) and 735.66 mg AIBN (reaction initiator). The solution was 
sealed and purged with Argon, and placed into an oil bath at 70°C for 2-3 hours. 
Samples were taken hourly to be analyzed by Gel Phase Chromatography (GPC) 
analysis to monitor the molecular weight increase of the polymer and the molar 
conversion (described in the section 2.3.4. Chemical characterization of HB 
PEGDA). When the molecular weight reached 10-20 kDa, the reaction was stopped 
by removing the mixture from the heating bath and opening the flask to let oxygen 
enter to prevent polymer gelling within the flask. The polymer was purified first by 
precipitating in a 2:1 volume ratio of diethyl ether: hexane and then by dialysis. The 
dialyzed solution was then lyophilized in a freeze dryer for 4 days. 
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Figure 2.7: RAFT polymerization of PEGDA to HB PEGDA. 
 
 
2.3.4. Chemical characterization of HB PEGDA 
 
Samples for GPC analysis were prepared by dissolving 3 mg of polymer in 1 mL 
of dimethyl formamide (DMF). The samples were filtered (0.45 µm pore size) 
through a filter syringe into small amber GPC vials. The samples were analyzed in 
an Agilent 1260 Infinity GPC/SEC system (Agilent Technologies) to monitor 
molecular weight, molar conversion and polydispersity as the reaction proceeded. 
This system is equipped with a refractive index detector (RI), with two columns in 
series (30 cm PLgel mixed-C) and eluted using DMF (containing 0.1% LiBr) as 
mobile phase. 
 
For characterizing molecular structure, 1H Nuclear Magnetic Resonance (NMR) 
was used. The final polymer samples were dissolved in chloroform-D (CDCl3) and 
1H NMR analysis was carried out on a 400 MHz Varian NMR spectroscopy system. 
Data were analyzed using MesReNova 6.1 processing software. 
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According to literature, HB polymers are characterized to have abundant functional 
groups, an irregular 3D topology, low viscosity, and high solubility13.  These 
particular properties make them ideal to be used as one of the components in an in 
situ formed hydrogel system. Low viscosity and high solubility allow them to be 
dissolved easily in an aqueous solution as pre-hydrogel polymer solution. Their 3D 
topology and abundant functional groups allow ease of contact when crosslinking 
with HA-SH's thiol groups and the formation of a mechanically strong hydrogel 
structure. 
 
 
2.3.5. Preparation of HB PEGDA/HA-SH hydrogels 
 
To prepare hydrogel samples for further characterization, HB PEGDA polymer was 
dissolved in 1X 7.4 PBS buffer at concentrations from 10-20 w/w% (Table 2.1). 
HA-SH solution was prepared at concentrations of 1-4 w/w% (Table 1). To form a 
hydrogel, equal volumes of HB PEGDA and HA-SH solutions were mixed and 
pipetted into a 7.5 mm diameter cylinder mold or into a Teflon surface to form a 
bead. Total volume of this hydrogel cylinder was 200 µL (hydrogel has a height of 
approximately 5 mm). 
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Table 2.1: Composition of prepared HB PEGDA/HA-SH hydrogels.  
Hydrogel 
code 
HB PEGDA 
solution 
concentration 
- Prehydrogel 
(% wt./wt.) 
HA-SH 
solution 
concentration 
-  
Prehydrogel 
(% wt./wt.) 
Hydrogel 
relative 
HB 
PEGDA/HA-
SH amount 
(dry wt./dry 
wt.) 
Overall 
hydrogel 
composition 
(wt./wt.) 
5.0-1.0 10.0 2.0 5.0: 1.0 6.0% 
10-0.5 20.0 1.0 20.0: 1.0 10.5% 
10-1.0 20 2.0 10.0: 1.0 11.0% 
10-2.0 20 4.0 5.0: 1.0 12.0% 
 
Except for gelation time, all characterizations were performed on HB PEGDA/HA-
SH 5.0-1.0 and 10.0-1.0 
 
 
2.3.6. Gelation time 
 
The gelation time for the hydrogels was obtained using the vial-tilt method14. 
Briefly, 500 µL HB PEGDA solution was combined with 500 µL HA-SH 
solution, using the concentrations shown in Table 2.1. These vials were tilted side 
to side and observed for 5 s. The gelation was considered complete when no flow 
was observed for 5 s.  
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2.3.7. Rheological characterization of hydrogel 
 
Rheometry is used to study the flow of matter, particularly liquids and "soft solids". 
This allows the properties of hydrogels to be characterized and compared with each 
other. Gelation, in rheological terms, can be defined as the change of a substance 
from viscoelastic liquid to a viscoelastic solid15. 
 
 
2.3.7.1. Frequency Sweep and Strain Sweep Tests 
 
 
Figure 2.8: Hydrogel on rheometer plate: 20 mm parallel plate Rheometry was 
performed on a TA Discovery Hybrid Rheometer-2 (DHR-2) with 8 mm diameter parallel 
plates and TRIOS software for analysis of data. 
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With the aim of determining the rheological properties of the HB PEGDA/HA-SH 
hydrogels, detailed dynamic rheological assessments were conducted on hydrogels. 
Rheological profiles were obtained by pipetting an excess 90 µL of pre-forming HB 
PEGDA/HA-SH hydrogel (the individual components were mixed, but the solution 
was still liquid) into the rheometer plate at room temperature. The 8 mm disc plate 
was lowered until a height of 1.5 mm was achieved. Estimated volume of analyzed 
hydrogel was 75.4µL. 
 
Storage moduli (G') and loss moduli (G") were measured from sweep tests. A 
frequency sweep profile (at 10% strain) was obtained at a range of 0.1 to 100 Hz. 
Strain sweep profile (at 10 Hz) was obtained at a range of 0.1% to 100% strain. 
 
The shear elastic (or storage) modulus, G’, gives a measure of the energy that is 
stored elastically by the system per cycle when subjected to frequency oscillation15. 
It is what gives a viscoelastic material its characteristic "solidness". Meanwhile, the 
shear viscous (or loss) modulus, G”, represents a measure of the energy that is 
dissipated during flow per cycle of oscillation15. It describes how "liquid" a 
viscoelastic material is. When G' is greater than G", then a material can be describe 
as behaving more like a solid. 
 
 
2.3.8. Swelling and water uptake profile 
 
In order to determine the water absorption profile of hydrogels, 200 µL samples of 
10-1 and 5-1 HB PEGDA/HA-SH hydrogels were prepared. These were selected 
by considering the HA-SH composition constant and observing the physical 
properties of the hydrogel based on the HB PEGDA present. These samples were 
placed in pre-weighed 20 mL scintillation vials and weighed. Then 2 mL 1X 7.4 
pH PBS was added to these vials. The samples were incubated at 37°C.  
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At different time points (initially every 2 hours for the first 8 hours, then every 24 
hours for the first week and every 2 days onward) up to 6 weeks, PBS was removed 
and the bottle was weighed. After weighing, 2 mL of fresh PBS solution was added 
again and the bottle was returned to the incubator. Measurements were performed 
in quadruplicates. 
 
Water absorption was calculated based on this formula: 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑎𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑜𝑛 =
𝑊𝑡 − 𝑊0
𝑊0
∗ 100%         (𝑒𝑞. 4) 
Where Wt = weight of hydrogel at time point t in, W0 = initial weight of the hydrogel. 
 
 
2.3.9. Degradation profile of hydrogels 
 
The degradation profile was obtained from the swelling and water uptake profile 
performed in Par. 2.3.8. Degradation was considered to occur when the Percent 
absorption of the hydrogel began to decrease after reaching its highest attainable 
Percent absorption. Since the data did not give a decrease in percent absorption as 
far as Day 64 for HB PEGDA/HA-SH 10-1.0 (with the planned study intended to 
last only for 28 days), the degradation point for HB PEGDA/HA-SH 5.0-1.0 was 
taken as the time period where the samples dissolved  int the system as there was 
no graduate decrease after the maximum swelling point was obtained.  
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2.4. Results and discussion 
 
2.4.1. Chemical characterization of HB PEGDA 
 
2.4.1.1. Gel Phase Chromatography 
 
GPC analysis showed that polymer weight-average molecular weight (Mw) after 2 
hours and 40 minutes reaction was 16,656 Da, while number-average molecular 
weight (Mn) was 11,060 Da, polydispersity index was 1.5, and molar conversion 
from monomer to polymer was 32.5%. These properties were obtained from the 
Agilent GPC software by integrating the GPC curve measured on samples 
polymerized at the corresponding time (Figure 2.9). 
 
 
Figure 2.9: GPC profile of HB PEGDA at different reaction times. 
 
In other syntheses, by not fully purging the reaction flask with Argon, the reaction 
could be slowed down to 7-10 hours, in order to obtain a hyperbranched polymer 
of the same molecular weight.  
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2.4.1.2. Nuclear Magnetic Resonance 
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Figure 2.10: 1H NMR spectrum of HB PEGDA Mw 16,656 Da. 
 
1H NMR spectra (Figure 2.10) allowed the analysis of the branched structure and 
amount of pendant acrylate groups. The pendant acrylate groups were identified as 
three characteristic chemical shifts at 6.4-5.8 ppm. The PEG groups were identified 
as the chemical shift at 4.34-3.95 ppm. From these shifts, the vinyl ratio was 
calculated to be 57 mol% and the vinyl content was 0.99 mmol vinyl/g polymer. 
The higher the vinyl content, the greater were the chances for the polymer to 
crosslink faster. The DB for hyperbranched polymers has been typically ranged at 
40-60%, thus the calculated value (57%) suggested high degree of branching17. 
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2.4.2. Gelation time and rheological characterization of hydrogel 
 
2.4.2.1. Gelation time 
 
 
Figure 2.11: Gelation time of hydrogels at different time points. 
 
Gelation time is reported in Figure 2.11 as a function of hydrogel composition. 
Results showed that an increased amount of HB PEGDA from 83% (5.0:1.0) to 
95% (20.0: 1.0) caused a marked decrease in the gelation time. This result could be 
attributed to the higher availability of acrylate groups for crosslinking. However, 
gelation time further decreased in the case of the 10.0:1.0 hydrogel which showed 
a slightly lower HB PEGDA content (91%) respect to 20.0: 1.0 hydrogel (Figure 
2.10). Both hydrogels showed very close overall hydrogel concentration (Table 
2.1). Hence, this result suggests that gelation was minimized by a proper relative 
amount of HB PEGDA to HASH. 
 
The gelation time was also affected by hydrogel overall concentration (overall 
concentration was 6%, 10.5%, 11%, 12% for HB PEGDA/HASH 5.0:1.0, 20.0: 1.0, 
10.0:1.0, 10-2.0, respectively). A comparison between the first (5.0:1.0) and fourth 
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(10-2.0) compositions in Figure 2.10, having the same relative amount of polymers 
and a different hydrogel overall concentration (6% versus 12%), suggested that a 
more concentrated hydrogel favored gelation. This result was due to lower water 
content, accelerating gelation. Indeed, the lowest gelation time (42 s) was measured 
for 10-2.0 hydrogel (83% HB PEGDA, 12% overall concentration) while the 
highest gelation time (585 s) was measured for 5.0:1.0 hydrogel (83% HB PEGDA, 
12% overall concentration). Hence the gelation time decreased by 93% while 
concentration was increased by 50%. Such gelation rate was extremely fast and 
incompatible with perspective clinical application. 
 
The hydrogels synthesized in this study showed slightly lower gelation times than 
those reported in previous studies. Previous literature described the synthesis of 
hyperbranched PEG-based polymers to be crosslinked with HA-SH and, for a 
variety of concentrations, gelation times ranging from one to five minutes were 
reported 10.  
 
As a conclusion, based on the gelation time values, HB PEGDA/HASH 10.0:1.0 
was selected as an optimal hydrogel: its gelation rate was fast but compatible with 
a perspective clinical application. As a comparison HB PEGDA/HASH 5.0:1.0 
hydrogel was also further characterized. 
 
 
2.4.2.2. Results from frequency sweep and strain sweep tests 
 
The frequency sweep profiles of the HB PEGDA/HA-SH hydrogels 5.0-1.0 and 10-
1.0 at 10% oscillation strain are depicted in Figure 2.12. For a perfect solid, these 
storage and loss values are G"=0 and G'=a finite value15. For a perfect liquid, G"=a 
finite value and G'=015. As hydrogels are neither perfect solids or perfect liquids, 
their G' and G" values are higher than zero. When G">G', the sample is considered 
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more viscous than elastic (solution), when in G"<G', the sample is more elastic than 
viscous (hydrogel). From Figure 2.11, in both 5.0-1.0 and 10-1.0 compositions, the 
storage moduli were consistently higher than the loss moduli at all time points, 
meaning that the material was in hydrogel form. 
 
Storage modulus is also connected to how well-crosslinked a material is. A 
hydrogel that has more crosslinked junctions is able to store more deformation 
energy in an elastic manner. From the data, when the frequency was increased, this 
caused the hydrogel to increase its G' and G" as it stored the energy exerted on it, 
to prevent the gel from deforming. As there is little observable difference in the G' 
and G" values between 5.0-1.0 and 10-1.0, both hydrogels were similarly 
crosslinked.  
 
 
 
Figure 2.12: Frequency sweep profile of HB PEGDA/HA-SH  
hydrogels (at 10% oscillation strain). 
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In Figure 2.13, the strain sweep profiles of the HB PEGDA/HA-SH hydrogels are 
shown, under a constant frequency of 10 Hz. As with Figure 2.11, the storage 
moduli were consistently higher than the loss moduli for both polymer 
compositions. However, in this profile, when the rotational strain on the hydrogel 
was increased, the G" decreased slightly, while the G' slightly increased, with the 
storage and loss moduli points gradually diverging from each other. This means 
that in higher strains, the hydrogels behaved more like a solid material.  
 
 
Figure 2.13: Strain sweep profiles of HB PEGDA/HA-SH hydrogels (at 10 Hz 
frequency). 
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2.4.3. Physical characterization of hydrogel 
 
The selected hydrogel compositions were used to form hydrogel beads, by pipetting 
30µL of HB PEGDA/HA-SH pre-crosslinked solution onto a hydrophobic Teflon 
surface. The average diameter of these beads was 4 mm (see Figure 2.14 a). Such 
hydrogels could also be poured into moulds to produce cylindrical hydrogels (see 
Figure 2.14 b). 
 
When producing these hydrogels, the operator should be fast as to avoid time 
hydrogel crosslinking within the pipette. 
 
 
Figure 2.14: Hydrogel samples fabricated for characterization, a) 30 µL beads 
with 4 mm diameter, b) 200 µL beads with 7.5 mm diameter and 5 mm height. 
 
 
2.4.3.1. Swelling and water uptake profile 
 
Figure 2.15 shows water adsorption percentage as a function of time. The hydrogels 
displayed the trend to adsorb water as time progressed. In the first two weeks, 
adsorbed water was less than 10% of hydrogel initial mass, but as the entangled 
polymers in the hydrogel began to uncoil, more water was taken in progressively.  
 
HB PEGDA/HA-SH 5.0-1.0, which contained a lower overall polymer amount 
(overall concentration 6%) and a different HB PEGDA/HASH dry weight ratio 
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(83/17) respect to HB PEGDA/HA-SH 10-1.0 (overall concentration: 11%; HB 
PEGDA/HASH dry weight ratio of 91/9) was completely dissolved after 28 days. 
HB PEGDA/HA-SH 5.0-1.0 hydrogel was able to take water up to a maximum of 
57% of its weight in 27 days while HB PEGDA/HA-SH 10-1.0 hydrogel was able 
to absorb up to 131% of its weight in 64 days.  
 
HB PEGDA/HA-SH 10-1.0 hydrogel was resistant in a water environment for at 
least 64 days: such hydrogel contained a higher overall polymer quantity than the 
HB PEGDA/HA-SH 5.0-1.0 hydrogel and it was probably better crosslinked thanks 
to an optimal HB PEGDA/HA-SH ratio. 
 
 
Figure 2.15: Water adsorption profile of hydrogels. 
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2.4.3.2. Degradation profile 
 
The degradation studies in most hydrogels often do not take more than 3 weeks9,18. 
As observed for HB PEGDA/HA-SH 5.0-1.0, degradation did not start until day 28, 
then "burst" after day 28. For this hydrogel, it continued to swell and take in water 
despite its more altered shape. In its final stages, it appeared as a semi-solid flat gel 
until it was finally indistinguishable from the PBS medium where it was soaked in. 
Figure 2.16 illustrates the progression. 
 
 
Figure 2.16: Top illustration: Representation of the HB PEGDA/HA-SH hydrogel 
degradation. Bottom photographs: Progression of HB PEGDA/HA-SH 5.0-1.0 adsorbing 
water and degrading (left to right: day 4, 14, 20, 22). 
 
 
For HB PEGDA/HA-SH 10-1.0, there was some alteration in its shape but it 
continued to hold an overall cylindrical structure on day 64, as seen in Figure 2.17. 
 
 
Figure 2.17: Representative images of HB PEGDA/HA-SH 10-1.0 hydrogel at day 64 
during water adsorption test. 
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As a conclusion, the hydrogels demonstrated their slow degradation which is 
fundamental for in vivo applications. Particularly, HB PEGDA/HA-SH 10-1.0 
hydrogel also showed shape retention, which is an important ability for its future 
perspective applications in wound healing.  
 
 
2.5. Conclusions 
 
In this chapter, HB PEGDA was synthesized and chemically characterized. This 
polymer had a vinyl content of 0.99 mmol/gram polymer, molecular weight of 
16,656 Da, and a polydispersity of 1.5. Using this polymer, HB PEGDA/HA-SH 
hydrogels were formed via thiol-ene click chemistry. The gelation time of the 
material ranged from 42 to 585 seconds, depending on the HB PEGDA and HA-
SH relative amount and hydrogel overall concentration. The HB PEGDA/HA-SH 
10.0/1.0 hydrogel composition (91 wt.% HB PEGDA; 11 wt./v. % hydrogel overall 
concentration) was selected as it showed a relatively fast gelation time at 63 s, 
which was compatible with a possible future in vivo application. Additionally, water 
adsorption test showed that HB PEGDA/HA-SH 10.0/1.0 hydrogel retained its 
shape after 64 days incubation, with no signs of degradation and a progressive 
swelling up to 131% after 64 days. Rheological analyses indicated that 
PEGDA/HA-SH 10.0/1.0 was a weak hydrogel with G’ in the 5-10 kPa range at 10 
Hz frequency and within 0-100% strain (strain sweep tests). Hence it was suitable for 
applications in the regeneration of soft tissues such as skin.  
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Chapter 3  Antibacterial 
Reactive Oxygen Species 
Production in HB PEGDA/HA-SH 
Hydrogel 
  
3.1. Abstract 
 
HB PEGDA/HA-SH 10-1.0 and HB PEGDA/HA-SH 5.0-1.0 hydrogels were used 
to encapsulate glucose oxidase (GO) enzyme and glucose to produce an 
antibacterial injectable hydrogel for wound dressing. Varying amounts of GO (0-
2000 U/L) were dissolved in HB PEGDA solutions (20 w/w% and 10 w/w%). 
Glucose (1-20 w/w%) was dissolved in 2 w/w% HA-SH solution. In 24 hours, 250 
U/L GO and 2.5 w/w% glucose in the HB PEGDA/HA-SH 10-1.0 hydrogel 
produced 16.02±4.16 mM H2O2 in shaken conditions and 9.11±0.92 mM H2O2 in 
static conditions. This hydrogel also demonstrated cytocompatibility with NIH/3T3 
mouse fibroblast cells after 24 hours. Hydrogen peroxide continuously produced by 
the HB PEGDA/HA-SH 10-1.0 (w/w%) hydrogel loaded with 250 U/L glucose 
oxidase and 2.5 w/w% glucose demonstrated antibacterial activity against several 
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strains of bacteria, primarily Gram-positive bacteria (S. aureus, A. baumannii, S. 
epidermidis, and A. baumannii) and antibiotic-resistant Gram-positive bacteria 
(MRSA, MRSE). On the other hand, hydrogel  antibacterial activity on Gram-
negative bacteria (E. coli and P. aeurignosa) and antibiotic-resistant P. Aeruginosa 
was less relevant with reduced inhibition zones in the agar diffusion test. When the 
glucose oxidase concentration in the hydrogel was increased from 250 U/L to 500 
U/L, the material demonstrated antibacterial activity on antibiotic resistant E. coli. 
Thus, these hydrogels have the potential to be used as in situ forming antibacterial 
wound dressings. 
 
The main experiments were performed in Professor Wenxin Wang's Wound 
Healing and Skin Research Laboratory in Charles Institute of Dermatology, School 
of Medicine, University College Dublin, Ireland. Antibacterial agar diffusion tests 
were performed by the PhD candidate Ayesha Idrees (Politecnico di Torino) during 
her secondment period at Universtätsklinikum Knappschaftskrankenhaus Bochum 
– Department of Experimental Surgery/ Clinic of Surgery under Dr. Jochen Salber’s 
supervision, as a part of the EU Horizon 2020 “HyMedPoly” project. 
 
 
3.2. Introduction 
 
Enzymes are complex proteins obtained from living organisms that are capable of 
catalyzing a number of reactions1. Their functions are often defined in their name. 
The six classes of enzymes are: 
 
• Hydrolases 
• Oxidoreductases 
• Transferases 
• Lyases 
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• Isomerases 
• Ligases 
 
Oxidoreductates, such as glucose oxidase work by catalyzing the transfer of 
electrons from the reducing agent or electron donor, to the oxidizing agent or 
electron acceptor1. In the reaction previously described in Chapter 1, Figure 1.5, 
GO works to specifically oxidize glucose in order to produce the antibacterial 
reactive oxygen species, H2O2. The specific selectivity of this enzyme for glucose 
eliminates oxidation of other substrates. 
 
The enzyme unit (U) is a unit for the amount of a particular enzyme and its value is 
typically given in the product specifications of a purchased enzyme instead of 
mass2. One U is defined as the amount of the enzyme that produces a certain amount 
of enzymatic activity, and for this study, one unit is the amount that catalyzes the 
conversion of 1 micro mole of glucose substrate into 1 micro mole H2O2 per 
minute2. 
 
As previously mentioned, it was found that 10 mM H2O2 can enhance angiogenesis 
in wound healing, while 166 mM can retard wound closure3. In this chapter, the 
concentration of enzyme and glucose within the hydrogel required to produce 10-
20 mM H2O2/day was determined. 
 
 
3.2.1. Common bacterial species found in wound sites 
 
The presence of bacteria in wounds may cause complications and slow the healing 
process. In a retrospective study performed on 213 patients by Bessa, et al., 2013, 
Staphylococcus aureus was found to be the most common bacterial specie in 
different types of wounds (37%), followed by Pseudomonas aeruginosa (17%), 
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Proteus mirabilis (10%), Escherichia coli (6%) and Corynebacterium spp. (5%)4. 
Early chronic wounds contain mostly Gram-positive organisms while wounds that 
have not healed for several months that have a deep structure involvement which 
contain anaerobic and Gram-negative micro-organisms5. 
 
 
3.2.2. Bactericidal effects of ROS 
 
One of the objectives of this research was to synthesize a drug-free antibacterial 
material. As previously discussed in Chapter 1, honey contains enzymes which 
catalyze the formation of ROS from glucose and oxygen, that have the potential to 
prevent or inhibit bacterial infections. However, the antibacterial effect of ROS 
might come at the cost of cell cytotoxicity when ROS concentration exceeds a 
maximum value. Thus, by encapsulating glucose oxidase enzyme and glucose 
within a hydrogel, the rate of formation and release of hydrogen peroxide can be 
controlled at some extent. In this work, testing HB PEGDA/HA-SH hydrogel on 
several bacterial strains, some of which antibiotic-resistant, was aimed at observing 
its activity and measure zones of inhibition in relation to the GO enzyme 
concentration. 
 
 
3.3. Materials and methods 
 
Hyperbranched poly(ethylene gycole diacrylate) (HB PEGDA) was synthesized as 
discussed in Chapter 2.  
 
Glucose, Titanium oxysulfate (TiOSO4), Sulfuric acid (H2SO4), Glucose oxidase 
enzyme (E.C. 1.1.3.4), Phosphate buffer solution tablets (PBS 7.4), Hank's buffer 
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solution, High-Glucose Dubelcco's Modified Eagle Medium (DMEM), Fetal 
Bovine Serum (FBS), Resazurin sodium salt, Penicillin-Streptomycin (PS) were 
provided by Sigma Aldrich, UK. Thiolated Hyaluronic acid (HA-SH, 80% degree 
of thiolation, 400 kDa) was provided by Vornia Ltd., Ireland. NIH/3T3 mouse 
fibroblast cells (ATCC® CRL-1658™) were obtained from ATCC, UK. 
 
Experiments on ROS characterization and cytocompatibility testing in NIH/3T3 
mouse fibroblast cells were performed in Professor Wenxin Wang's Wound Healing 
and Skin Research Laboratory in Charles Institute of Dermatology, School of 
Medicine, University College Dublin, Ireland. Antibacterial agar diffusion tests 
(described in the next paragraph) were performed by the PhD candidate Ayesha 
Idrees (Politecnico di Torino) during her secondment period at Universtätsklinikum 
Knappschaftskrankenhaus Bochum – Department of Experimental Surgery/ Clinic 
of Surgery under Dr. Jochen Salber’s supervision, as a part of the EU Horizon 2020 
“HyMedPoly” project. A. Idrees also performed cell tests on hydrogels prepared by 
J.M. Vasquez, which are discussed in A.Idrees’s  accepted PhD thesis. 
 
 
3.3.1. Glucose oxidase 
 
Glucose oxidase is a protein dimer with the molecular weight of 160 kDa6. The 
active site where the glucose binds is located in a deep pocket. The ideal pH for 
glucose oxidation is 5.5 but it can be performed over a pH range of 4-7. The activity 
of this enzyme is quantified in terms of units. The commercially available enzyme 
that we utilized in these studies has an activity of 19,290 U/g. This value was used 
to stoichiometrically calculate the amount required to prepare a stock GO solution 
of 10,000 U/L in PBS at pH 7.4. 
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3.3.2. Preparation of HB PEGDA/HA-SH hydrogel with glucose 
oxidase/glucose for the formation of ROS 
 
Enzyme solutions listed in Table 3.1 grouped as Solution A were prepared from the 
10,000 U/L stock solution by dilution with PBS at pH 7.4 until the desired 
concentration was obtained. A volume of Solution A was mixed with an equal 
volume of 40 w/w% HB PEGDA solution to obtain Solution B. For comparison on 
the ROS produced between two different polymer compositions in the hydrogel 
with an identical enzyme concentration, 1000 U/L solution A was mixed with 20 
w/w% HB PEGDA and 10 w/w% HB PEGDA; the end product was a hydrogel 
with 250 U/L in HB PEGDA/HA-SH 10-1.0 and HB PEGDA/HA-SH 5.0-1.0. 
 
Table 3.1. Enzyme concentrations prepared for ROS formation in hydrogel. 
Enzyme 
solution in 
PBS 7.4 (U/L) 
(Solution A) 
Concentration 
in HB 
PEGDA (U/L) 
(Solution B) 
Enzyme 
Concentration 
in hydrogel 
(U/L) 
Enzyme 
Concentration 
Code in graphs 
0 0 0 0 
100 50 25 25 U/L 
200 100 50 50 U/L 
500 250 125 125 U/L 
1000 500 250 250 U/L 
2000 1000 500 500 U/L 
 
 
Glucose solutions, grouped under Solution C and listed in Table 3.2, were prepared 
by dissolving glucose in PBS at pH 7.4. A volume of Solution C was mixed with 
an equal volume of 4 w/w% HA-SH in order to obtain Solution D. 
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Table 3.2 Glucose concentrations prepared for ROS formation in hydrogel. 
Glucose solution 
prepared (w/w%) 
(Solution C) 
Concentration in 
HA-SH (w/w%) 
(Solution D) 
Concentration in 
hydrogel (w/w%) 
Code in 
graphs 
20 10 5 5.0% 
10 5 2.5 2.5% 
1 0.5 0.25 0.25% 
0 0 0 0 
 
Solution B was mixed with an equal volume of Solution D. After several seconds 
for proper dispersion, the mixture solution was pipetted into beads or cylindrical 
molds as described in Chapter 2. Using the HB PEGDA/HA-SH hydrogel 10.0/1.0 
containing 250 U GO, and 2.5 w/w% glucose, Figure 3.1 illustrates the preparation 
of solutions B and D before they are combined together to form a hydrogel. 
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1000 U/L GO in 
PBS 7.4
40 w/w% HB 
PEGDA
10 w/w% glucose
4 w/w% HA-SH
500 U/L GO
20 w/w% HB 
PEGDA
5 w/w% glucose
2 w/w% HA-SH
250 U/L GO
2.5 w/w% glucose
10 w/w% HB PEGDA
1 w/w% HA-SH
Solution B
Solution D  
Figure 3.1: Preparation of HB PEGDA/HA-SH hydrogel containing GO and 
glucose. 
 
The moment the hydrogel is formed as a crosslinked semi-rigid gel is considered as 
the initial time point (t = 0) in time-related characterizations such as the 
concentration of ROS produced at a particular time point. 
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3.3.3. Pertitanic acid assay for the analysis of hydrogen peroxide 
formation and release 
 
Once the GO and glucose have been combined, it is assumed that they begin to 
produce H2O2. The production of hydrogen peroxide was quantified by colorimetric 
pertitanic assay7. The assay solution was prepared by dissolving 25 grams of TiSO4 
in 1 L of 2M sulfuric acid (H2SO4) solution. The reaction that occurs with H2O2 is: 
 
𝑇𝑖4+ + 𝐻2𝑂2 +  2𝐻2𝑂 → 𝐻2𝑇𝑖𝑂4(𝑝𝑒𝑟𝑡𝑖𝑡𝑎𝑛𝑖𝑐 𝑎𝑐𝑖𝑑, 𝑦𝑒𝑙𝑙𝑜𝑤) + 4𝐻
+ 
 
The amount of pertitanic acid can be used to identify the amount of H2O2 formed 
by measuring solution absorbance intensity at the wavelength of 407 nm. For 
obtaining the standard curve,100 µL of solutions with 0-20 mM H2O2 were pipetted 
into a 96-well plate as shown in Figure 3.2. Then, 50 µL of the prepared assay 
solution (ROS assay solution) was added into each well containing a sample. The 
plate was shaken in the the plate reader for 15 s before the absorbance was read in 
a SpectraMax M3 Multi-Mode Microplate Reader (Molecular Devices), with Soft-
Max Pro Software used to obtain and analyze the data. 
 
 
Figure 3.2: Standard solutions of H2O2 with ROS assay solution. 
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The equation to obtain the H2O2 concentration (mM) can be derived from the 
standard curve shown in Figure 3.3. 
 
𝐻2𝑂2  =  
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 −  0.0724
0.1777
          (𝑒𝑞. 5) 
 
 
Figure 3.3: Calibration curve of H2O2 by the pertitanic acid assay. 
 
To measure the H2O2 produced by a hydrogel at a given time point, 200 µL of 
hydrogel was placed in a scintillation vial. Afterwards, 9800 µL PBS pH 7.4 was 
added as the medium for H2O2 diffusion. These vials were placed in an incubator at 
37°C to simulate body temperature. 100 µL of this solution was transferred to a 96-
well plate. The absorbance was then measured at 407 nm after adding 50 µL ROS 
assay solution and shaking the plate to allow the reaction to occur. This diluted 
concentration was then used to calculate the actual concentration of H2O2 produced 
and released from the hydrogel. Each measurement was done in 4 replicates. 
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3.3.4. Alamar Blue cytocompatibility tests 
 
Before the hydrogel samples were prepared for this test, the polymer solutions B 
and D were sterilized by passing the solutions through a 0.25 μm syringe filter. All 
preparation steps were performed inside a fume hood and UV-sterilized apparatus 
was used. 
Hydrogel samples were prepared by pipetting 30 µL of the pre-crosslinked hydrogel 
solution on a hydrophobic Teflon surface. The hydrophobic material creates a 
surface tension with the solution, hence the hydrogel forms a semi-spherical bead 
as previously shown in Figure 2.13. 
Hydrogels were tested for cytocompatibility using a non-contact method by placing 
them in a transwell insert in a 24-well plate as illustrated in Figure 3.4. In this 
cytocompatibility assay, the viability of the cells was tested while H2O2 was 
continuously produced and released into the cell medium.  
 
 
Figure 3.4: Illustration of HB PEGDA/HA-SH hydrogel in a 24-well plate in 
DMEM medium with NIH/3T3 cells on well surface. Diameter of hydrogel, 
transwell insert, and individual well are in scale relative to each other. 
 
Cytotoxicity of the HB PEGDA/HA-SH hydrogel was evaluated using NIH/3T3 
mouse fibroblast cells (ATCC® CRL-1658™). Briefly, cell suspension containing 
30,000 cells/mL was cultured in full cell medium (High-Glucose Dulbecco's 
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Modified Eagle Mixture, containing 10 v/v% Fetal Bovine Serum, and 1 v/v% 
Penicillin-Streptomycin) in a 24-well plate. Then, 1 mL of the prepared full cell 
medium was added to each well and incubated at 37°C overnight. 
 
The day after the cells were incubated, the wells were washed with sterile Hanks 
Buffer Solution. Afterwards, 1 mL of fresh full cell culture medium was added to 
each well and transwell inserts containing hydrogel samples were placed. Positive 
control (PC) for this experiment was a set of wells that did not contain any hydrogel 
or transwell insert. Each setup was done in 4 replicates. 
 
The plate was incubated for 24 hours at 37°C, after which the Alamar Blue assay 
was performed. The transwell inserts were removed and the cells were washed once 
again. Then 1 mL of Alamar Blue solution was added to each well, and the plate 
was returned to incubate for 6 hours at 37°C. Alamar Blue solution was prepared 
by dissolving 3 mL of resazurin blue in 27 mL Hanks Buffer Solution to obtain a 
10 v/v% Alamar Blue solution. 
  
The absorbance and fluorescence were then measured using the SpectraMax M3 
Multi-Mode Microplate Reader (Molecular Devices) with the preset method 
Alamar Blue (AB) protocol to quantify the value of each well. This value was 
obtained from taking the fluorescence measurements at 530-560 nm and the 
absorbance measurements at 570 nm and 600 nm which the protocol processed and 
simplified into a single final reading.  The percent cell viability was calculated as: 
 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%)
=  
𝑅𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝑆𝑎𝑚𝑝𝑙𝑒 𝑊𝑒𝑙𝑙 −  𝑅𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝐴𝑙𝑎𝑚𝑎𝑟 𝐵𝑙𝑢𝑒
𝑅𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝑁𝑜 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑊𝑒𝑙𝑙 − 𝑅𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝐴𝑙𝑎𝑚𝑎𝑟 𝐵𝑙𝑢𝑒
∗ 100%   (𝑒𝑞. 6) 
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3.3.5. Agar diffusion test 
 
In testing for the antibacterial activity of the honey-mimetic hydrogels, the agar 
diffusion test method was used. According to the protocol, a suspension of the 
bacteria (1–2 × 108 CFU/mL) was prepared to a  McFarland 0.5, then spread evenly 
onto an appropriate agar (such as Müller-Hinton agar) in a Petri dish. The agar 
typically contains (w/v%): 30.0% beef infusion, 1.75% casein hydrolysate, 0.15% 
starch, 1.7% agar with the pH adjusted to neutral at 25 °C8. Thermo Scientific Oxoid 
wafer discs are loaded with antibiotic solution (Oxacillin for Gram-positive bacteria 
and Gentamicin for Gram-negative bacteria) and placed onto the surface of the agar. 
For this set of experiments, the HB PEGDA/HA-SH 10-1.0 (w/w%) hydrogel half-
spherical beads loaded with 0-500 U/L GO enzyme and 2.5 w/w% glucose were 
placed on agar surface. After 24 hours of incubation at  37°C, zones of growth 
inhibition around each of the hydrogel beads were measured to the nearest 
millimeter. Data was presented as images of these petri dish samples and compiled 
into a graph of inhibition zone diameter versus glucose oxidase concentration in 
hydrogel. Samples were done in duplicates. 
 
Bacterial strains used were: Staphylococcus aureus (ATCC 29213 of wound 
source), Staphylococcus epidermidis (ATCC 12228), Escherichia coli (ATCC 
25922), Pseudomonas aeruginosa (ATCC 27853), A. baumanii. Antibiotic-resistant 
strains used were: Methicillin-resistant Staphylococcus aureus (MRSA), 
Methicillin-resistant Staphylococcus epidermidis (MRSE), VIM-2 producing drug 
resistant Pseudomonas aeruginosa, and KPC-2 producing drug resistant 
Escherichia coli. 
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3.4. Results and discussion 
 
3.4.1. H2O2 production in HB PEGDA/HA-SH 
 
Effect of enzyme concentration on ROS production 
 
Figure 3.5 shows the H2O2 concentrations with a varying amount of glucose oxidase 
enzyme (at constant 2.5 w/w% glucose concentration) produced within a span of 
24 hours in HB PEGDA/HASH 10.0-1.0 hydrogel. This set-up was performed in 
static conditions. 
 
ROS production increased as a function of enzyme concentration from 25 to 250 
U/L, while keeping constant the glucose concentration at 2.5 w/w%. However, 
statistical analysis showed that there was no significant increase in ROS production 
between 250 U/L and 500 U/L enzyme concentration with production of 9.11±0.92 
and 8.21±0.47 mM H2O2, respectively. Since the objective was to have a hydrogel 
producing 10-20 mM H2O2/day, GO concentrations of 250 U/L and 500 U/L were 
selected. Statistical analysis (p = 0.06) showed that the hydrogen peroxide 
concentrations between 250 U/L and 500 U/L were not significantly different. 
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Figure 3.5: H2O2 concentration after 24 hours from HB PEGDA/HASH 10.0/1.0 
hydrogels containing varying amounts of enzyme and 2.5 w/w% glucose. Release was 
obtained in static conditions. 
 Hydrogel composition: 10 w/w% HB PEGDA/1 w/w% HA-SH. 
 
Effect of mixing and glucose concentration on H2O2 production 
 
Figure 3.6 shows H2O2 production from hydrogels with two enzyme concentrations 
(250 and 500 U/L) and two glucose concentrations (2.5 and 5.0 w/w %). In this 
experiment, slightly higher concentrations of hydrogen peroxide were obtained by 
putting the samples in an incubator shaker operating at 15 rpm instead of using a 
stationary incubator. Agitation improved the efficiency of the GO and glucose to 
form hydrogen peroxide. An independent-sample t-test was conducted to compare 
ROS production with or without shaking (using the measurements with parameters 
held constant: 250 U/L GO, 2.5 w/w% glucose in HB PEGDA/HA-SH 10-1.0). 
There was a significant difference in the ROS concentrations using the non-shaking 
method (9.07±0.67 mM H2O2) and with shaking method (16.02±4.16 mM H2O2) 
conditions (p < 0.01). These results suggest that incubating the samples in an 
incubator shaker produces a higher H2O2 production than incubating the samples 
without any agitation, as expected. The subsequent experiments were conducted in 
an incubator shaker. 
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In determining the effect of glucose concentration on the ROS production, an 
independent-sample t-test was conducted to compare 2.5 w/w% glucose versus 5.0 
w/w% glucose with 250 U/L GO at 24 hours in HB PEGDA/HA-SH 10-1.0. There 
was no significant difference in the 2.5 w/w% glucose (16.02±4.16 mM H2O2) and 
5.0 w/w% glucose (19.53±3.36 mM H2O2) conditions (p = 0.18). This was due to 
glucose oxidase being the limiting agent, producing hydrogen peroxide at a rate 
depending on its enzyme activity. Thus, using 250 U/L GO, optimal glucose 
concentration was 2.5 w/w% after 24 h. 
 
Similar results are obtained for the three other settings, when time and enzyme 
concentration were held constant: no significant difference in ROS concentration 
when the glucose concentration was increased from 2.5 w/w% to 5.0%. Hence for 
each time and enzyme concentration, optimal glucose concentration was 2.5 w/w%. 
 
 
Figure 3.6: H2O2 production from HB PEGDA/HASH 10.0/1.0 hydrogel with 250 U/L 
and 500 U/L GO and 2.5 w/w% and 5.0 w/w% glucose concentrations. Measurements 
were obtained at t = 24 hours and t = 48 hours. Release was obtained in an incubator 
shaker operating at 15 rpm.  
Hydrogel composition: 10 w/w% HB PEGDA/1 w/w% HA-SH. 
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H2O2 Formation Profile at Varying Hydrogel Compositions 
 
Figure 3.7 shows H2O2 concentration produced from hydrogels with different 
polymer compositions (HB PEGDA/HASH 10.0/1.0 and 5.0/1.0) and as a function 
of time. The concentration of H2O2 was found to increase with time. In the case of 
HB PEGDA/HASH 5.0/1.0, this concentration reached a peak at 24 hours, as glucose 
progressively reduced during the reaction and/or diffused out of the hydrogel 
network. 
 
The hydrogels based on 5 w/w% HB PEGDA produced more hydrogen peroxide 
consistently at different time points except at 48 hours. However, the independent-
samples t-test that compared H2O2 production in HB PEGDA/HA-SH 10-1.0 and 
HB PEGDA/HA-SH 5.0-1.0 (at 24 hours, 250 U/L GO, and 2.5 w/w% glucose 
parameters held constant) showed that this difference was not statistically 
significant (p = 0.18). This suggested that hydrogel composition did not 
significantly affect ROS production, therefore it would be preferable to use HB 
PEGDA/HA-SH 10-1.0 as it has other interesting properties for wound healing 
applications, such as shape retention, water stability for longer and quick 
crosslinking, respect to HB PEGDA/HA-SH 5.0-1 hydrogel. 
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Figure 3.7: H2O2 concentration produced by HB PEGDA/HASH 10.0/1.0 and 5.0/1.0 
hydrogels containing 250 U/L GO, 2.5 w/w% glucose at different time points. Release 
was obtained in an incubator shaker operating at 15 rpm.  
 
A drop in H2O2 production 24 hours to 48 hours was observed from for HB 
PEGDA/HASH 5.0/1.0 hydrogel. Statistical results showed that this decrease was 
significant. This could be due to a release of glucose from the less concentrated 
hydrogel into the medium or to the saturation of the solution with H2O2 and its 
incubation at 37°C for an extended period of time causing H2O2 to decompose into 
water and oxygen (hydrogen peroxide decomposition requires two H2O2 molecules 
to decompose in the balanced equation: 2H2O2 → 2H2O + O2). HB PEGDA/HA-
SH 10-1.0 showed a superior concentration, therefore both glucose and H2O2 were 
probably slowed down. 
 
 
3.4.2. Alamar Blue cytocompatibility tests 
 
Figure 3.8 and 3.9 show the results of the cytocompatibility of NIH/3T3 mouse 
fibroblasts when indirectly incubated for 24 hours with HB PEGDA/HA-SH 10-1.0 
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loaded with 0-20 mM H2O2 (Figure 3.8) and GO enzyme/glucose (Figure 3.9) for 
24 hours. The hydrogels were placed in transwell inserts with the produced H2O2 
diffusing into the cell culture media. PC represents the positive control, the set of 
wells with no treatment and used as a reference for calculating the cell viability. In 
Figure 3.8 and 3.9, NIH/3T3 mouse fibroblast cells grown in tissue culture plates 
served as the positive control. In Figure 3.8, the samples (except the positive 
control) were hydrogels loaded with different concentrations of hydrogen peroxide 
to initially test their cytocompatibility in concentrations similar to those produced 
by the GO/glucose loaded hydrogels from Figures 3.5 to 3.7. Non-contact 
cytocompatibility analysis showed that the cell viability for these hydrogels were 
higher than 100% which means that hydrogels with 0-20 mM H2O2 were 
cytocompatible with NIH/3T3 cells. 
 
 
Figure 3.8 : Cell viability of NIH/3T3 cells with HB PEGDA/HA-SH 
10.0/1.0 hydrogels loaded with different concentrations of H2O2 after 24 
hours after 24 hours in a static release (non-shaken method) set-up. 
 
Non-contact cytocompatibility data in Figure 3.9 included different conditions. 
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Some of these conditions (2.5 U/L GO-0.25% glucose; 2.5 U/L GO-2.5% glucose; 
25 U/L GO-0.25% glucose; 25 U/L-2.5% glucose) did not reach the target H2O2 
concentration range of 10-20 mM/day, however they were also included in the 
cytocompatibility analysis.  
 
Figure 3.9 shows positive cell viability in all GO/glucose concentrations except for 
500 U/L-2.5% and 1000 U/L-2.5% (cell viability less than 80%).  
 
 
Figure 3.9: Cell viability of NIH/3T3 cells with HB PEGDA/HA-SH 10.0/1.0 
hydrogels loaded with varying GO/glucose concentrations after 24 hours in a 
static release (non-shaken method) set-up. 
 
Results showed that with 20 mM H2O2 production (Figure 3.8), a cytocompatibility 
of 123% with respect to the positive control was measured. However, in Figure 3.9, 
cell viability analysis for hydrogels with 500 U/L GO -2.5% glucose (expected to 
produce 8.21±0.47 mM H2O2 in 24 hours) showed their significantly lower 
cytocompatibility of 19%. This lower cytocompatibility could be attributed to the 
differences in the rate of released H2O2 between the systems, i.e. it is likely the 
majority of the H2O2 in the hydrogels of Fig. 3.8 was released in the first hours, 
decomposing into water and oxygen after 24 h.  
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GO-glucose amounts of 1000 U/L-2.5% (Fig. 3.9) were added to confirm the low 
cytocompatibility with high GO concentration. Thus, the highest tested 
cytocompatible concentration was 250 U/L glucose oxidase with 2.5 w/w% glucose 
for NIH/3T3 mouse fibroblast cells. 
 
 
3.4.3. Antibacterial testing results 
 
Disc diffusion results are shown in Figures 3.10 to 3.12 and sorted according to 
tested bacterial type: Gram-positive (Fig. 3.10) and Gram-negative bacteria 
(Fig.311. and Fig. 3.12). The overall trend was that increasing the GO enzyme 
concentration increased the measured zone of inhibition. Also, it can be observed 
that the hydrogels produced greater zones of inhibition in the Gram-positive group 
than in the negative group. This is likely due to the Gram-positive bacteria’s lack 
of an outer cell membrane which made them more vulnerable to the oxidative 
damage ROS like H2O2 produced. Even antibiotic resistant Gram-positive bacteria 
displayed zones of inhibition as seen in Figure 3.10. 
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Figure 3.10: Results of antibacterial agar diffusion tests on Gram-positive bacteria 
with HB PEGDA/HA-SH hydrogel 10-1.0 with fixed 2.5 w/w% glucose and 
varying GO concentrations labelled from 25-500 U/L (Data obtained from Ayesha 
Idrees). 
 
From Figures 3.11 and 3.12, the zones of inhibition of the Gram-negative bacteria 
appeared more reduced and were present only in concentrations 250 U/L and 500 
U/L. To obtain a proper assessment of the zones of inhibition, they were measured 
using ImageJ software and are presented in Figures 3.13 and 3.14 
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Figure 3.11: Part 1 of results of antibacterial agar diffusion tests on Gram-negative 
bacteria with HB PEGDA/HA-SH hydrogel 10-1.0 with fixed 2.5 w/w% glucose 
and varying GO concentrations labelled from 25-500 U/L (Data obtained from 
Ayesha Idrees). 
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Figure 3.12: Part 2 of results of antibacterial agar diffusion tests on Gram-negative 
bacteria (A. baumannii) with HB PEGDA/HA-SH hydrogel 10-1.0 with fixed 2.5 
w/w% glucose and varying GO concentrations labelled from 25-500 U/L (Data 
obtained from Ayesha Idrees). 
 
From Figures 3.13 and 3.14, the zones of inhibition were measured and grouped 
according to the GO concentrations used and type of bacteria. Figure 3.13 shows 
the zone of inhibition values of Gram-positive bacteria and Figure 3.14 shows the 
zone of inhibition values of Gram-negative data. 
 
 Figure 3.13 shows that at a concentration as low as 25-50 U/L, zones of inhibition 
could be measured for MRSA and MRSE. It is possible that the altered structure of 
MRSA and MRSE made them mode vulnerable to hydrogen peroxide than their S. 
aureus and S. epidermidis counterparts. As the concentration is increased to 125 
U/L, zones of inhibition were observed in S. aureus, S. epidermidis.  
In 125 U/L the zones of inhibition for MRSA and MRSE were increased, meaning 
that increasing the GO concentration increases the antibacterial activity within the 
same bacterial strain. While inhibition zones were observed much earlier for the 
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antibiotic-resistant bacteria, their normal strains displayed larger zones of inhibition 
in later concentrations 
 
 
 
Figure 3.13: Measured zones of inhibition of the HB PEGDA/HA-SH 10-1.0 (with 
2.5 w/w% glucose) containing different GO concentrations for Gram-positive 
bacteria (Data obtained from Ayesha Idrees). 
 
 
In Figure 3.14, no zones of inhibition were observed for 25 U/L and 50 U/L glucose 
oxidase, which meant that they had no antibacterial activity for the Gram-negative 
bacteria at these particular GO concentrations. As the concentration is increased to 
125 U/L, zones of inhibition were observed in P. aeruginosa, and VIM-2 producing 
drug-resistant P. aeruginosa. Further increasing the concentration to 250 U/L, E. 
coli and A. baumannii displayed zones of inhibition, thus this concentration showed 
antibacterial activity already in 8 out of the 9 bacterial species used.  
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Figure 3.14: Measured zones of inhibition of the HB PEGDA/HA-SH 10-1.0 (with 
2.5 w/w% glucose) containing different GO concentrations for Gram-negative 
bacteria (Data obtained from Ayesha Idrees). 
 
The highest GO concentration at which NIH/3T3 mouse fibroblasts showed 
positive cell viability was 250 U/L. The 500 U/L GO enzyme concentration did not 
have a positive cell viability with NIH/3T3 mouse fibroblasts (see Par. 3.4.2) but 
was nonetheless tested for antibacterial activity. Results showed that at this 
concentration, inhibition zones were observed in KPC-2 drug resistant E. coli.. 
However, the use of a concentration of 500 U/L GO to produce H2O2 could be 
applied only for applications where bacteria can be primarily attacked, e.g. as a first 
treatment of highly infected wounds. Alternatively, in the future efforts should be 
spent to the development of novel tailored delivery systems able to deliver ROS 
only to bacteria and not to cells. 
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3.5. Conclusions 
 
Glucose oxidase and glucose produced ROS in the form of hydrogen peroxide 
within an in situ HB PEGDA/HA-SH (10-1.0 and 5.0-1.0) hydrogel with the former 
being the more preferred hydrogel composition to use in terms of its physical 
characteristics (lower gelling time and higher water absorption and shape stability). 
In 24 hours in an incubator shaker (37°C, 15 rpm), 250 U/L GO and 2.5 w/w% 
glucose in the HB PEGDA/HA-SH 10-1.0 hydrogel produced 16.02±4.16 mM 
H2O2. This same material produced also 9.11±0.92 mM H2O2 in static conditions. 
This concentration, and those lower than it, were cytocompatible in in vitro tests 
using NIH/3T3 mouse fibroblast cells. 
 
Hydrogen peroxide continuously produced by the HB PEGDA/HA-SH 10-1.0 
(w/w%) hydrogel loaded with 250 U/L GO and 2.5 w/w% glucose demonstrated 
antibacterial activity in several strains of bacteria, primarily Gram-positive bacteria 
(S. aureus, A. baumannii, S. epidermidis, and A. baumannii) and antibiotic-resistant 
Gram positive bacteria (MRSA, MRSE). It showed antibacterial activity, albeit with 
lower zones of inhibition on Gram-negative bacteria (E. coli and P. aeurignosa) 
and antibiotic-resistant P. Aeruginosa. When the concentration was increased from 
250 U/L to 500 U/L GO in the hydrogel, the material demonstrated additionally 
antibacterial activity on antibiotic resistant E. coli. However, as cytocompatibility 
in NIH/3T3 mouse fibroblast cells within 24 hours was only positive up to the 
concentration of 250U/L, the best antibacterial activity accompanied by positive 
cell viability was achieved using HB PEGDA/HA-SH 10-1.0 (w/w%) with 250 U/L 
GO and 2.5 w/w% glucose. 
 
The results obtained from this chapter allowed the researchers to select HB 
PEGDA/HA-SH 10-1.0 (w/w%) with 250 U/L GO and 2.5 w/w% glucose as a 
promising hydrogel, to be used as a drug-free antibacterial wound dressing for 
88 
 
combatting antimicrobial resistance, especially considering it displays antibacterial 
activity in three antibiotic-resistant bacteria. 
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Chapter 4 Functionalization of 
HB PEGDA for Glucose Oxidase 
Immobilization 
  
4.1. Abstract 
 
An improvement to the HB PEGDA/HA-SH hydrogel system is to redesign the 
hyperbranched polymer to have functionalities for enzyme grafting. Covalent 
immobilization of the GO enzyme into a hyperbranched substrate,  in contrast to 
simple encapsulation of the enzyme within the hydrogel as described in Chapter 3, 
may provide some benefits, such as a prolonged enzyme activity within the 
hydrogel, both avoiding its diffusion and protecting the enzyme from possible 
degradation or denaturation. Through Deactivation-Enhanced Atom Transfer 
Radical Polymerization (DE-ATRP) a hyperbranched polyethylene glycol 
diacrylate-co-glycidyl methacrylate (HB PEGDA-co-GMA or HB PcG) was 
synthesised with PEGDA to GMA molar ratio of 5:1. The epoxy group of the 
glycidyl methacrylate can be exploited for reaction with the amine and amide 
groups of the GO enzyme. 1H NMR analysis suggested successful GO 
immobilization to the the HB PcG polymer. The HB PcG demonstrated similar 
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characteristics to HB PEGDA in its ability to crosslink and form a hydrogel when 
mixed with HA-SH solution. Gelation time ranged from 1.1 to 9.4 minutes 
depending on HB PcG and HA-SH concentration. This hydrogel was able to swell 
to a maximum of 139% of its weight at day 20 and underwent complete 
dissolution/degradation after 6 days. Using 250 U/L GO and 2.5 w/w% glucose (the 
ideal GO and glucose concentrations established for HB PEGDA/HA-SH 10-1.0 
honey-mimetic hydrogen peroxide-producing system) 8.3 mM H2O2 was produced 
after 24 hours. However, HB PEGDA-co-GMA/HA-SH 10-1.0 hydrogel showed 
less cytocompatibility when compared to HB PEGDA/HA-SH 10-1.0 hydrogels 
with the same enzyme/glucose concentration . For example, while HB 
PEGDA/HA-SH 10-1.0 with 250 U/L GO, and 2.5 w/w% glucose had a cell 
viability of 107% when using NIH/3T3 cells after 24 hours, HB PEGDA-co-
GMA/HA-SH 10-1.0 only had 65% cell viability. This means that while HB 
PEGDA-co-GMA has the potential to be used as an enzyme immobilizing material, 
able to  form a hydrogel in situ with HA-SH, its biocompatibility is still suboptimal. 
Improvements to the system can be done by decreasing the molar ratio of GMA 
with respect to HB PEGDA to decrease the cytotoxic effect of its epoxide groups. 
An alternative is to ensure the epoxide groups are successfully deactivated, either 
by reacting and immobilizing the enzyme or by the addition of some other reagent 
(such as converting it into an alcohol functional group). This activity was performed 
in Professor Wenxin Wang's Wound Healing and Skin Research Laboratory in 
Charles Institute of Dermatology, School of Medicine, University College Dublin, 
Ireland. 
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4.2. Introduction 
 
4.2.1. Enzyme immobilization 
 
Enzyme immobilization unto a substrate provides many benefits. These include 
being able to reuse the enzyme without diffusing into its surrounding environment 
(e.g. enzymes entering and coming into contact with wound tissue) or being washed 
away by solvents in in vivo or in vitro experiments, stabilizing the enzyme, and 
increasing the thermal stability of the enzyme1. Enzymes may be immobilized 
physically binding them to a substrate or by chemical conjugation. Covalent 
binding of enzymes to substrates may exploit the reaction between the lateral 
reactive groups of the enzymes (e.g. -NH2 groups in arginine and lysine, -CONH2 
in glutamine, and -SH in cysteine) with functional groups in the substrate such as 
imidazole, indolyl, phenolic hydroxyl, etc1. 
 
Glucose oxidase is often used as the model enzyme in immobilization tests. It has 
been immobilized in various substrates such as surface-grafted acrylic acid 
electroactive polyaniline films, pyrolytic graphite (based on simple absorption 
methods), and pyrole-functionalized polystyrene2–4. In creating a more stable, 
covalently immobilized substrate it is necessary to modify the material into a 
copolymer or surface modify it in order to have the immobilizing functional groups. 
 
 
4.2.2. Methods for immobilizing glucose oxidase 
 
In one study performed by Valentova et al., 1981 glucose oxidase ws immobilized 
on two substrates: bead cellulose and a copolymer containing glycidyl methacrylate 
(GMA)5. Through a shake flask method, glucose oxidase was dissolved in a PBS 
buffer solution with pH 7.5, then the carrier material was incubated for 16 hours at 
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4°C. As glycidyl methacrylate, shown in Figure 4.1 contains a vinyl group and an 
epoxy group (also known as an oxirane group), the vinyl group can be used for free 
radical polymerization to create a hyperbranched copolymer by reacting with 
polyethylene glycol diacrylate (PEGDA).  
 
 
Figure 4.1: Chemical structure of glycidyl methacrylate. 
 
Possible reactions of certain amino acids in the protein with the oxirane group are 
shown in Figure 4.2. These amino acids may also react with other groups as 
aldehydes, as shown in a study perfroming lipase immobilization in poly(vinyl 
acetate [PVA]-acrylamide) microspheres6. Glucose oxidase has also been 
immobilized in PVA nanofibres for sensor applications7. A hyperbranched 
copolymer can also be made from these other monomers, but for this study the focus 
will be on an epoxide-functionalized copolymer. 
 
Figure 4.2: Possible reactions of lateral side groups in GO enzyme with an polymer 
containing an epoxide functional group. 
93 
 
 
This reaction has been already described for HB PEGDA synthesis in Chapters 2 
and 3. In the final bifunctional HB polymer, the epoxy group may react with the 
amine and amide groups found in the GO enzyme. Another variation in Valentova’s 
study is that the polymer substrate synthesized in this study is liquid and can form 
a hydrogel when mixed with a thiolated polymer via Michael addition crosslinking. 
In most immobilization studies, the enzymes are immobilized onto a solid substrate 
(eg. electrodes, films, beads) and can be separated from the enzyme medium by 
simple decanting and washing. In this proposed polymer synthesis, recovering the 
copolymer with immobilized enzymes from the rest of the not immobilized 
enzymes requires liquid-liquid separation methods, such as centrifugation. 
 
As a side note, another study has immobilized glucose oxidase in a polydopamine-
coated substrate8. This method of immobilizing glucose oxidase will be investigated 
in later chapters 5 to 8 as an alternative form of GO immobilization. This system 
makes use of the quinone groups found in polydopamine which react with available 
amine, amide, or thiol groups in the enzyme via Michael addition reaction. 
 
 
4.2.3. Synthesis reaction for HB PEGDA-co-GMA and GO 
grafting strategy  
 
HB PEGDA was synthesized in Wenxin Wang’s Wound Healing and Skin 
Research Laboratory both through RAFT (discussed in Chapter 2) and DE-ATRP. 
The reason why DE-ATRP synthesized HB PEGDA was not discussed in detail 
was that it self-crosslinked while undergoing lyophilization for removal of water 
and trace organic solvents after dialysis.  
94 
 
On the other hand, DE-ATRP was used for synthesizing HB PEGDA-co-GMA 
copolymer as it tends to give higher molar conversion yields than RAFT synthesis 
during the comparison of DE-ATRP-synthesized HB PEGDA (62.0%) with RAFT-
synthesized HB PEGDA (32.5%, reported in Chapter 2). The theoretical structure 
of HB PEGDA-co-GMA is presented below in Figure 4.3. 
 
 
Figure 4.3. Chemical structure of HB PEGDA-co-GMA or HB PcG. 
 
 
When GO enzyme is mixed with the HB PcG polymer solution and reacted with 
the polymer substrate at 4 °C for at least 16 hours in a flask with continuous shaking, 
a reaction, as shown in Figure 4.4, is expected to occur5. This immobilization step 
should leave the vinyl groups intact and allow them to react via Michael-addition 
thiol-ene crosslinking with a polymer such as thiolated hyaluronic acid. 
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Figure 4.4: Immobilization of glucose oxidase in HB PEGDA-co-GMA. 
 
DE-ATRP is a free radical polymerization reaction which differs from RAFT in 
that it makes use of a metal catalyst in the initiation and propagation steps to have 
a higher rate of reaction than the termination stage. When a radical is generated in 
the ATRP system, there are three possible situations: 1) propagation with the 
monomer, 2) termination, 3) deactivation into dormant species9. These reactions 
can happen simultaneously with the dominant event depending on its rate relative 
to the other two. Figure 4.5 depicts the general steps that occur in an ATRP 
synthesis, with copper (II) chloride as the metal catalyst. 
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Initiation
R-Cl + Cu+2/Ln
kact
kact
R + Cu+3Cl/Ln
R +
R
kpi P1
Propagation
Pn-Cl + Cu
+2/L
kact
kact
Pn + Cu
+3/L
Pn +
R
kp Pn+1
Termination
Pn Pm Pn+m
Pn Pm
kt+
+
 
Figure 4.5: Steps in general ATRP synthesis with copper (II) chloride as the metal 
catalyst. L = ligand 
 
Following a similar DE-ATRP synthesis performed by A, et al., 2017, HB PEGDA-
co-GMA was synthesized using the similar reagents for the metal catalyst, initiator, 
ligand, and reducing agent10. 
 
 
4.3. Materials and Methods 
 
Polyethylene glycol diacryate (PEGDA, MW 575), glycidyl methacrylate (GMA), 
ethyl α-bromoisobutyrate (EBriB), N,N,N′,N′′,N′′-Pentamethyldiethylenetriamine 
(PMDETA), copper (II) chloride, ascorbic acid, hexane, butanone, acetone, 
aluminium oxide (Al2O3), diethyl ether, glucose, glucose oxidase enzyme (GO, 
E.C. 1.1.3.4), phosphate buffer solution pH 7.4 (PBS), Hank's buffer solution, high-
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glucose Dubelcco's modified eagle medium (DMEM), fetal bovine serum (FBS), 
resazurin sodium salt and penicillin-streptomycin (PS) were bought from Sigma 
Aldrich, UK. Thiolated Hyaluronic acid (HA-SH, 80% degree of thiolation, 400 
kDa) was provided by Vornia  Ltd., Ireland. NIH/3T3 mouse fibroblast cells 
(ATCC® CRL-1658™) were obtained from ATCC, UK. 
 
Experiments were performed in Professor Wenxin Wang's Wound Healing and 
Skin Research Laboratory in Charles Institute of Dermatology, University College 
Dublin, Ireland. 
 
 
4.3.1. Synthesis of HB PEGDA-co-GMA 
 
HB PEGDA-co-GMA (PEGDA to GMA molar ratio of 5:1) was synthesized via 
DE-ATRP synthesis. Briefly, in a 250 mL double-neck flask, the following reagents 
were dissolved in 120 mL butanone: 34.5 g PEGDA, 2.13 g GMA, 3.90 g EBriB 
(initiator), 86.65 mg PMDETA (ligand), and 67.23 mg copper (II) chloride (metal 
catalyst). The solution was sealed and purged with Argon for 30 minutes. After that, 
22 mg of ascorbic acid dissolved in 100 μL H2O (reducing agent) was added. The 
solution was purged with Argon again for another 15-20 minutes. It was then sealed 
and placed into an oil bath at 50°C for 6-8 hours. Samples were taken out hourly to 
be analyzed by GPC analysis to monitor the molecular weight increase of the 
polymer and the molar conversion. When the molecular weight reached 10-20 kDa, 
the reaction was stopped by removing the mixture from the heating bath and 
opening the flask to let oxygen enter to prevent polymer gelling within the flask. 
 
The polymer was purified first by precipitating in a 2:1 volume ratio of diethyl 
ether: hexane solution. After the precipitating the polymer (which settled into the 
bottom layer), the solution of diethyl ether and hexane (containing the unreacted 
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monomers and other reagents) was decanted, 30 mL of acetone was added to 
decrease the viscosity for the next stage, the removal of the copper catalyst. 
 
A chromatography column was prepared in order to remove the copper from the 
solution afterwards. As shown in Figure 4.6, the column was prepared by 
assembling layers, from bottom to top of: 1-2 cm cotton, 2-4 cm sand, 20-30 cm 
aluminum oxide, and approximately 0.5 cm sand again (to cover aluminum oxide 
and prevent it from being removed).  
 
 
 
Figure 4.6: a) Separation column for removing copper from the polymer solution, b) an 
up-close look at the color change as CuCl2 forms a complex with Al2O3 
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At the bottom of the separation column a double neck flask was placed, with one 
neck connected to the column and the other to a vacuum pump. This column was 
washed with acetone first to wet the column before the polymer solution was poured 
down. Excess solvents were removed from the recovered polymer solution in an 
evaporating flask before being dialyzed and freeze-dried for the final step of the 
purification process. It was noted that DE-ATRP synthesized HB PcG was more 
stable than DE-ATRP synthesized HB PEGDA as it did not self-crosslink in the 
lyophilization process. It is probable that the addition of the epoxide group inhibited 
the contact between the acrylate groups from interacting with each other, as later 
results would show that HB PcG contained a lower vinyl content than HB PEGDA. 
 
 
4.3.2. Chemical characterization of HB PEGDA-co-GMA 
 
The procedure for chemical characterization was then same applied for HB PEGDA 
and described in Chapter 2, section 2.3.4, except that for every hourly sample taken 
from the reacting flask for GPC analysis, the copper was removed by passing the 
sample through a Pasteur pipette containing aluminum oxide and cotton (to prevent 
the Al2O3 passing through the pipette).  Afterwards 100 μL of this polymer solution 
(containing varying amounts of butanone, formed polymer, and monomers) was 
diluted in 900 μL dimethyl formamide (DMF).  Additionally, the final sample for 
GPC analysis was prepared by dissolving 3 mg of polymer in 1 mL of Dimethyl 
Formamide (DMF).  
 
The DMF-dissolved samples were filtered (0.45 µm pore size) through a filter 
syringe into small amber GPC vials. The samples were analyzed in an Agilent 1260 
Infinity GPC/SEC system (Agilent Technologies) to monitor molecular weight, 
molar conversion and polydispersity as the reaction proceeded. The used system is 
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equipped with a refractive index detector (RI), with two columns in series (30 cm 
PLgel mixed-C), eluted using DMF (containing 0.1% LiBr) as mobile phase. 
 
For characterizing molecular structure, 1H Nuclear Magnetic Resonance (NMR) 
was used. The final polymer samples were dissolved in chloroform-D (CDCl3) and 
1H NMR analysis was carried out on a 400 MHz Varian NMR spectroscopy system. 
Data were analyzed using MesReNova 6.1 processing software.  
 
Chemical characterization from the 1H NMR spectra calculated the degree of 
hyperbranching based on vinyl groups and the amount of available epoxide groups. 
According to literature, HB polymers are characterized to have abundant functional 
groups, an irregular 3D topology, low viscosity, and high solubility11.  These 
particular properties make them ideal to be used as one of the components in an in 
situ formed hydrogel system. Their low viscosity and high solubility allow these 
polymers to be dissolved easily in an aqueous solution as pre-hydrogel polymer 
solution. Their 3D topology and abundant functional groups allow ease of contact 
when reacting with HA-SH thiol groups and the formation of a mechanically strong 
hydrogel structure. 
 
 
4.3.3. Preparation of HB PEGDA-co-GMA/HA-SH hydrogels 
 
To prepare hydrogel samples for further characterization, HB PEGDA-co-GMA (or 
HB PcG) polymer was dissolved in 1X 7.4 PBS buffer at concentrations from 10-
20 w/w% (Table 1). HA-SH solution was prepared at a concentrations of 1-4 w/w% 
(Table 1). To form a hydrogel, equal volumes of HB PcG and HA-SH solutions 
were mixed and pipetted into a 7.5 mm diameter cylinder mold or into a teflon 
surface to form a bead. Total volume of this hydrogel cylinder was 200 µL 
(hydrogel has a height of approximately 5 mm). 
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Table 4.1: Composition of prepared HB PcG/HA-SH hydrogels  
Hydrogel 
code 
HB PcG 
solution 
concentration - 
Prehydrogel 
(% wt./wt.) 
HA-SH 
solution 
concentration -  
Prehydrogel 
(% wt./wt.) 
Hydrogel relative 
HB PcG/HA-SH 
amount 
(dry wt./dry wt.) 
Overall 
hydrogel 
composition 
(wt./wt.) 
5.0-1.0 10.0 2.0 5.0 : 1.0 6.0% 
10-1.0 20 2.0 10.0 : 1.0 11.0% 
10-2.0 20 4.0 5.0 : 1.0 12.0% 
 
Except for gelation time and cytocompatibility assays, characterizations were 
performed only on HB PEGDA-co-GMA/HA-SH 10.0-1.0 to compare its 
properties with those of HB PEGDA/HA-SH 10-1.0 hydrogel. 
 
 
4.3.4. Characterization of HB PEGDA-co-GMA/HA-SH hydrogel 
 
4.3.4.1. Gelation time 
 
The gelation time for the hydrogels was obtained using the vial-tilt method12. 
Briefly, 500 µL HB PEGDA-co-GMA solution was combined with 500 µL HA-SH 
solution, using the concentrations collected in Table 2.1. These vials were tilted 
side to side and observed for 5 s. The gelation was considered complete when no 
flow was observed for 5 s.  
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4.3.4.2. Rheological properties  
 
Rheometry was performed on a TA Discovery Hybrid Rheometer-2 (DHR-2) with 
8 mm and 20 mm diameter parallel plates and TRIOS software for analysis of data.  
 
With the aim of determining the rheological properties of the HB PEGDA-co-
GMA/HA-SH hydrogels, detailed dynamic rheological assessments were 
conducted on hydrogels. Rheological profiles were obtained by pipetting excess 90 
µL pre-forming HB PEGDA/HA-SH hydrogel (the individual components were 
mixed, but the solution was still liquid) into the rheometer plate, at room 
temperature. The 8 mm disc plate was lowered until a height of 1.5 mm was 
achieved. Estimated volume of analyzed hydrogel was 75.4µL. 
Storage moduli (G') and loss moduli (G") were measured from sweep tests.  A 
frequency sweep profile (at 10% strain) was obtained at a range of 0.1 to 100 Hz. 
Strain sweep profile (at 10 Hz) was obtained at a range of 0.1% to 100% strain. 
 
 
4.3.4.3. Swelling and degradation profile 
 
In order to determine the water absorption profile of hydrogels, 200 µL samples of 
10-1.0 and 5.0-1.0 HB PcG/HA-SH  hydrogels were prepared. These samples were 
placed in pre-weighed 20 mL scintillation vials and weighed. Then 2 mL 1X 7.4 
pH PBS was added to these vials. The samples were incubated at 37°C.  
 
At different time points (initially every 2 hours for the first 8 hours, then every 24 
hours for the first week, then every 2 days onward up to 4 weeks), PBS was removed 
and the vial containing hydrogel was weighed. After weighing, 2 mL of fresh PBS 
solution was added again and the vial was returned to the incubator. Measurements 
were performed in quadruplicates. 
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Water absorption was calculated based on this formula, taken from Chapter 2: 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑎𝑏𝑠𝑜𝑟𝑝𝑡𝑖𝑜𝑛 =
𝑊𝑡 − 𝑊0
𝑊0
∗ 100%         (𝑒𝑞. 4) 
Where Wt = weight of hydrogel at time point t in, W0 = initial weight of the hydrogel.  
 
Degradation was observed when the water absorption percentage was negative. The 
time for complete degradation was the time at which hydrogel could not be 
observed any more in the PBS solution. 
 
 
4.3.5. Immobilization of glucose oxidase 
 
Glucose oxidase was immobilized by dissolving an excess amount (4000 U/L) of 
glucose oxidase into a 10 w/w% solution of HB PEGDA-co-GMA. The solution 
was placed in a shaker for 96 hours in 4°C. Afterwards, the solution was placed in 
a centrifuge vial and centrifuged at 11,000 RPM for separating the unimmobilized 
enzyme. Separation was possible as the polymer had a higher density than water 
and two phases were observed after centrifugation; a yellowish polymer at the 
bottom and a clear liquid on top. The supernatant was removed and H2O was added 
for further centrifugation. The final product (a water soluble, GO enzyme-
conjugated HB PEGDA-co-GMA copolymer) was dissolved in chloroform-D 
(CDCl3) and 1H NMR analysis was carried out on a 400 MHz Varian NMR 
spectroscopy system. Data were analyzed using MesReNova 6.1 processing 
software. The results were compared with the spectrum of the control HB PEGDA-
co-GMA polymer. 
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4.3.6. ROS production in HB PEGA-co-GMA/HA-SH 
 
Following the procedure of making ROS-producing hydrogels in Chapter 3, Section 
3.3.2, 250 U/L and 500 U/L GO- /2.5 w/w% glucose-loaded hydrogels were 
prepared. These two enzyme concentrations and one glucose concentration were 
selected from the range of previously used concentrations based on the most 
favorable results from the HB PEGDA/HA-SH experiments. 
 
When preparing the HB PcG with GO enzyme solution, the pre-hydrogel solution 
was left to react for 96 hours at 4°C with the enzyme to allow immobilization to 
occur before being crosslinked with the glucose-loaded HA-SH solution.  
 
ROS pertitanic acid assay sampling and protocol were similar to those described in 
Chapter 3, Section 3.3.3. 
 
 
4.3.7. Alamar Blue cytocompatibility test 
 
Alamar Blue cytocompatibility test sample preparation, protocol, and data analysis 
were similar to those performed in Chapter 3, Section 3.3.4. 
 
 
4.4. Results and Discussion 
 
4.4.1. Chemical characterization of HB PEGDA-co-GMA 
 
GPC analysis showed that after 8 hours reaction polymer weight-average molecular 
weight (Mw) was 10,126 Da, number-average molecular weight (Mn) was 4,616 
Da, polydispersity index was 2.2, and molar conversion from monomer to polymer 
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was 73.15%. These properties were obtained from the Agilent GPC software by 
integrating the GPC curve measured on samples polymerized at the corresponding 
time (Figure 4.7). 
 
 
Figure 4.7: GPC profile of HB PEGDA-co-GMA (5:1 PEGDA to GMA molar 
ratio) synthesized via DE-ATRP reaction. 
 
Comparing with the RAFT-synthesized HB PEGDA, the yield for this DE-ATRP 
reaction was approximately twice. However the homogeneity of the HB PcG 
polymer was lower given the high polydispersity index of 2.2 compared to HB 
PEGDA (1.5). This was likely due to the copolymer nature and the distribution of 
the GMA in the polymer chains causing irregularity. 
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Figure 4.8: 1H NMR spectrum of HB PEGDA-co-GMA (5:1). 
 
1H NMR spectra (Figure 4.8) allowed the analysis of the branched structure and 
amount of pendant acrylate groups. The pendant acrylate groups were identified as 
three characteristic chemical shifts at 6.4-5.8 ppm. The oxirane/epoxide group was 
identified as three shifts found at 2.6-3.3 ppm. The PEG groups were identified as 
the chemical shift at 4.34-3.95 ppm. Degree of hyperbranching was 29.8 mol% for 
vinyl group content and 19.4 mol% for epoxide group content. As the average 
degree of hyperbranching is between 40-60%, this material can be considered a low 
hyperbranched polymer based on vinyl content only. However, if degree of 
hyperbranching is based on its total functional groups (epoxide and vinyl), the 
degree of hyperbranching was 49.2 mol% which is an average degree of 
hyperbranching compared to the high degree of hyperbranching of HB PEGDA (57 
mol%)13. 
 
 
Acrylate group 
PEG group 
Epoxide group 
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4.4.2. Gelation time 
 
Gelation time results are shown in Figure 4.9. In comparing the gelation times of 
hydrogels based on HB PcG with those based on HB PEGDA at the same 
composition, HB PcG based hydrogels consistently required a higher time for 
crosslinking. This can be attributed to the lower vinyl content in HB PcG than in 
HB PEGDA. Like HB PEGDA/HA-SH hydrogels discussed in Chapter 2, Section 
2.4.2.1, HB PcG/HA-SH demonstrated a similar trend with decreasing gelation 
times with an increase of polymeric material concentration.  
 
 
Figure 4.9: Gelation time of HB PEGDA-co-GMA/HA-SH  
hydrogels of varying compositions. 
 
By increasing the HB PcG content from 5 w/w% to 10 w/w% in constant 1 w/w% 
HA-SH, the gelation time reduced from 9 minutes to 5 minutes, being 1.8 times 
faster. This change was less drastic than that observed for HB PEGDA/HA-SH 5.0-
1.0 to 10-1.0 where the gelation time became 9.3 times faster. A possible reason is 
that the presence of epoxide groups in the hyperbranched copolymer interact as well 
with the thiol groups or inhibit the acrylate groups from reacting with the thiol 
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groups (it was observed that this polymer is less prone to self-crosslinking than DE-
ATRP synthesized HB PEGDA). Another cause is due to the hyperbranched 
copolymer having a lower amount of vinyl groups per gram than the original 
material. 
 
By increasing the HA-SH content from 1 w/w% to 2 w/w% in constant 10 w/w% 
HB PcG, the gelation time, the gelation time was 4.5 times faster. This can be 
attributed to the increased availability of HA-SH thiol groups coming into contact 
with the vinyl groups in HB PcG.  
 
 
4.4.3. Rheological characterization of hydrogel 
 
4.4.3.1. Frequency sweep 
 
Recalling from Chapter 2, the frequency sweep profiles of the HB PcG/HA-SH 
hydrogels 10-1.0 and 5.0-1.0 at 10% oscillation strain are depicted in Figure 4.10. 
For a perfect solid, these storage and loss values are G"=0 and G'=a finite value14. 
For a perfect liquid, G"=a finite value and G'=014. As hydrogels are neither perfect 
solids or perfect liquids, their G' and G" values are higher than zero. When G">G', 
the sample is considered more viscous than elastic (solution), when in G"<G', the 
sample is more elastic than viscous (hydrogel). From Figure 4.10, in both 5.0-1.0 
and 10-1.0 compositions, the storage modulus was higher than the loss moduli at 
each frequency, hence the material was in hydrogel form. 
 
Storage modulus is also connected to how well-crosslinked a material is. A 
hydrogel that has more crosslinked junctions is able to store more deformation 
energy in an elastic manner. When comparing the G’ values at the same frequency 
(e.g. 100 Hz), HB PEGDA/HA-SH 10-1.0 G’ was 1.29 MPa and HB PcG/HA-SH 
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10-1.0 G’ was 1.26 MPa. This result was found in each frequency measurement 
conducted for both hydrogels. This means both hydrogels showed approximately 
the same rheological properties. 
 
 
 
Figure 4.10: Frequency sweep of HB PEGDA-co-GMA/HA-SH 10-1.0 and 5.0-1.0  
hydrogels at 10% strain. 
 
4.4.3.2. Strain sweep 
 
In Figure 4.11, the strain sweep profile of the HB PEGDA-co-GM/HA-SH 10-1.0 
hydrogel is reported, at a constant frequency of 10 Hz. As in Figure 4.10, the storage 
modulus G’ was higher than the loss modulus G’’ at each strain which is 
characteristic of a hydrogel that behaves more like a solid than a liquid. However, 
with increasing the strain, G" initially decreased, reaching a minimum, then 
increasing. The behavior of G’ was similar, although the decrease was less 
pronounced and the minimum was reached at higher strain than for G’’. This is 
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from the material “relaxing” after the initial strain exerted on it15. Relating this to 
biomedical applications, the hydrogel showed the potential to undergo stresses 
during its use. 
 
 
 
 
Figure 4.11: Strain sweep of HB PEGDA-co-GMA/HA-SH 10-1.0 and 5.0-1.0 hydrogels 
at 10 Hz oscillation frequency. 
 
 
4.4.4. Physical characterization of hydrogel 
 
4.4.4.1. Water adsorption profile  
 
In Figure 4.12, HB PcG/HA-SH 10-1.0 showed a faster water uptake in the 
beginning than HB PEGDA/HA-SH 10-1.0. By day 20, the HB PcG hydrogel had 
already absorbed 139% of its weight in water while HB PEGDA showed  only 13%. 
This rapid swelling however caused a faster degradation as the H2O adsorbed by 
the hydrophilic parts of the hyperbranched polymer might have uncoiled the 
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polymer network and hydrolyzed some parts. After the measurement at day 22, the 
calculated water uptake was found to have dropped to 73% before complete 
degradation in PBS by day 26. 
 
On the other hand, the water adsorption of HB PEGDA/HA-SH 10-1.0 hydrogel 
gradually increased with time and the hydrogel was still present after 43days. 
 
HB PEGDA/HA-SH 10-1.0 as a hydrogel has a lower rate of degradation and lower initial 
water uptake than HB PEGDA-co-GMA/HA-SH 10-1.0 as the former has a higher vinyl 
content per gram polymer. This means that the HB PEGDA hydrogel is more crosslinked 
than HB PcG at the same weight concentration and its polymer chains uncoil and expand 
much slower as water permeates the interstices of the hydrogel matrix.  
 
 
 
Figure 4.12: Swelling profile of HB PEGDA-co-GMA/HA-SH 10-1.0 and HB 
PEGDA/HA-SH 10-1.0. 
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4.4.5. Immobilization of glucose oxidase 
 
The epoxide group can be confirmed by the presence of two peaks at 3.2 and 2.8 
ppm in the 1H NMR spectra. Enzyme was immobilized into the polymer by reacting 
the enzyme amine groups with the epoxide groups in glycidyl methacrylate for 96 
hours. The polymer/enzyme mix was then centrifuged at 11,000 rpm and 37°C to 
remove the unimmobilized enzyme before analyzing the conjugated polymer by 1H 
NMR. Figure 4.13 showed new shift from 2.0 to 2.2 ppm which was attributed to 
the presence of the enzyme covalently bound to the polymer and a decrease in the 
original shift at 3.5 ppm as the epoxide group concentration is reduced (but not fully 
removed, meaning some epoxy groups still remain) as it reacts and conjugates with 
amine, amide, and thiol functional groups in the GO enzyme. 
 
 
Figure 4.13: 1H NMR spectra of [1] HB PEGDA-co-GMA with Glucose Oxidase 
Enzymes (in red), [2] HB PEGDA-co-GMA (in teal) 
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To confirm the presence of active immobilized GO enzymes, centrifuged HB 
PEGDA-co-GMA polymer (to remove any unimmobilized enzymes in the polymer 
solution) was crosslinked with 2.5 w/w% glucose-loaded HA-SH to form an HB 
PcG/HA-SH 10-1.0 hydrogel. The amount of H2O2 formed by this hydrogel was 
quantified after 24 hours. Pertitanic assay results show that 2.17±0.82 mM H2O2 
was produced from the immobilized enzymes in the HB PEGDA-co-GMA/HA-SH 
10-1.0 hydrogel.  This concentration is much lower than the targeted 10-20 mM 
H2O2 a day production, but this nonetheless shows that partial immobilization of 
biologically active / functional glucose oxidase in the hydrogel can occur. 
 
 
4.4.6. ROS production in HB PEGDA-co-GMA/HA-SH 10-1.0 
 
Figure 4.14 shows the ROS production results of HB PEGDA-co-GMA/HA-SH 
10-1.0 at varying enzyme concentrations for both 24 h and 48 h with the glucose 
concentration held constant at 2.5 w/w%. When comparing the effect of 250 U/L 
and 500 U/L GO concentrations, there was no significant difference during the first 
24 hours (8.29±0.89 and 8.77±1.11 mM H2O2 respectively). However, for t = 48 h 
the difference between the two concentrations (11.21±1.58 and 13.37±1.62 mM 
H2O2 respectively) was more statistically significant. 
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Figure 4.14: H2O2 production in HB PEGDA-co-GMA/HA-SH 10-1.0 at varying 
concentrations of GO enzyme (glucose concentration 2.5 w/w%) after 24 and 48 hours. 
 
A comparison between HB PcG/HA-SH and HB PEGDA/HA-SH hydrogels (at the 
same time measurement, GO concentration, and glucose concentration) showed that 
HB PcG/HA-SH produced significantly lower H2O2. The reduced H2O2 production 
could be attributed to GO being immobilized and unable to diffuse and react with 
glucose. Another reason could be a partial denaturation of the immobilized GO. In 
future in-depth studies, the active enzyme to denatured enzyme can be quantified 
through measuring the total protein content in the material. 
 
However, when considering the influence of incubation time on H2O2 production, 
for HB PcG/HA-SH, H2O2 increased from 24 h to 48 h at both GO concentrations 
of 250 U/L and 500 U/L. This was not found for HB PEGDA/HA-SH hydrogel with 
the difference in concentrations being statistically insignificant. This means that the 
HB PcG/HA-SH hydrogel was more active in producing consistently more H2O2 
beyond 24 hours, allowing reaction with diffusing glucose. On the contrary, for HB 
PEGDA/HA-SH hydrogel, GO enzyme may diffuse out of the hydrogel as a 
function of time. 
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4.4.7. Alamar Blue cytocompatibility test 
 
Figure 4.15 shows the results for the indirect cytocompatibility testing of HB 
PcG/HA-SH hydrogels that were loaded with GO enzyme and glucose using 
NIH/3T3 mouse fibroblast cells after 24 hours. Positive control represents the cell 
viability on tissue culture plates. 
 
 
Figure 4.15: Cell viability of NIH/3T3 cells with HB PcG/HA-SH 10-1.0 and 5.0-1.0 
hydrogels loaded with two different enzyme concentrations (250 U/L and 500 U/L) at a 
constant glucose concentration (2.5 w/w%) after 24 hours. 
 
As H2O2 concentration produced in HB PcG/HA-SH 10-1.0 was lower than the 
corresponding H2O2 concentration produced in HB PEGDA/HA-SH, the lower 
cytocompatibility was not caused by the H2O2 produced.  
 
HB PcG/HA-SH 5.0-1.0 was then tested to determine the effect of the amount of 
the enzyme-immobilized HB PcG polymer on the cytocompatibility of the 
hydrogel. There was a higher cell viability for HB PcG/HA-SH 5.0-1.0 with respect 
to HB PcG/HA-SH 10-1.0 which can be probably attributed to the lower amount of 
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glycidyl methacrylate groups as a concentration of GMA monomers at around 5 
mM has been observed to cause a decrease in viability for human lymphocytes16. It 
is probable that some exposed epoxide functional groups (which did not react or 
conjugated with an enzyme) in the hydrogel could have caused the cytotoxic effect. 
 
Finally, cytotoxicity increased with increasing enzyme amount from 250 to 500 U/L 
due to increased H2O2 production similar to what has been observed in Chapter 3 
regarding HB PEGDA/HA-SH hydrogels loaded with similar GO concentrations. 
 
 
4.5. Conclusions 
 
HB PEGDA-co-GMA was successfully synthesized via DE-ATRP method as a 
liquid polymer enzyme-immobilizing substrate (as most substrates in enzyme 
immobilization tend to be solid) capable of immobilizing GO enzyme and to 
crosslink into a hydrogel in the presence of HA-SH. This material had a vinyl 
content of 29.8 mol% and epoxide content of 19.4 mol%. When compared to the 
original HB PEGDA polymer, HB PcG’s degree of functionalization is lower but 
still considered to be a normal hyperbranched polymer. 
 
 The gelation time that ranged from 1.1 to 9 minutes depending on the amount of 
polymer in the hydrogel; the higher the HB PcG and HA-SH concentration, the 
lower the required gelation time will be. HB PcG/HA-SH 10-1.0 hydrogel was 
capable of considerable swelling up to 139% of its weight after 20 days and then 
fully degrading after 26 days.  
 
HB PcG immobilized glucose oxidase enzymes which actively produced H2O2 in 
the presence of glucose. After 24 hours, at 250 U/L GO and 2.5 w/w% glucose, HB 
PcG/HA-SH 10-1.0 produced 8.29±0.89 mM H2O2. This still falls close to the 
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desired concentration target of 10-20 mM H2O2 after 24 hours even if HB 
PEGDA/HA-SH 10-1 at similar GO and glucose concentrations produced higher 
yields (it is likely some enzymes were hydrolyzed or deactivated during the 
immobilization process). Despite its potential for enzyme immobilization 
applications, for this specific research on wound healing, the HB PcG/HA-SH 10-
1.0 hydrogel  (with 250 U/L GO enzyme and 2.5 w/w% glucose) yielded low 
cytocompatibility using NIH/3T3 cells and did not appear suitable for use as an in 
situ wound healing device.  
 
In the future HB PEGDA-co-GMA could be explored for immobilizing other 
enzymes than GO for alternative applications. However, cytocompatibility issues 
can be resolved by decreasing the GMA used (possibly at a 10:1 HB PEGDA to 
GMA molar ratio) or by improving the immobilization process to cap all of the 
epoxide groups. Other monomers that have the potential to immobilize enzymes 
such as vinyl acetate may also be investigated in future studies to explore the 
synthesis of other hyperbranched functionalized copolymers. 
 
 
4.6. References 
 
(1)  Datta, S.; Christena, L. R.; Rajaram, Y. R. S. Enzyme Immobilization: An 
Overview on Techniques and Support Materials. 3 Biotech 2013, 3 (1), 1–
9. https://doi.org/10.1007/s13205-012-0071-7. 
(2)  Bianco, P.; Haladjian, J.; Bourdillon, C. Immobilization of Glucose 
Oxidase on Carbon Electrodes. J. Electroanal. Chem. 1990, 293 (1–2), 
151–163. https://doi.org/10.1016/0022-0728(90)80059-F. 
(3)  Li, Z. F.; Kang, E. T.; Neoh, K. G.; Tan, K. L. Covalent Immobilization of 
Glucose Oxidase on the Surface of Polyaniline Films Graft Copolymerized 
118 
 
with Acrylic Acid. Biomaterials 1998, 19 (1–3), 45–53. 
https://doi.org/10.1016/S0142-9612(97)00154-3. 
(4)  Ekinci, O.; Boyukbayram, A. E.; Kiralp, S.; Toppare, L.; Yagci, Y. 
Characterization and Potential Applications of Immobilized Glucose 
Oxidase and Polyphenol Oxidase. J. Macromol. Sci. Part A Pure Appl. 
Chem. 2007, 44 (8), 801–808. 
https://doi.org/10.1080/10601320701407300. 
(5)  Valentova, O.; Marek, M.; Svec, F.; Stamberg, J. Comparison of Different 
Methods of Glucose Oxidase Immobilization. Biotechnol. Bioeng. 1981, 
XXIII (1981), 2093–2104. 
(6)  Zhang, D. H.; Yuwen, L. X.; Li, C.; Li, Y. Q. Effect of Poly(Vinyl Acetate-
Acrylamide) Microspheres Properties and Steric Hindrance on the 
Immobilization of Candida Rugosa Lipase. Bioresour. Technol. 2012, 124, 
233–236. https://doi.org/10.1016/j.biortech.2012.08.083. 
(7)  KIM, K.-O.; KIM, B.-S. Immobilization of Glucose Oxidase on a 
PVA/PAA Nanofiber Matrix Reduces the Effect of the Hematocrit Levels 
on a Glucose Biosensor. J. Fiber Sci. Technol. 2017, 73 (1), 27–33. 
https://doi.org/10.2115/fiberst.fiberst.2017-0004. 
(8)  Zhou, L.; Jiang, Y.; Ma, L.; He, Y.; Gao, J. Immobilization of Glucose 
Oxidase on Polydopamine-Functionalized. 2015, 1007–1017. 
https://doi.org/10.1007/s12010-014-1324-1. 
(9)  Wang, W.; Zheng, Y.; Roberts, E.; Duxbury, C. J.; Ding, L.; Irvine, D. J.; 
Howdle, S. M. Controlling Chain Growth: A New Strategy to 
Hyperbranched Materials. Macromolecules 2007, 40 (20), 7184–7194. 
https://doi.org/10.1021/ma0707133. 
(10)  A, S.; Xu, Q.; Zhou, D.; Gao, Y.; Vasquez, J. M.; Greiser, U.; Wang, W.; 
Liu, W.; Wang, W. Hyperbranched PEG-Based Multi-NHS Polymer and 
119 
 
Bioconjugation with BSA. Polym. Chem. 2017, 8, 1283–1287. 
https://doi.org/10.1039/C6PY01719C. 
(11)  Zheng, Y.; Li, S.; Weng, Z.; Gao, C. Hyperbranched Polymers: Advances 
from Synthesis to Applications. Chem. Soc. Rev. 2015, 44 (12), 4091–4130. 
https://doi.org/10.1039/C4CS00528G. 
(12)  Deshmukh, M.; Singh, Y.; Gunaseelan, S.; Gao, D.; Stein, S.; Sinko, P. J. 
Biodegradable Poly(Ethylen Glycol) Hydrogels Based on a Self-
Elimination Degradation Mechanism. Biomaterials 2011, 31 (26), 6675–
6684. https://doi.org/10.1016/j.biomaterials.2010.05.021.Biodegradable. 
(13)  Wang, D.; Zhao, T.; Zhu, X.; Yan, D.; Wang, W. Bioapplications of 
Hyperbranched Polymers. Chem. Soc. Rev. 2015, 44 (12), 4023–4071. 
https://doi.org/10.1039/C4CS00229F. 
(14)  Moura, M. J.; Figueiredo, M. M.; Gil, M. H. Rheological Study of Genipin 
Cross-Linked Chitosan Hydrogels. Biomacromolecules 2007, 8, 3823–
3829. 
(15)  Zuidema, J. M.; Rivet, C. J.; Gilbert, R. J.; Morrison, F. A. A Protocol for 
Rheological Characterization of Hydrogels for Tissue Engineering 
Strategies. J. Biomed. Mater. Res. Part B Appl. Biomater. 2014, 102 (5), 
1063–1073. https://doi.org/10.1002/jbm.b.33088. 
(16)  Poplawski, T.; Pawlowska, E.; Wisniewska-Jarosinska, M.; Ksiazek, D.; 
Wozniak, K.; Szczepanska, J.; Blasiak, J. Cytotoxicity and Genotoxicity of 
Glycidyl Methacrylate. Chem. Biol. Interact. 2009, 180 (1), 69–78. 
https://doi.org/10.1016/J.CBI.2009.02.001. 
 
Part II 
 121 
 
Chapter 5 Preparation and 
Characterization of Wound 
Healing Thermoplastic 
Polyurethane Patches 
 
 
 
5.1. Abstract 
 
In this chapter, the physicochemical and mechanical properties of a set of four 
commercially available thermoplastic polyurethanes (TPUs) are discussed. TPUs 
were characterized in order to determine their suitability to be used as wound 
patches, which will be further discussed in this and later chapters. Polyurethanes 
have been used in many wound healing applications, mainly for their versatility. A 
polyurethane is made of monomer units joined by carbamate (urethane) linkages, 
which are formed from the reaction of isocyanates and alcohols. A thermoplastic 
polyurethane or TPU is a type of polymer that becomes pliable or mouldable above 
its melting temperature and solidifies upon cooling. 
 
Suitable TPUs for electrospinning wound healing scaffolds were selected among 
the four available ones. The selected material should be biocompatible in order to 
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be used for wound healing applications, for this reason medical grade TPUs were 
considered. Other requirements include hydrophilicity, water adsorption ability and 
mechanical properties similar to currently available wound patches. TPUs were 
processed into films by solvent-casting method for the characterization of their 
properties. The physicochemical properties of TPUs were thus characterized. 
Hydrophilicity of the films was measured through static contact angle tests and 
water adsorption measurements as a function of time.  Degradation rate was also 
characterized. Finally, the tensile mechanical properties of the films were evaluated 
(elastic modulus, tensile strength, and ultimate elongation percentage).  
 
Two TPUs satisfied the requirements:  Lubrizol SP60D60 (TPU A) and Lubrizol 
SP93A100 (TPU C). Their ability to be electrospun into fibrous patches was 
evaluated. Through a trial and error procedure, the parameters for electrospinning 
the polymers were optimized. Different combinations of settings of polymer 
solution concentration and solvent type, voltage, solution flowrate for 
electrospinning the samples were tried and then fibre morphology was analyzed by 
SEM. The desired morphology was to have thin, consistent fibres with no defects 
at a range of 10-1000 nm. 
 
As SP93A100 gave more bead-like defects during electrospinning, instead of 
consistently fibrous texture as in the case of SP60DO, SP60D60 (simply coded as 
TPU A) was selected to be optimal for further studies on wound healing fibrous 
patches. This material is an aliphatic polyether TPU with the following properties: 
static contact angle of 72.0±2.9°; water absorbance percentage of 44.7±4.9% after 
24 hours and 60.6±3.0% after 4 weeks; Young’s modulus of 25.1±1.5 MPa, 
ultimate tensile strength of 10.4±0.7 MPa, and ultimate elongation percentage of 
386±63%. Optimal electrospinning parameters for this polymer were: 15 w/v% 
solution concentration in 90 v/v% CHCl3, 10 v/v% formic acid, 20 kV voltage; 20 
cm distance between the spinneret and the metal collector, and solution feed rate of 
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1.5 mL/h. Such electrospinning parameters yielded elastic, fibrous patches with an 
average fibre diameter of 1.12±30 μm. 
 
The obtained fibrous patches were surface grafted with GO enzyme using a facile 
and versatile mussel inspired surface functionalization approach as discussed in the 
next Chapter.  
 
This part of the Ph.D activity was performed at Politecnico di Torino. 
  
 
5.2. Introduction 
 
Electrospinning is a process which enables nanofibres to be formed by an 
electrostatically driven jet of polymer solution1. These fibres are collected as 
membranes with diameters ranging from 2 nm to 10µm1,2.  Figure 5.1 depicts the 
general layout of an electrospinning set-up: a polymer solution is loaded into a 
syringe and extruded out through the syringe nozzle at a constant rate using a 
syringe pump. A positive electrode is attached to the syringe needle and a negative 
electrode is attached to a flat metal collector where the fibres will deposit. Once a 
potential difference is applied, generally 10-40 kV through the system, the polymer 
shoots out as a fibrous thread, moving from the positive charge (syringe needle) to 
the negative charge (collector2–4). 
 
 
Figure 5.1: Schematic of formation of electrospun fibres. 
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As this polymer solution is propelled outwards the needle with the application of 
sufficient voltage, its shape transforms from a spherical tip into a cone shaped figure 
when the repulsive electrostatic force is less than the surface tension in the polymer 
solution, as shown in Figure 5.25. This phenomenon is called the Taylor cone. When 
this repulsive electrostatic force is greater than the surface tension, a charged jet 
occurs, and the polymer is ejected out in varying directions results in the fibres 
having a broad diameter divergence. 
 
Figure 5.2: Effect of applied voltage on electrospinning fibres. 
 
Thus, one of the most important parameters to optimize is the potential difference 
applied. If it is too low, the polymer solution cannot be electrospun as it is incapable 
of forming a Taylor cone. This property differs for each type of polymer solution, 
as it depends on surface tension and conductivity. Alternatively, by adding an 
organic acid such as formic acid into the polymer solution, the solution conductivity 
can be increased leading to thin consistent fibres respect to the original solution 
when the same voltage is applied6. 
 
Electrospun fibres present several properties that can be advantageous in the 
biomedical field. First of all they can mimic the fibrous structure of the extracellular 
matrix (ECM) and provide a scaffold for cells to grow out on biodegradable and 
bioresorbable materials7. Fibre diameters can be in the nanometer scale and provide 
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a large surface area for cells to adhere and grow7. While cells attached on a 
microfibre structure tend to assume a flat morphology, cells adherent on a 
nanofibrous matrix grow three-dimensionally assuming an in vivo-like 
morphology8. 
 
 Electrospun fibres can also be surface modified in order to immobilize bioactive 
molecules, including enzymes. Such substrates are advantageous for surface 
modification thanks to their high surface area leading to high density of 
functionalising molecules. One of the possible techniques used to surface modify 
electrospun fibres is via "mussel-inspired" coatings, which will be treated in the 
next Chapter9. 
 
Electrospun polymer fibres are suitable for wound healing applications due to 
having characteristics such as: oxygen permeability, biomimetic structure, and 
depending on the type of polymer used they can possess an adequate hydrophilicity 
to support cell adhesion10. Fibrous membranes can also be modified or 
functionalized to have antibacterial properties that prevent infections as the wound 
is healing. These characteristics are also similar to those of hydrogels described in 
previous Chapters. Other desired characteristics are adequate elasticity and tensile 
strength to withstand wear and stresses as the patient moves about during the wound 
healing process. 
 
Several electrospun fibres have already been put to use in the commercial 
biomedical applications such as artificial heart valves that were developed by 
Xeltis, which they advertised to serve as a scaffold for new cardiac tissue to grow 
in and eventually replace the scaffold as the material degrades11. They have also 
been used as a synthetic bone regeneration scaffold such as Rebossis by Ortho 
ReBirth12.  
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For wound healing applications, antibacterial nanofibre mats have been fabricated 
to reduce chronic wound biofilms. One of the methods was to incorporate silver 
into the fibre matrix of the mat13,14. In other works, plant-based antimicrobials such 
as shikonin, alkannin, or murivenna oil have been loaded into electrospun fibres 
and displayed antibacterial activity against S. aureus and E. coli15–17. 
 
Suitable polymers for electrospinning wound healing patches should meet several 
properties: mainly biocompatibility, hydrophilicity, elasticity, and tensile strength 
similar to currently available wound patches. Tensile strength and percent 
elongation at break for a gelatin-based bioadhesive wound dressing material was 
reported to be 12.7 MPa and 40.4% respectively18. PCL electrospun nanofibres had 
a tensile strength of 12 MPa and elongation at break of 98%19. A comparative study 
on commercial wound dressing mechanical properties (including Medifoam N, a 
commercial TPU foam; Allevyn; Biatain; Askina; Lyofoam Extra; Cellosorb 
Adhesive, etc.) have been reported to have the following a tensile strength range of 
0.108-2.43 MPa and percent elongation at break of 180%-1101%20. Hence, tensile 
strength and elongation at break should be ideally in this range. 
 
 
5.2.1. Thermoplastic Polyurethanes 
 
Polyurethanes have been used in many wound healing applications, mainly for their 
versatility. A polyurethane is made of monomer units joined together by carbamate 
(urethane) linkages, which are formed from the reaction of isocyanates and 
alcohols21. A thermoplastic polyurethane or TPU is a type of polymer that becomes 
pliable or mouldable at a certain elevated temperature and solidifies upon cooling. 
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Figure 5.3: Chemical structure of urethane bond by reaction of an isocyanate group and a 
hydroxyl group. When difunctional monomers react, a linear polyurethane forms. 
 
As many medical grade TPUs are commercially available, in this work one of these 
TPUs was selected and processed into an electrospun fibrous patch for wound 
healing applications. Specifically, the focus of Part II in this research (conducted in 
Politecnico di Torino) was based on the application of a commercially available 
TPU for fabricating a wound healing device. The steps of the work were: i) 
electrospinning TPU into a fibrous patch, ii) surface modification of the patch to 
make its surface reactive, iii) grafting of glucose oxidase enzyme on the modified 
patch surface, iv) production of  H2O2 by this functionalized fibrous patch 
exploiting a glucose source, iv) testing patch biological properties, such as 
cytocompatibility. 
 
Tecophilic brand polyurethanes produced by Lubrizol have been used in biomedical 
electrospinning research, with additional substances such as murivenna oil to 
improve hemacompatibility in wound healing and in the fabrication of ventricles 
for an artificial heart17,21,22. In this work, commercially available polyurethanes 
from Lubrizol were selected based on their hydrophilicity and water absorption 
properties. The work was then addressed to obtain reproducible fibrous membranes 
with regular morphology for subsequent modification with GO enzyme. This 
allowed to finally select on TPU material allowing fibre production with no defects. 
The use of a biocompatible material is expected to speed up the preclinical and 
clinical tests needed for the future approval and application of the functionalized 
membrane.  
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5.3. Materials and methods 
 
Chloroform (CHCl3), formic acid (FA), phosphate buffer solution (PBS) - pH 7.4 
tablets were purchased from Sigma Aldrich, Italy. 
 
 
5.3.1. Thermoplastic Polyurethanes for electrospinning 
 
Thermoplastic aliphatic polyurethanes: Lubrizol Tecophilic SP-93A-100, SP-60D-
60, SP-80A-150, Lubrizol Tecoflex SP-80A-150 were provided by Velox GmBH, 
Germany.  
 
As a shorthand, the TPUs were given the codes: 
• A = Tecophilic SP-60D-60 
• B = Tecophilic SP-80A-150 
• C = Tecophilic SP-93A-100 
• D = Tecoflex SP-80A-150 
 
A summary of TPU properties as reported in their specification sheets and provided 
in Table 5.123,24: 
 
Table 5.1. Summary of reported physical and mechanical properties of Lubrizol 
TPUs. 
 SP-80A-150 SP-93A-100 SP-60D-60 SG-80A-150 
Shore Hardness 70A 83A 41D 72A 
Specific Gravity 1.10 1.13 1.15 1.04 
Ultimate Tensile (MPa)   
Dry 13.79 15.17 57.23 39.99 
Wet 4.83 9.65 21.37 - 
Ultimate Elongation (%)  
Dry 1000% 1040% 500% 600% 
Wet 600% 620% 300% - 
Water Absorption 150% 100% 60% - 
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To test their properties, TPU films were prepared via the solvent casting method. 
This consisted of dissolving 1 g of TPU in 10 mL chloroform and pouring the 
polymer solutions into 10 cm diameter glass dishes, taking care that no bubbles 
were formed. These were left overnight under vented hood to evaporate chloroform. 
The films were then peeled out and cut into the appropriate sample shapes needed 
for the characterizations. 
 
 
 
5.3.2. Physical and mechanical properties of TPU cast films  
 
Tests were performed on TPU films to determine their physical mechanical 
properties to select suitable TPUs for wound healing patches. Primarily, one 
important factor in TPU selection was surface hydrophilicity as it would improve 
surface functionalization via mussel inspired coating. Additionally, hydrophilic 
materials are also useful to absorb wound exudates.  It is also ideal that the 
mechanical properties of the TPUs are in the range of the values listed for several 
commercial wound dressings mentioned in Section 5.2. 
 
 
5.3.2.1. Static Contact Angle 
 
Static contact angles were measured at room temperature using a CAM 200 
Instrument (KSV NIMA, Biolin Scientific, Finland) equipped with an Attention 
Theta software (Biolin Scientific, Finland) for data acquisition. Three Milli-Q water 
droplets (volume 5 μL) were deposited on each 1 cm x 5 cm TPU film sample and 
data were collected thereafter for 10 s with a time frame of 10 ms. The data were 
expressed as mean value ± SD from 6 measurements. 
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5.3.2.2. Water Absorption and dry weight loss measurements 
 
TPU film samples were cut to obtain squared samples of 1 cm per 1 cm area. Each 
dry sample was weighed (W0) and placed in a bijoux vial. Next 5 mL of 7.4 pH PBS 
was pipetted into the vial and samples were incubated at 37°C for specific time 
points, including short term analysis (2, 4, 6, 8, 24 hours) and long term 
measurements (1, 2, 3, 4 weeks). At each time point, the samples were withdrawn 
from vials and placed in a paper towel until they were free of water droplets and 
weighed to measure the wet weight of the sample at time t (WWt). The samples were 
then dried in the incubator overnight to remove the absorbed moisture. The samples 
were weighed to measure their dry weight at time t (WDt). WDt lower than W0 this 
was an indication of degradation or dissolution. Measurements for each TPU type 
were carried out in quadruplicates. 
 
The equation for water absorption used is: 
%𝑎𝑑𝑠𝑜𝑟𝑝𝑡𝑖𝑜𝑛𝑡 =
𝑊𝑊𝑡 − 𝑊0
𝑊0
∗ 100% 
 
The equation for dry weight loss is: 
%𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛𝑡 =
𝑊0 − 𝑊𝐷𝑡
𝑊0
∗ 100% 
 
 
5.3.2.3. Tensile mechanical Testing 
 
The mechanical properties such as tensile strength, Young's modulus, and 
elongation at break are important factors in characterizing TPUs for wound dressing 
applications. These factors indicate the ability of the material to maintain integrity 
during the processing, surface modification, and application on wounds (especially 
when the patient is moving). Films were cut into dog bone shapes with the test area 
having dimensions: 5 mm x 15 mm. Thickness was measured by a digital caliper. 
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The cross sectional area was calculated as the thickness multiplied by 5 mm. Stress 
was calculated as the measured force over this cross sectional area. Samples were 
measured in triplicates per TPU type. 
 
Mechanical properties of the films were measured using a Universal Testing 
Machine MT®S QTest ™/10. The traction force was applied along the length of the 
samples at a displacement rate of 10 mm/min with a 50 N load cell. A readout of 
the maximum length (Lmax) was also given by the testing machine which can be 
used for calculating the ultimate elongation percentage with the original length (L0) 
of the sample. The equation used is: 
𝑈𝑙𝑡𝑖𝑚𝑎𝑡𝑒 𝐸𝑙𝑜𝑛𝑔𝑎𝑡𝑖𝑜𝑛 % =
𝐿𝑚𝑎𝑥 − 𝐿𝑜
𝐿0
∗ 100% 
 
 
5.3.3. Electrospinning of TPU patches, imaging of electrospun 
fibres, and optimization of process parameters 
 
An electrospinning apparatus (Linari Engineering SRL, Italy) was used to obtain 
the electrospun TPU fibrous membranes. This includes the syringe pump and 
voltage supply. In finding the optimum parameters, the following range of values 
were used: 
• Voltage: 20-25 kV 
• Syringe pump feed rate: 1.0-1.5 mL/h 
• Polymer concentration in solvent: 10-15 w/v% 
• Solvent type: chloroform (pure); chloroform (90 v/v%) + formic 
acid (10 v/v%) 
 
The distance between the spinneret and the metal collector was set at 20 cm and the 
polymer solution was extruded out of a 21 G metal needle. After the optimal settings 
using chloroform were obtained, with respect to the voltage, feed rate, and polymer 
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concentration, the set-up was further optimized by observing if an improvement in 
fibre consistency would be obtained in modifying the organic solution from pure 
chloroform to an organic solution consisting of 10 v/v% formic acid (FA) and 90 
v/v% CHCl3. The addition of FA was considered to increase conductivity in the 
polymer solution through an increased level of free ions (CHOO- and H+)25. 
 
 After electrospun fibres were formed and collected, they were analysed under a 
scanning electron microscope (SEM) with regards to their morphological 
properties. Scanning Electron Microscopy was performed using a LEO 1420 
microscope (Zeiss, Germany) at 20 kV and a working distance of 15 mm. The 
diameters of the fibres in electrospun membranes were measured on SEM images 
using ImageJ software. Measurements in the diameter were taken from thirty 
random locations  and one-way ANOVA was used to determine if there is a 
significant difference in the fibre diameters from the electrospinning set-ups that 
were used. 
 
 
5.4. Results and discussion 
 
 
5.4.1. Static contact angle of TPU cast films 
 
 
Figure 5.4 shows the static contact angle measurements of the different solvent-cast 
TPU films. In contact angle measurements, a material which gives a value less than 
90° is considered to be hydrophilic26. The hydrophilic TPUs were:  A (72±2.9°) and 
C (78.6±0.4°). ANOVA test showed that at a significance level of 0.05 the contact 
angles between all the materials were significantly different from each other ( p-
value <0.00001). It is worth noting that while the differences between TPU A and 
TPU C were statistically significant, the averages of the two materials were close 
in value that they could be similar enough in terms of hydrophilic property. This 
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property of hydrophilicity is important to allow the material to be functionalised by 
mussel-inspired strategy. 
 
 
Figure 5.4: Static Contact Angle Measurements of TPUs. Columns are the average 
values and bars are the standard deviation. 
 
 
5.4.2. Swelling and degradation results of TPUs 
 
Figure 5.5 shows the short term swelling (2-24 hours) of the TPUs while Figure 5.6 
shows the long term swelling of the TPUs (1-4 weeks). In the long-term study, 
samples were also monitored to detect signs of significant degradation or 
dissolution. 
 
In Figure 5.5, A, B, and C TPUs displayed the ability to swell and take in water 
despite B had a low surface hydrophilicity in the contact angle test. When the TPUs 
were ranked based on highest to lowest percent water absorption from all the time 
points, B was found to have the highest, then followed by C, A, and finally D. As 
D was not part of the Tecophilic polymer series (which are water adsorbing TPUs), 
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it was not unexpected that it did not swell or adsorb water given that its material 
product sheet did not mention any water retention values as it did for A, B, and C.  
 
The water adsorption of TPU A and TPU C slightly decreased after the first 8 hours 
before increasing to the starting value after 24 hours. There was a slight decrease in 
the measurement of water adsorption for B from 1 hours (96.9±7.0%) to 3 hours 
(73.8±6.5%) but it eventually returned to 97.2±4.3% after 24 hours. The reason for 
the decreased water adsorption is not clearly known but it is probable that the 
polymer interstices in the film were expanding (more water could be absorbed) and 
contracting (less water could be absorbed) before approaching equilibrium swelling 
value. 
 
 
 
Figure 5.5: Short-term water adsorption results for TPUs. 
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adsorption was around 40% from 1 to 3 weeks and increased to 60.6±3.0%, after 4 
weeks. In the case of TPU D, water adsorption was close to 0% at each time-point. 
In summary, after 4 weeks, TPUs B, C, and A had the water adsorbing values of 
122.3±5.5%, 92.3±2.1%, and 60.6±3.0%, respectively. These values are similar to 
the reported water adsorption data in the Lubrizol material data sheet with TPU B, 
C, A having 150%, 100% and 60% water adsorption percentage, respectively.  
 
Looking at the water absorption values from the short-term and long-term data, it 
was observed that despite some fluctuations, TPUs A, B, and C retained a certain 
minimum water content throughout the experiment. This can be attributed to the 
water retained through hydrophilic interactions with the polymer. 
 
 
 
Figure 5.6: Long-term water adsorption results for TPUs. 
 
Regarding material degradation, no significant change in the dry mass (less than 
1% its original weight) was observed after 4 weeks (data not reported). It can be 
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D did not adsorb water. No signs of degradation could be detected for each TPU up 
to 4 weeks. 
 
 
 
5.4.3. Mechanical test results 
 
 
Figure 5.7 shows the stress strain curves of the four TPU films (obtained from a 
Trial 1 out of the 4 sets performed) to show their general trend. In each trial, the 
ultimate tensile strength and Young’s modulus was calculated before being reported 
in Figure 5.8 as the average of these values. In comparing the values with 
commercial wound dressings, a material is considered suitable for electrospinning 
if it has the following mechanical properties: 0.108-2.43 MPa for ultimate tensile 
strength and percentage of elongation at break of 180%-1101%20. 
 
 
Figure 5.7: Stress-strain curves of the four TPUs (Trial 1 measurements). 
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Figure 5.8 shows the dry ultimate tensile strength (UTS) and Young’s modulus of 
the TPU samples. TPU B (27.8±3.5 MPa) had the highest ultimate tensile strength, 
followed by TPU D (13.1±0.9 MPa), TPU A (10.4±0.7 MPa), and finally TPU C 
(7.6±0.5 MPa).  All of the TPUs had UTS values higher than the upper limit of 2.43 
MPa, which means that they have better tensile properties than the current wound 
dressings and can withstand the wear and stresses that wound dressings undergo. 
 
A high Young’s modulus means that the material is relatively stiff and it will only 
change its shape slightly when a load is applied. For most polymers, they are ranged 
from <10 to 104 MPa with foams being the lowest in value and an elastomer such 
as rubber having approximately 0.3 MPa27,28. TPU A (25.2 ± 1.5 MPa) had the 
highest Young’s modulus, followed by TPU C (14.0 ± 0.3 MPa), TPU B(10.4 ± 2.0 
MPa), and finally TPU D (5.9 ± 2.4 MPa). As expected, TPU D which is from a 
flexible series (Tecoflex) instead of the hydrophilic series (Tecophilic) had the most 
elastic property among the TPU. 
 
 
Figure 5.8: Ultimate tensile strength properties of TPUs. 
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Figure 5.9 shows the stress vs elongation profile of the TPUs obtained from Trial 
1. The ultimate elongation percentage was taken as the average maximum length, 
Lmax, from the four measurements for each TPU performed. 
 
 
Figure 5.9: Stress-elongation curves of the four TPUs (Trial 1 measurements).   
 
 
Figure 5.10 shows the ultimate elongation percentage of the TPUs: they were 
stretched to lengths several times their original length before breaking in two pieces. 
All TPUs could undergo wide deformation without rupture, which is desirable in 
wound dressing that undergo physical and mechanical stresses when applied to 
patients. TPU B had the highest percentage of elongation of 833±115%, followed 
by TPU D (742±116%), TPU C (397±26%), and TPU A(386±63%). The percent 
elongation between TPU B and TPU D had no statistical difference found between 
them. Also the percentage elongation between TPU A and C appeared similar 
enough and  upon further t-test analysis it was found that there was no statistical 
difference to be found between them (p = 0.79). All of these values, even the lowest 
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which is TPU A fall in the range of acceptable ultimate percent elongation for 
wound dressing materials. 
 
 
Figure 5.10:  Ultimate Elongation Percentage of TPUs. 
 
 
All of the polymers had mechanical properties that fall in the range commercial 
wound dressings, making them acceptable to be processed into wound healing 
materials.  
 
 
5.4.4. Electrospinning of whitelisted TPUs and morphological 
characterization 
 
 
5.4.4.1. Morphological characterization of electrospun TPU patches 
 
Among the TPUs, TPU A (SP-60D-60) and C (SP-93A-100) were selected to be 
used for electrospinning as they had the lowest static contact angle values, :  
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they were able to retain water at least 40% of their weight (44.7±2.7% for A and 
72.0±5.0% for C).  Hydrophilic behaviour is required for further functionalization 
by mussel-inspired approach (Chapters 6-7). Water retention ability is an important 
property for wound healing as for example it allows exudate adsorption. Finally, 
mechanical properties as reported in Section 5.4.3 were within the range of values 
for the ultimate tensile strength and ultimate percent elongation for commercial 
wound dressings. 
 
Selected polymers were electrospun at varying flowrates and voltages while the 
distance of needle to collector (20 cm) and polymer in chloroform concentration 
(15 w/v%) were kept constant. Morphology of electrospun membranes is shown in 
Figure 5.11 and 5.12. 
 
Figure 5.11 shows electrospun TPU A membranes prepared using different 
flowrates and voltages: it was observed from comparing Fig 5.11a with Fig. 5.11c 
(flowrate held constant at 1.0 mL/h) and Fig. 5.11b with Fig. 5.11d (flowrate held 
constant at 1.5 mL/h) that more defects and more irregular fibre diameters were 
obtained at a voltage of 25 kV respect to 20 kV, thus the voltage of 20 kV is the 
more favourable parameter. Furthermore, the fibres were more uniform in Fig. 
5.11b (flowrate 1.5 mL/h) than in Fig. 5.11a (flowrate 1.0 mL/h). Best morphology 
for TPU A fibrous patches was the one fabricated using 1.5 mL/h and 20 kV as 
presented in Figure 5.11b. 
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Figure 5.11: TPU A (SP-60D-60) electrospun fibres: a) 20 kV + 1.0 mL/h, b) 20 kV + 
1.5 mL/h, c) 25 kV + 1.0 mL/h, d) 25 kV + 1.5 mL/h 
 
 
Figure 5.12 shows electrospun TPU C membranes prepared using different 
flowrates and voltages: it was observed that comparing Fig. 5.12a with Fig. 5.12c 
(flowrate held constant at 1.0 mL/h) and Fig. 5.12b with Fig. 5.12d (flowrate held 
constant at 1.5 mL/h) that more defects and more irregular fibre diameters were 
obtained at a voltage of 25 kV than 20 kV, thus the voltage of 20 kV is the more 
favourable parameter. Furthermore, the fibres were more uniform in Fig. 5.12a 
(flowrate 1.0 mL/h) than in Fig. 5.12b (flowrate 1.5 mL/h). Best morphology of 
TPU C patches was the one fabricated with 1.0 mL/h and 20 kV as presented in Fig. 
5.12a. 
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Figure 5.12: Type C (SP-93A-100) TPU electrospun fibres: a) 20 kV + 1.0 mL/h, b) 20 
kV + 1.5 mL/h, c) 25 kV + 1.5 mL/h , d) 25 kV + 1.0 mL/h 
 
 
Figure 5.13 shows the effect of 10 w/v% polymer solution concentration on fibre 
morphology. Parameters kept constant in this setup were: 25 kV applied voltage, 
1.5 mL/h flowrate, 20 cm distance between collector and needle. TPU A samples 
were beads sprayed onto the collector while TPU C appeared to have some small 
fibres connecting one bead to another.  
 
Surface tension decreased with concentration, leading to spraying in the case of 
TPU A. In the case of TPU C, beaded defect were present due to incomplete solvent 
evaporation. Hence, 10% was not a correct solution concentration to be used for 
electrospinning.  
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Figure 5.13: TPU A (left) and C (right) electrospun in 10 w/v% chloroform. 
 
 
The next step in the electrospinning optimization was to find a co-solvent that 
would improve the conductivity of the solution in order to create thinner fibres. 
This was done by dissolving the polymers in a blend of 90 v/v% chloroform and 10 
v/v% formic acid to provide ionic charges of HCOO- and H+ in the solution.  
Polymer concentration was still maintained at 15 w/v% in this solvent mixture. The 
best electrospinning parameters for TPUs A and C selected using chloroform 
solutions were then applied to polymer solutions in solvent mixture. These 
parameters are summarized in Table 5.2. 
 
Table 5. 2. Shorthand for electrospinning parameter set-ups  
 
I II III IV 
Polymer (TPUs) C C A A 
Concentration (w/v%) 15 15 15 15 
Voltage (kV) 20 20 25 20 
Flowrate (mL/h) 1 1.5 1.5 1.5 
Nozzle-collector distance (cm) 20 20 20 20 
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Figures 5.14 to 5.17 show the comparison of SEM morphology of membranes 
electrospun using parameters in Table 5.2 with and without the addition of formic 
acid to the polymer solution. Generally, while some defects can still be observed, 
upon SEM observation the fibres in the chloroform/formic acid (CHCl3/FA) 
solution had better consistency and appeared thinner than their counterparts. Thus, 
the addition of formic acid, increasing the conductivity of TPU polymer solution, 
was an effective approach for improving electrospinning.  
 
 
Figure 5.14: Electrospinning Setup I 
 
 
Figure 5.15: Electrospinning Setup II 
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Figure 5.16: Electrospinning Setup III 
 
 
 
Figure 5.17: Electrospinning Setup IV 
 
Using ImageJ software, the diameters of the fibres were measured by taking 30 
random measurements in the SEM images. Values are plotted in Figure 5.18 and 
tabulated for further clarification in Table 5.3. By adding formic acid into the 
solvent, in a setup with the same operating parameters, the fibres became much 
thinner and more uniform based on their decreased standard deviation. Additionally 
they could densely deposit on the collector (Fig. 5.14-5.17).  
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Figure 5.18: Measurement of average fibre diameters. 
 
 
Table 5.3. Tabulation of fibre diameters of electrospun TPUs 
 
Chloroform only Chloroform + Formic Acid 
I II III IV I II III IV 
Average 
(μm) 2.5 2.1 3.0 3.2 1.4 1.4 1.2 1.1 
SD (μm) 0.7 0.7 1.1 1.1 0.6 0.4 0.3 0.3 
Min (μm) 1.4 1.0 0.8 1.4 0.7 0.7 0.7 0.7 
Max(μm) 3.7 3.6 5.6 6.4 3.1 2.2 1.8 1.7 
         
% SD 26.8 32.7 37.4 36.1 38.4 29.0 27.3 26.5 
 
TPU A or Lubrizol Tecophilic SP60D60 was finally selected based on its 
hydrophilic properties, good mechanical performance, and when electrospun in 
different parameters it gave the thinnest and most consistent fibres. The polymer 
solution was also much more convenient than TPU C to handle as it was not too 
viscous nor too runny and did not clog the electrospinning needle as often as TPU 
C did when being electrospun. 
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The optimal electrospinning parameters were: 15 w/v% TPU A solution 
concentration in an organic solvent that consists of 90 v/v% chloroform and 10 
v/v% formic acid; flowrate of 1.5 mL/h through a 21 G needed placed at a distance 
of 20 cm from the collector with an applied voltage of 20 kV. The final electrospun 
product appeared as a thin elastic sheet. Upon SEM analysis of this material, a 
network of thin fibres randomly arranged to form a mesh-like structure of randomly 
arranged fibres was observed. 
 
 
5.5. Conclusions 
 
In this work, four types of commercially available TPUs were characterized: 
Lubrizol Tecophilic SP60D60 (TPU A), Lubrizol Tecophilic SP80A150 (TPU B), 
Lubrizol Tecophilic SP93A100 (TPU C), Lubrizol Tecoflex SP80A150 (TPU D). 
Considering tensile mechanical properties, these materials showed ultimate tensile 
strength and elongation percentage at break values which were within the reported 
ranges for commercially available polymer wound dressings. Hence, the selection 
was mainly based on hydrophilicity (static contact angle and percentage of water 
absorption). Based on that, TPU A and TPU C were electrospun at different 
parameters and their morphology was assessed based on reduced number of defects, 
fibre thickness, and fibre consistency. 
 
Finally, TPU A/Lubrizol Tecophilic SP60D60 (an aliphatic polyether as described 
in the material data sheet) yielded the most optimal results for electrospinning as it 
produced the thinnest fibre diameters with the lowest standard deviation, suggesting 
uniform structure. Optimal electrospinning parameters were: 15 w/v% polymer in 
organic solution (90 v/v% CHCl3, 10 v/v% formic acid), 20 kV voltage, 20 cm 
distance between the spinneret and the metal collector,  1.5 mL/h feed rate through 
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a 21 G needle. Such random fibrous patches showed an average fibre diameter of 
1.1 ± 0.3 μm.  
 
 In terms of physical and mechanical properties, films of the selected TPU had a 
static contact angle of 72.0±2.9°, water absorbance of 44.7±4.9% after 24 hours and 
60.6±3.0% after 4 weeks, ultimate tensile strength of 10.4±0.7 MPa, and Young’s 
modulus of 25.1±1.5 MPa, elongation percentage of 386±63%. The final 
electrospun product appeared as a thin, elastic sheet. Upon SEM imaging of this 
material, a network of thin fibres randomly arranged to form a mesh-like structure 
was revealed. This would be useful for applications where the loading of drugs or 
antibacterial agents should be performed. It also has the potential to act as a scaffold 
for cells to grow into and to be utilized for wound healing purposes. In later 
chapters, its application as a honey-mimetic wound healing device via polyDOPA 
surface modification to graft glucose oxidase enzymes will be explored and 
discussed. 
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Chapter 6 Preparation and 
Characterization of "Bio-
artificial" Electrospun TPU 
Wound Healing Patch 
  
6.1. Abstract 
 
This chapter describes GO enzyme surface functionalization mediated by 3,4-
dihydroxyphenylalanine (DOPA)-based coating - polyDOPA (PDA) -  with the aim 
to prepare ROS-producing electrospun wound patches, made of a medical grade 
commercially available thermoplastic polyurethane (TPU). One commercially 
available TPU was selected for its hydrophilic properties, tensile strength, 
elongation properties, and was processed by electrospinning to form membranes 
which pores may allow glucose and H2O2 diffusion (Chapter 5), facilitating both 
the formation and the release into the wound of antibacterial H2O2 . Electrospun 
TPU fibrous patches discussed in Chapter 5 were proposed as the protective 
covering of the wound dressing hydrogels discussed in Chapters 2-3, while 
providing an additional source of antibacterial ROS. 
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The current chapter clarifies the design of the GO-functionalized TPU wound 
patches. The theoretical background behind the DOPA-mediated method of 
functionalization and surface modification of the wound patch with GO is here 
discussed while the subsequent chapters deal with the experimental preparation of 
the functionalized TPU patches. TPU patches could also be used alone (without the 
underlying hydrogel) and ROS could also be produced by periodically adding a 
glucose-releasing hydrogel on the top of the TPU covering (Chapter 8). 
This “bio-artificial” wound healing patch, based on a synthetic polymer (TPU) and 
a natural component (GO) was developed at Politecnico di Torino.   
 
 
6.2. Introduction 
 
6.2.1. Improved design for wound healing and protection 
 
Taking the concept of enzyme immobilization from Chapter 4, this is here applied 
to the development of a dual-purpose wound patch that can both protect the 
antibacterial hydrogel (e.g. HB PEGDA/HA-SH loaded with glucose oxidase and 
glucose) from outside contamination and provide an additional method of ROS 
production through its surface-immobilized GO enzyme. Additionally, this system 
differs from the immobilized-GO system in Chapter 4 in that the immobilized 
enzymes are confined on the substrate surface instead of being immobilized 
throughout the hydrogel.  
 
This wound patch should let H2O2 be formed from glucose embedded in the bottom 
HB PEGDA/HA-SH hydrogel or added on its top through an additional top 
hydrogel and allow H2O2 diffuse into the bottom hydrogel layer.  
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6.2.2. Requirements of wound healing patches 
 
In designing wound healing devices, the material should meet the following general 
requirements: cover the wound to prevent infection, provide a moist and warm 
environment, and be physically and chemically compatible to the nature of the 
wound1. Additional specific requirements of wound patch here designed are 
hydrophilicity and porous structure. The desired wound healing properties have 
been discussed more in depth in Chapter 1 and 5. 
 
 
6.2.3. State of the art of polymers for wound healing patches 
 
Apart from wound healing hydrogels which were previously discussed from 
Chapters 1 to 4, other polymeric wound patches also exist with different wound 
healing functionalities such as foams, fibres, and films.  
 
Porous polymer foams have been applied in wound healing and are commercially 
available such as Simpurity, a polymer pad which was reported to have an 
absorption capacity of more than 10 times its weight among its listed properties2. 
Wound dressings made of polyurethane flat foams have been produced by Finesse 
Medical, Ltd3.   
 
Among a list of polymer processing technologies, electrospinning polymers into 
non-woven fibres provide particular interest in wound healing applications as they 
are capable of exhibiting a texture similar to textiles while having a porous structure 
that would allow the drainage of wound exudates and the permeation of oxygen into 
the wound for healing4.  
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Other properties that make electrospun fibres relevant to wound healing are: i) their 
ability for long term delivery of bioactive compounds to tissues at the wound site, 
ii) ability for physical protection of the wound, iii) loading of up to 40% of drugs, 
with the release controlled by manipulating the type and composition of the 
fibres4,5. 
 
Electrospun fibres can also be surface modified in order to immobilize enzymes. 
Enzyme grafting was mediated by “mussel-inspired” pre-coating6–8. For this 
research, thermoplastic polyurethanes (TPUs) were selected as the polymer 
substrate for electrospinning, surface functionalization, and immobilization given 
their established versatility in wound healing applications9–11. The substrate used in 
this chapter was Lubrizol SP60D60 TPU fibre patch fabricated in Chapter 5, which 
was coded here simply as TPU since only one type of polyurethane was used. 
 
 
6.2.4. Coating techniques for wound healing patches 
 
To give the TPU adhesive properties for the purposes of adhering to the hydrogel 
tissue and immobilizing GO, the concept of mussel-inspired coatings was exploited. 
This mussel-inspired coating is based on the substance secreted by mussels which 
is a type of liquid protein that hardens rapidly into a solid, water-resistant adhesive 
material12. This liquid protein was found to contain 3,4-dihydroxyphenylalanine 
(DOPA) , a catechol containing amino acid12. When L-DOPA is in a basic solution 
such as pH 8.5 and has access to oxygen (i.e. the solution is aerated by stirring or 
shaking), it oxidizes to form polyDOPA. The chemical structure of L-DOPA is 
show in Figure 6.1. Upon oxidation, it may deposit onto almost any type of substrate 
(metals, glass, polymers, etc.), coating the material in the form of a crosslinked and 
branched polymer, polyDOPA8.   
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Figure 6.1: Chemical structure of L-DOPA 
 
 
6.2.4.1. Applications of polyDOPA coatings 
 
Figure 6.2 shows the oxidation of L-DOPA into polyDOPA13. Upon L-DOPA 
oxidation, polyDOPA (PDA) deposits itself into the substrate: this coating contains 
a type of functional group, called quinone, to which various molecules can be 
grafted, such as bioactive molecules, growth factors, and enzymes14 (see Figure 6.4 
for these types of reactions).  
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Figure 6.2: Oxidation process of L-DOPA into polyDOPA 
 
Polydopamine was used for coating materials in some studies (derived from 
dopamine) while other studies utilized polyDOPA (produced from DOPA) and 
authors generally assigned the acronym PDA to the coatings. For this study, PDA 
will refer only to polyDOPA. Such coating is used in a wide variety of biomedical 
applications, having adhesive properties for surface functionalization in binding 
bioactive molecules, growth factors, enzymes, and biomimetic molecules (e.g. 
gelatin and chitosan) 15–17. Figure 6.3 shows polyDOPA and polydopamine 
formation from their monomer units and their polymer structure. 
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Figure 6.3: Structure of L-DOPA, dopamine, and their polymer 
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The coating process by self-oxidation requires immersing the material in a 
dopamine or in a DOPA solution (e.g. 2 mg/ml dopamine in, pH 8.5 in TRIS buffer 
10 mM) for 8-24 hours17–22. By using a catalyst (organic or inorganic) this reaction 
has the potential to be made much quicker, reducing the required time for surface 
modification and potentially resulting in a thicker PDA coating in the substrate. 
 
What makes PDA versatile for binding an array of organic molecules is its ability 
to covalently react with functional groups such as imidazole, amine, or thiols as 
reported in Figure 6.423. In immobilizing enzymes, the main mode for conjugating 
them to the PDA-coated substrate is to take advantage of Michael type addition 
which can occur in mild aqueous conditions. 
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Figure 6.4: Possible reaction pathways in a PDA-coated surface (R’ = polymeric 
backbone). Image drawn by the author, modified from Bazaka, K., et al. (2015)24. 
 
 
6.2.4.2. Immobilization of enzymes on PDA-coated surfaces 
 
In a study carried out by Zhou L., et al (2014), graphene oxide was coated with 
polydopamine and the model enzyme was glucose oxidase25. Results showed that 
the following properties were improved after immobilization: thermal and pH 
stability, storage stability, and resistance towards GO-denaturing agents, with the 
immobilized enzyme activity almost identical to the free enzyme activity25. Thus, 
an electrospun TPU can be fabricated and coated with PDA, as shown in Figure 
6.5, creating an intermediate material, TPU-PDA. When coated, the material 
exhibits a light brown to black colour due to the PDA deposition on the substrate. 
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Using an oxidizing catalyst, the rate of deposition can be manipulated and 
increased. 
 
 
 
Figure 6.5: PDA-coating of electrospun thermoplastic polyurethane fibre patch (end- 
product named as TPU-PDA). 
 
 
After the fibre patch was coated with PDA, glucose oxidase was immobilized onto 
the TPU-PDA material by immersing the substrate into a GO solution. Through 
primarily Michael type addition of R’-NH2 functional groups, the enzyme binds 
itself to the PDA substrate, where the quinone groups form from catechols, as 
shown in Figure 6.6. The lateral amine groups of the enzyme (such as those found 
in arginine, lysine, and glutamine) reacts with the quinone groups in the PDA 
coating and the enzyme is grafted into the TPU fibre substrate. 
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Figure 6.6: Enzyme immobilization on TPU-PDA (end-product named as  
TPU-PDA-GO). 
 
 
Figure 6.7 shows a few of the possible reaction pathways of three amino acids that can be 
found in enzymes with the quinone groups in a PDA-coated material. They show the amino 
acids grafted at one site in the phenol ring however, they can also graft itself in other 
locations as depicted in Figure 6.4. 
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Figure 6.7: Reaction of several amino acids with a quinone group 
 found in a PDA-coated substrate. 
 
 
6.3. Theoretical design of multilayer wound healing 
patch 
 
In the next chapters 7 to 8, the development of a glucose oxidase-immobilized, 
PDA-coated, electrospun TPU (TPU-PDA-GO) fibre patch will be described. The 
electrospun fibre patch (with its fabrication and characterization process described 
in chapter 5) can be used as a protective covering for the HB PEGDA/HA-SH 
hydrogel containing GO enzyme and glucose, as depicted in Figure 6.8 which 
schematically shows the multilayer wound patch. This protective fibre patch can 
also serve as an additional ROS source, exploiting both glucose contained in the 
bottom hydrogel and released from an additional top hydrogel. Particularly, the top 
glucose-loaded hydrogel can be removed and replaced to replenish the glucose 
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source, during the wound healing process without the need to peel off the HB 
PEGDA/HA-SH hydrogel and the TPU-PDA-GO wound patch. 
 
 
Figure 6.8: Overall multilayer antibacterial ROS-producing wound healing device 
 
An alternative use for the fibre mat is to directly place it on the wound surface 
without the GO/glucose loaded bottom hydrogel and to deliver a replenishable 
glucose source on top of the TPU-PDA-GO fibre mat.  
This represents an innovative application. In the previous literature,  Lin CC., et al. 
(2016) showed that PDA-coated electrospun fibre mats cultured with adipose-
derived stem cells were capable of osteogenesis15. A PDA-coated electrospun fibre 
mat has also been used as a wound healing scaffold when grafted with basic 
fibroblast growth factor in the study carried out by Sun, X., et al. (2014)26.  
In this work, TPU-PDA-GO will potentially function as an antibacterial wound 
healing patch to be used alone or in combination with HB PEGDA/HA-SH 
hydrogel and will help tissue regeneration acting as a tissue scaffold. 
 
The next chapters will deal with the development of the TPU-PDA-GO electrospun 
fibre patch and finally the glucose-loaded top hydrogel as well as their relevant 
physicochemical properties. 
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Chapter 7 PolyDOPA Surface 
Coatings of Selected Wound 
Healing Thermoplastic 
Polyurethane Patch 
  
 
 
7.1. Abstract 
 
In this work, polyDOPA (PDA) coating was deposited on electrospun TPU fibre 
patches to produce TPU-PDA surface functionalized patches. PDA 
functionalization was performed as an intermediate coating for further surface 
grafting with GO enzyme. As a novelty, this chapter focuses on the use of an 
oxidizing enzyme, lactoperoxidase (LPO) to reduce the time required for PDA 
surface functionalization.  
TPU fibre patches were immersed in a solution of DOPA at alkaline pH in aerated 
conditions: DOPA underwent oxidation into polymerizing DOPAquinone, 
gradually forming polyDOPA. The rates of DOPA oxidation changed based on the 
addition of different quantities of LPO. Based on absorbance measurements of 
polyDOPA solutions at 450 nm, it was found that the addition of 1.4 U/mL LPO to 
DOPA solution (2 mg/mL in 10 mM TRIS buffer at pH 8.5) reduced the coating 
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time from 7 hours to 2.5 hours respect to enzyme-free conditions. PDA-coating 
procedures using LPO were set at 3 hours to assure adequate coating.  
Thus, the introduction of LPO in a DOPA (or even dopamine) solution may be used 
to reduce the time needed for PDA formation by dip-coating, to make this type of 
surface functionalization more efficient. This part of the activity was carried by the 
Ph.D student at Politecnico di Torino. 
 
 
7.2. Introduction 
 
7.2.1. Oxidation mechanism of mussel inspired L-3,4-
dihydroxyphenylalanine (DOPA) 
 
 
Mussels have been observed in marine environment to adhere to all types of 
surfaces, sustaining their bonds through mussel adhesive proteins or MAPs1. There 
are 7-8 different proteins found in the  mussel byssal threads, and six of these 
contain high concentrations of L-3,4-dihydroxyphenylalanine (L-DOPA)2. A 
synthesized adhesive version of this when applied to surface-functionalized 
materials is polyDOPA (PDA) which is formed from the oxidation of L-DOPA 
(other studies utilize the conversion of dopamine into polydopamine). Figure 6.3 
below shows for both L-DOPA and dopamine the structure of the original 
compounds, the quinone derivatives, and their forms as a polymer. 
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Figure 6.3: Structure of L-DOPA, dopamine, and their polymer derivatives. 
 
 
The auto-oxidation of DOPA and dopamine have been treated in various studies. In 
the presence of oxygen, dopamine is found to oxidize into dopaminequinone which 
may polymerise forming polydopamine3. By altering the pH of a DOPA or 
dopamine solution, its oxidation can be manipulated; for example, the addition of 
small amounts of acid can  inhibit the oxidation process4. The step by step oxidation 
reaction from L-DOPA to polyDOPA was presented in Figure 6.2 in Chapter 65. 
Through its mussel adhesive-like properties, this material deposits itself into 
various types of substrates, including electrospun TPU fibres. 
 
In material science applications aimed at mimicking mussel adhesive property, 
polyDOPA or polydopamine  films may be formed on the surface of substrates 
incubated  in a dopamine or  DOPA solution at basic pH (typically at pH 8.5)6. This 
is due to the spontaneous oxidation of dopamine or DOPA followed by its 
polymerization and deposition onto the substrate surface. 
 
171 
 
 
HO
HO
NH2
OHO
O
O
NH2
OHO
HO
HO NH
OH
O
2e-+2H+
Oxidation
OxidationO
HO N OH
O
2e-+2H+
HO
HO NH
OH
O
PolyDOPA
L-DOPA
+
+
O O
NH2+
O-O
HO OH
NH2+
O-O
 
Figure 6.2: Oxidation process of L-DOPA into polyDOPA 
  
A surface-coated polyDOPA or polydopamine material can be grafted with 
compounds or large molecules that contain imidazole, amine, and thiol groups 
which react with the o-quinone group formed in the oxidation of DOPA or 
dopamine (see Figure 6.4). This allows it to immobilize enzymes, growth factors, 
natural polymers (eg. gelatin), etc. onto its surface. It was observed that the o-
quinone group was particularly reactive to compounds with amine and thiol groups 
of the functional groups named7. 
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Figure 6.4: Possible reaction pathways in a PDA-coated surface (R’ = polymeric 
backbone). Image drawn by author, modified from Bazaka, K., et al. (2015)8. 
 
 
7.2.2. Enhancing rate of oxidation of DOPA 
 
One possible coating process requires immersing the material in a dopamine 
solution (e.g. 2 mg/ml dopamine in pH 8.5 in TRIS buffer (10 mM)) for 8-24 hours9–
14). While being immersed, the material – depending on its chemical nature- might 
undergo changes in its physicochemical and mechanical properties as a result of 
material hydrolytic degradation in the basic environment. Reduction in coating time 
could be useful in preserving the material physicochemical characteristics. 
Several studies investigated various agents for increasing the rate of oxidation of 
DOPA into PDA. Self-polymerisation of DOPA or dopamine can be improved by 
increasing the aeration of the solution (e.g. by increasing the rate of agitation or 
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shaking) or temperature, as reported by Zhou, P., et al (2014)15. Another study by 
Ruch, D., et al (2011) increased the rate of oxidation by adding metal ions such as 
copper (Cu2+) or iron (Fe3+), as the metal ions are reduced and gains electrons, the 
DOPA becomes oxidized and loses electrons as shown in Figure 6.216. 
Different oxidizing agents may be used, including hydrogen peroxide, potassium 
permanganate, benzoyl peroxide, acetone, etc17. Even oxygen itself serves as an 
oxidizing agent to DOPA (in turn, DOPA acts as a reducing agent to oxygen with 
trace amounts of hydrogen peroxide produced as a result4). As oxidation proceeds, 
these reagents are consumed and eventually depleted. However, for enzymes they 
act merely as catalysts to enhance the oxidation rate and are not consumed in the 
oxidation process. In this research, enzymes were used as they do not actively take 
part to the reaction.  
 
 
7.2.3. Oxidizing enzymes 
 
Dopamine was found to be oxidized by several enzymes including lactoperoxidase 
(LPO), prostaglandin H synthase, xanthine oxidase, etc3. Among these enzymes 
LPO is the cheapest, it is commercially available, and easily obtained from bovine 
milk18. LPO is stable over a broad pH range of 4-11, which includes the typical pH 
for PDA-coating preparation by self-polymerisation19. Literature on the oxidizing 
effect of enzymes on dopamine did not describe their use for polydopamine coating 
applications, they mainly investigated the mechanism of dopamine oxidation in 
relation to Parkinson’s disease and other neurodegenerative diseases in the presence 
of lactoperoxidase and other previously mentioned enzymes3. Thus, the approach 
in using LPO enzyme for surface coating materials with polyDOPA or 
polydopamine (starting from L-DOPA and dopamine, respectively) is a completely 
novel approach. 
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The main objective of this chapter was to develop a novel, easy and fast process for 
the preparation of PDA-coated electrospun TPU membranes (previously fabricated 
in Chapter 6) using LPO oxydising enzyme, optimizing the process conditions. 
 
 
7.3. Materials and methods 
 
Lubrizol Tecophilic SP-60D-60 was purchased from Velox GmBH, Germany and 
processed into electrospun fibres as described in Chapter 6. 3-(3,4-
Dihydroxyphenyl-2,5,6-d3)-D,L-alanine (D,L-DOPA), TRIS buffer, 
Lactoperoxidase enzyme (LPO, EC number 1.11.1.7, 200 U/mg activity) were 
purchased from Sigma Aldrich, Italy. 
 
7.3.1. Preparation of LPO enzyme solutions 
 
A stock solution of 200 U/mL LPO was prepared by dissolving 10 mg of LPO in 
8.5 pH TRIS Buffer. From this solution, different LPO solutions were derived, as 
listed in Table 7.1, left column. These LPO solutions were mixed with an equal 
volume of DOPA solution (4 mg/L) in TRIS buffer solution. The final L-DOPA 
concentration in these solutions was 2 mg/mL, which is the concentration used in 
most of the PDA-coating studies14,20–22. On the other hand, LPO concentration in 
these solutions is reported in the middle column of Table 7.1 
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Table 7.1. LPO enzyme concentrations used and their respective set-up codes. 
 
 
 
7.3.2. Study of DOPA oxidation rate with lactoperoxidase 
 
In these experiments, the control solution was DOPA (2 mg/mL) without any 
enzyme added (LPO 0). In scintillation glass vials with a magnetic stirrer inside, 5 
mL of 4 mg/mL DOPA solution was pipetted. Afterwards, 5 mL of the various LPO 
enzyme concentrations were added as well (see Table 7.1). Each vial was stirred at 
300 rpm, with the vial uncovered in order for sufficient oxygenation to take place. 
 
At different time points, 100µL samples of each set-up was taken out and put into 
a well of a 96-well plate. Measurements were done in six replicates. The absorbance 
of the solution was measured at 450 nm using a Perkin Elmer Victor X3 multi-mode 
plate reader. In a previous study on the optical properties of eumelanin (dopamine 
is one of its major components) the researchers found that the optical density 
measured at given wavelengths, including 450 nm, could be considered an 
indication of extent of oxidation23. The same concept was here used to measure the 
amount of DOPA oxidized into PDA from the solution absorbance intensity at 450 
nm wavelength. The absorbance intensity of the TRIS buffer solution at 450 nm 
was also measured to establish a baseline. Time points for measurements were fixed 
every 30 minutes for 7 hours. "Full oxidation" absorbance was assumed as the 
reading of the control PDA solution after 7 hours incubation without the enzyme. 
This was based on previous studies by Irene Carmagnola et al. (in course of 
LPO solution 
concentration (U/mL) 
LPO concentration in the 
coating solution (U/mL) Set-up Code 
0 0 LPO 0 or Control 
0.35 0.175 LPO 0.18 
0.70 0.35 LPO 0.35 
2.10 1.05 LPO 1.1 
2.80 1.40 LPO 1.4 
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publication), which showed efficient PDA coating of polymer substrate after 7 
hours incubation in a DOPA solution (2 mg/mL). 
 
 
7.3.3. Surface coating of electrospun TPU with polyDOPA (PDA) 
with/without LPO enhancement (Part I) 
 
Scintillation vials containing the LPO + DOPA solutions were prepared similarly 
to the procedure previously mentioned in Table 7.1. A piece of electrospun TPU (1 
cm x 1 cm) was immersed in each of these solutions. Absorbance readings of the 
solutions were performed every 30 minutes for 7 hours as described in the previous 
Section 7.3.2. This part of the study was carried out to study whether the deposition 
of PDA on the substrate could yield a reduction in the solution absorbance 
measurements, as compared to measurements at Section 7.3.2. After the immersion, 
the film samples were washed in TRIS buffer thrice and dried before they were used 
for analysis. 
 
 
7.3.4. Surface coating of electrospun TPU with polyDOPA (PDA) 
with/without LPO enhancement (Part II) – Scaled-up Surface 
Modification 
 
Based on results from Section 7.3.2 and 7.3.3, two enzyme concentrations were 
selected for PDA coating of a larger quantity of TPU fibres to be used for further 
characterization and application studies.  
Figure 7.1 illustrates the set-up used for coating trials. In 250 mL beakers, 250 mL 
of DOPA only, LPO 1.4 + DOPA, or LPO 1.1 + DOPA solutions were prepared 
(close to the brim but not spilling). In each beaker, 4 strips (1 cm x 6 cm) of 
electrospun TPU were immersed with one end clipped to a rod. Beakers were stirred 
at 300 rpm with no covering to allow oxygenation of the solution. After 3 hours, 2 
strips from each setup were taken out and washed with TRIS buffer pH 8.5 several 
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times. After 7 hours, the final 2 strips from each setup were taken out and washed 
several times with deionized water. A small portion of the films were cut and were 
used for SEM imaging and FTIR analysis, which are described later. 
 
 
Figure 7.1: PDA-coating set-up for electrospun TPU fibres; the scheme of the set-up is 
shown on the left and the actual final product (TPU-PDA-LPO-1.4-7) is shown on the right. 
 
 
7.3.5. SEM analysis of PDA-coated TPU 
 
Scanning Electron Microscopy was performed using a LEO 1420 microscope 
(Zeiss, Germany) at 20 kV and a working distance of 15 mm. The diameters of the 
fibres in electrospun membranes were measured on SEM images using ImageJ 
software. Any difference in the morphology of the coated fibrous patches compared 
to the uncoated fibrous patches was analyzed. 
 
Coated and uncoated samples were analyzed by SEM. To prepare the samples for 
SEM analysis, samples of the modified fibre patch were cut into 2 mm x 2 mm 
squares and mounted onto SEM sample holder using conductive tape. The samples 
were coated with a thin layer of gold using a sputter-coating machine (30 mA, 50 
seconds) to improve its conductivity for imaging. 
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7.3.6. FTIR-ATR analysis of PDA-coated TPU 
 
Attenuated Total Reflectance Fourier Transform InfraRed Spectra (ATR-FTIR) of 
PDA-coated TPU was obtained at room temperature in the spectral range from 4000 
to 400 cm-1 using a Perkin–Elmer Spectrum 100 equipped with an ATR accessory 
(UATR KRS5) with diamond crystal. The spectra, obtained as a result of 16 scans 
with a resolution of 4 cm-1, were analyzed using the Perkin–Elmer Spectrum 
Software. Spectra were recorded on the uncoated TPU fibrous patch, the enzyme-
free PDA-coated TPU fibrous patch (TPU-PDA), enzyme-PDA coated fibrous 
patch (TPU-PDA-LPO) to compare coating efficiency in each case. 
 
 
7.4. Results and discussion 
 
7.4.1. PDA deposition as a function of LPO concentration 
 
Figure 7.2 reports images of a 24-multiwall plate containing the DOPA solution 
and different enzyme concentrations (0-1.4 U/L LPO) after 30 min, 3 hours, and 5 
hours incubation. All the DOPA-LPO starting solutions were transparent and 
indicate no oxidation has taken place yet. After 30 minutes, solutions displayed a 
progressively darker colour as the LPO concentration increased. Images also show 
that each type of solution became darker with increasing time. By hour five, the 
solution colours were nearly indistinguishable in terms of shade and could be 
differentiated precisely by measuring solution absorbance at 450 nm. 
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Figure 7.2: Images of L-DOPA solutions (2 mg/mL) oxidizing into PDA with 0-1.4 
U/mL LPO concentrations (1 column = 4 wells = 1 LPO concentration set-up) at different 
times (30 min, 3h and 5h) 
 
Figure 7.3 presents the measured absorbance of the solutions at a wavelength of 
450 nm as a function of time. The absorbance intensity value of control/LPO 0 
solution after 7 hours (0.764) was considered a reference of significant DOPA 
oxidation to PDA, based on previous investigation at Politecnico di Torino (data 
under publication). Hence, this value was used as a reference when comparing the 
oxidation extent of LPO-containing DOPA solutions relative to the enzyme-free 
DOPA solution. 
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Figure 7.3: Absorbance intensity at 450 nm of DOPA solutions containing different 
enzyme amounts as a function of time, as indicative of PDA formation 
 (SO = Solution only). 
 
Figure 7.4 reports the measured absorbance intensity of solutions at 450 nm when 
TPU patch was incubated in the solution at different times. By adding TPU 
membrane to the PDA-forming solutions, their absorbance intensity decreased 
respect to that of the corresponding solutions shown in Figure 7.3. This was 
attributed to PDA partially depositing on TPU film instead of remaining dispersed 
in the solution.  
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Figure 7.4: Absorbance intensity at 450 nm as a function of time for DOPA solutions 
containing different enzyme amounts, during the incubation of a TPU patch. Absorbance 
values were indicative of PDA deposition on the film, when compared to results in Figure 
7.3 (SO = Solution only). 
 
 
Figure 7.5 compares the behaviour of absorbance intensity for the DOPA solution 
without (SO) and with (WF) TPU film incubation, in the absence of LPO enzyme, 
as a function of time. The absorbance intensity of the solution after TPU membrane 
incubation for 7 h was 0.265 while it was 0.764 in the absence of TPU film. 
Assuming concentration of PDA in the system is proportional to absorbance, this 
means that approximately 65% of the formed PDA (at that time) deposited on the 
film, and that about 35% of the formed PDA remained dispersed in the solution. 
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Figure 7.5: Comparison of absorbance values of DOPA solutions with the same 
concentration (LPO 0) with and without TPU film, as a function of time. 
 
 
When the rate of PDA oxidation increased in the presence of the enzyme, the 
difference in the WF versus SO set-ups decreased as the amount of PDA that 
deposited in the film in faster-oxidizing solutions was only a smaller fraction 
compared to the overall oxidized PDA present in the solution. Figure 7.6 shows the 
behavior of absorbance values for LPO 1.4 with and without TPU film incubation. 
After 7 hours, the absorbance intensity of LPO 1.4 solution at WF condition was 
lower than in the absence of TPU film (SO condition). However, this difference 
was reduced compared to the measured difference between SO and WF solutions 
not contacting the enzyme (Figure 7.5). In the case reported in Figure 7.6, around 
30% of formed PDA was deposited while 70% remained in the solution. This means 
that at a high LPO concentration (1.4 U/mL), the presence of a substrate incubated 
in the DOPA-LPO solution caused a reduced decrease in the overall amount of 
polyDOPA in solution. Adding LPO enzyme increased the rate of oxidation and 
more PDA was formed which only partially could deposit on the substrate. Hence, 
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in the presence of LPO enzyme, the same solution volume could be used to coat 
more samples at the same time. For the procedure of coating, four TPU films were 
incubated in the same DOPA solution volume as described in Section 7.3.4, using 
conditions: LPO 0 and LPO 1.4 (referred to as oxidizing parameters) used with two 
coating times, the original 7 hour coating time and a reduced coating time that will 
be determined in the next section. 
 
 
 
Figure 7.6: Comparison of absorbance times DOPA solutions of the same concentration 
(LPO 1.4) with and without TPU film. 
 
 
7.4.2. Determining time for “reference” oxidation level 
 
The absorbance values reported in Figure 7.3 were used to calculate the oxidation 
percentage of DOPA at time t in the presence of LPO, respect to the reference 
oxidation level of DOPA without enzyme after 7 h, following the equation below: 
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𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑜𝑥𝑖𝑑𝑎𝑡𝑖𝑜𝑛 (𝑂%𝐿𝑃𝑂 𝑥𝑥,𝑡 ℎ) =
𝐴𝑏𝑠𝐿𝑃𝑂 𝑥𝑥,𝑡 ℎ
𝐴𝑏𝑠𝐿𝑃𝑂 0,7 ℎ
∗ 100%
=
𝐴𝑏𝑠𝐿𝑃𝑂 𝑥𝑥,𝑡 ℎ
0.764
∗ 100%     (𝑒𝑞. 7.1) 
 
Where: 
AbsLPO xx, t h = Absorbance of sample with LPO concentration xx at time t. (for 
example: the absorbance of sample with 1.1 U/mL LPO at 4.5 hours is written as 
AbsLPO 1.1, 4.5h. 
AbsLPO 0, 7h = Absorbance of sample with LPO concentration 0 U/mL at time 7 h  
 
 
Using equation 7.1, the absorbance intensity values could be used to calculate an 
oxidation percentage respect to the control set-up (Figure 7.7). At LPO 
concentration higher than 0.35 U/mL, the reference oxidation absorbance value 
(100%) could be reached at earlier times than 7 hours, which suggested that surface 
functionalization of substrates incubated in these solutions could occur faster than 
without enzyme.  
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Figure 7.7: Percentage oxidation of DOPA solutions in different conditions respect to the 
control set-up (SO) 
 
This data analysis was also applied to the absorbance values of the DOPA-LPO 
solutions that contained film samples (Figure 7.8). Particularly, for LPO 1.4 after 
2.5 hours, the percentage of oxidation was 110% relative to the reference value: 
absorbance intensity was 383% higher than the control after 2.5h. By adding an 
extra 30 minutes into this coating time, it can be assumed that sufficient coating is 
achieved by hour 3 for LPO 1.4.  
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Figure 7.8: Percentage oxidation of DOPA solutions in different conditions respect to 
the control set-up (WF) 
 
 
Looking at Figures 7.7 and 7.8, 100% oxidation rate increased in solutions that 
contained LPO. The oxidation time to achieve a certain oxidation level was found 
to decrease (meaning the reaction was much faster) by increasing the amount of 
LPO in the solution. The 100% reference oxidation time for each set-up was 
calculated by interpolating between two data time points with one having an 
absorbance intensity higher than 0.764 (100% or reference value) and the second 
having an absorbance intensity lower than 0.764. The basic interpolation (with Ox 
% for absorbance and t for the corresponding time point) is: 
 
𝑂𝑥 %1 − 𝑂𝑥 %2
𝑡1 − 𝑡2
=
𝑂𝑥 %1 − 𝑂𝑥 %3
𝑡1 − 𝑡3
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where Ox %1> 100% and Ox %3 < 100% which are known values and t2 is the 
unknown "complete" oxidation time. A sample calculation for the complete 
oxidation time of LPO 1.4 is as follows: 
 
Given data for LPO 1.4: at t = 3.5 h, Ox %LPO 1.4, 3.5 h = 89.5%; at t = 4, Ox %LPO 1.4, 
4 h = 107.6% 
 
Calculation: 
107.6% − 100%
4 − 𝑡100%
=
107.6% − 89.5%
4 − 3.5
 
 
𝒕𝟏𝟎𝟎% = 𝟑. 𝟖 𝒉 
 
 
The same calculation was done for the solutions, which contained TPU film: 
oxidation (absorbance value) after 7 hours for the control/LPO 0 set-up (WF) was 
used as a reference value to calculate the approximate time needed for reference 
oxidation. The calculated values are summarized and illustrated in Figure 7.9 
below. 
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Figure 7.9: Estimated time for reference oxidation in PDA-forming set-ups with LPO 
concentrations from 0 to 1.4 U/mL 
 
 
 
7.4.3. SEM analysis of PDA coated TPU 
 
Concerning the procedure of coating larger surfaces described in Section 7.3.4, 
three LPO set-ups were used for SEM imaging, LPO 1.1 and LPO 1.4, along with 
LPO 0 as the control. The TPUs of these LPO-based set-ups were coated with PDA 
at two different settings: 3 hours and 7 hours.  
 
Results from SEM analysis are shown in Figure 7.10 at a magnification of 5000x. 
The fibre diameter for the unmodified TPU was reported in Chapter 5 (1.12±0.30 
μm).  
 
PDA deposited on the TPU membranes (Figure 7.10 b-d) altered the fibre 
morphology with the appearance of larger areas (of a few microns) connecting close 
fibres as emphasized in the green and purple squares in the reported images. This 
feature was more evident with increase of the amount of LPO used. 
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Figure 7.10: SEM images (5000x magnification) of electrospun TPU fibrous 
membranes: a) uncoated, b) PDA-coated (7h), no LPO, c) PDA coated (7 h), 1.1 U/mL 
LPO, d) PDA coated (7h), 1.4 U/mL LPO. 
 
 
Figure 7.11 presents the percentage difference of average fibre diameters for the 
coated respect to uncoated TPU membranes. Higher standard deviations were 
observed in the more LPO-concentrated set-ups. This could be attributed to the 
PDA depositing more preferentially in some areas. 
 
Statistical analysis was used to compare the data and showed that there was a 
significant difference in fibre diameter change for the all PDA-coated materials 
(including LPO 0) when compared to the unmodified/uncoated fibre diameter. 
Starting with the lowest concentration, LPO: there was a  very significant difference 
in the measured fibre diameters for the unmodified TPU with the LPO 0 coated 
TPU (p = 0.01). 
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 However when comparing the fibre diameter change of LPO 0 with other LPO 
concentrations, there was no significant difference between them. For example, in 
comparing the fibre diameters of LPO 0 with LPO 1.4, there was no significant 
difference found between them (p = 1.00). This was the case as well for the other 
LPO concentrations used when compared with LPO 0, that the difference in fibre 
diameters was not significant. 
 
 
Figure 7.11. Percentage of fibre size difference when coating electrospun TPU fibres 
with PDA in the presence of difference LPO concentrations. Data were derived from an 
average of 40 measurements per each SEM image by ImageJ software. 
 
 
Overall, relative to the original fibre diameter, the PDA-coated samples were 
thicker by as much as 15-42% as PDA deposited on the fibre mats as evidenced by 
the darkened colour of the samples. 
 
 
7.4.4. FTIR analysis of PDA coated TPU 
 
Figure 7.12 shows the FTIR spectra of three samples: uncoated TPU in purple; 
PDA-coated (without using LPO) in red, and PDA-coated (using LPO 1.4) TPU 
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membrane in green. To maximize the amount deposited on the TPU, samples 
prepared with a PDA coating time of 7 h were used in the analysis. 
 
From the information that can be gathered in the material specification sheet, 
Lubrizol SP-60D-60 (the TPU used in this experiment) was classified as an 
aliphatic polyether thermoplastic polyurethane. The strong absorbance band at 1098 
cm-1 was assigned to the C-O stretching and confirms the presence of ether bonds 
in the polymer backbone. Other characteristic absorption bands of polyurethanes 
were observed. These included C=O stretching of urethane bonds (1691 cm-1) and 
N-H bending of urethane bonds (1524 cm-1). The low absorption at around 2900 
cm-1 was assigned to the C-H stretching of aliphatic backbone. 
I 
FTIR analysis of the PDA-coated TPUs suggested the presence of polyDOPA. In 
detail the absorption band at 3322 cm-1 was attributed to the O-H stretching of the 
catechol groups, the peak close to 3000 cm-1 was assigned to the stretching of C-H 
and the absorption at 1524 cm-1 and 1490 cm-1 was due to the C=C stretching of 
aromatic ring. Furthermore, a strong increase of the absorption due to the C=O 
stretching was also observable, attributed to quinone functionalities.  
 
On the other hand, there was no significant difference in FTIR spectra between the 
PDA-coated with or without the LPO enzyme. It is possible that a part of the LPO 
enzyme remained grafted to the PDA coating, however used LPO catalyst amount 
was low and hence difficult to be detected by FTIR-ATR analysis. Additionally, 
main FTIR-ATR adsorption bands of proteins (e.g. Amide I and Amide II) partially 
or totally overlap with bands in TPU-PDA spectra. 
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Figure 7.12: FTIR spectra of TPU membranes: purple = TPU; red = TPU-PDA (LPO 0); 
green = TPU-PDA (LPO 1.4). Coating time for reported spectra was 7 hours. 
 
 
7.5. Conclusions 
 
 
Electrospun TPU fibres previously fabricated in Chapter 6 were successfully coated 
with PDA: the white fibre mats gradually turned into varying degrees of brown to 
black depending on the coating parameters (use of an oxidizing enzyme catalyst 
and time used for coating). PDA coating by self-polymerization in oxidizing 
conditions took approximately 7 hours based on previous studies performed at 
Politecnico di Torino.  
 
LPO is an oxidizing enzyme that enhances the rate of oxidation of DOPA and PDA 
formation without taking part to the reaction.  Based on absorbance measurements 
at 450 nm, it was found that the addition of 1.4 U/mL LPO to a DOPA solution (2 
mg/mL in 10 mM TRIS buffer at pH 8.5) can reduce the coating time from 7 hours 
to 2.5 hours. In the next PDA-coating procedures, the reduced coating time was set 
at 3 hours. Measured fibre diameters of the PDA coated samples were observed to 
be 15-42% thicker than the uncoated fibres. 
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Thus, introducing LPO in a DOPA (or even dopamine) solution could reduce time 
needed for PDA dip-coating applications, making this type of surface 
functionalization more efficient. In the next chapter, the ability of PDA-coatings to 
covalently graft proteins will be investigated and characterized. 
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Chapter 8 Surface modification 
of TPU-PDA patches with glucose 
oxidase 
 
8.1. Abstract 
 
This chapter first discusses the immobilization of glucose oxidase into a PDA-
coated electrospun TPU fibre patches (TPU-PDA). Two types of TPU-PDA fibre 
patches were prepared: without LPO and with 1.4 U/mL LPO with the materials 
coated either for 3 hours or 7 hours. These four prepared TPU-PDA samples were 
immersed 10,000 U/L glucose oxidase enzyme for 24 hours to allow the enzyme to 
bind to the PDA layer. TPU-PDA-0-7-GO (TPU-PDA with no LPO and 7 hours 
coating grafted with glucose oxidase) showed an enzymatic activity of 12.6±2.0 U 
GO/g while TPU-PDA-1.4-7 (TPU-PDA with 1.4 U/mL LPO and 7 hours coating 
grafted with glucose oxidase) showed 16.4±3.8 U GO/g activity. The samples were 
then characterized in terms of morphological structure by SEM and FTIR-ATR 
analyses before and after surface functionalization, and their ability to produce 
H2O2 in the presence of a glucose source was tested using a colorimetric pertitanic 
acid assay which was also used to determine enzyme activity. 
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The second part of the chapter is dedicated to the preparation of a gelatin 
methacrylate hydrogel for glucose loading to be used in combination with TPU-
PDA-GO electrospun membranes. Gelatin methacrylate was synthesized by 
functionalizing gelatin with methacrylic anhydride, characterized by FTIR-ATR 
analysis, and crosslinked by UV irradiation with an intensity of 4 mW/cm2 at a 
wavelength of 365 nm. Finally 10 w/v% glucose loaded hydrogel with a 15 w/v% 
GelMA composition was prepared. A 100 μL volume of this hydrogel in 
combination with a 1 cm by 1 cm TPU-PDA-GO membrane (prepared using 1.4 
U/mL lactoperoxidase enzyme as a catalyst) could produce 3.69±0.50 mM H2O2 
per day when coated by immersing the patch in a DOPA-oxidizing solution for 7 
hours, as assessed by colorimetric pertitanic acid assay. While this combination did 
not produce as much H2O2 as that formed by GO/glucose-laden HB PEGDA/HA-
SH hydrogels (using the same hydrogel volume in the same PBS volume, i.e. 100 
μL hydrogel in 5 mL PBS), the TPU-PDA membrane demonstrated to be capable 
of efficient GO immobilization on its surface. 
 
 
8.2. Introduction 
 
The immobilization of glucose oxidase on the PDA coated TPU fibre surface was 
done by a Michael type addition of the enzyme, involving  the amine groups of the 
enzyme and the quinone groups of the PDA. This reaction was discussed in more 
detail in Chapter 6, with Figure 6.6 depicting grafting of GO enzyme on the PDA-
coated thermoplastic polyurethane (TPU) polymer. 
 
In Chapter 7, PDA was coated on an electrospun TPU fibre patch with and without 
the aid of an oxidizing agent, lactoperoxidase (LPO). This was done in order to 
reduce the time required for coating. This study compared the effect of coating time 
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on the amount of active glucose oxidase that was immobilized per gram of modified 
TPU fibre. The materials coated in a DOPA-oxidizing solution containing LPO 
(with PDA formed and deposited onto its surface) for 3 hours performed as well as 
the materials coated for 7 hours with no LPO enzyme: this confirmed that the 
addition of LPO was a viable solution for reducing the time required to coat 
substrates with polyDOPA or polydopamine. 
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Figure 6.6: Enzyme immobilization on TPU-PDA (end product named as TPU-PDA-
GO). 
 
The main purpose of this enzyme-grafting process was to obtain TPU fibre patches 
with immobilized glucose oxidase on their surface. When this patch is applied 
together with a glucose source for wound dressing applications, this material would 
catalyze glucose in the presence of oxygen and produce hydrogen peroxide as 
shown in Figure 1.4. With H2O2 being produced from this material, this would 
supplement the H2O2 produced from the HB PEGDA/HA-SH 10-1.0 hydrogel from 
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Chapter 3 and aid the wound healing process as it covers the hydrogel from 
exposure. 
 
 
Figure 1.4: ROS formation of H2O2 from glucose catalyzed by glucose oxidase (GO). 
 
 
8.3. Materials and methods 
 
Glucose oxidase, Phosphate Buffer Solution pH 7.4 tablets, sulfuric acid, porcine 
skin gelatin, methacrylic anhydride, titanium oxysulfate, glucose, Irgacure 2959 
were purchased from Sigma Aldrich, Italy. 
 
PDA-coated electrospun TPU fibres (TPU-PDA) were prepared as described in 
Chapters 5 (preparation of TPU fibres) and 7 (coating of PDA under different 
oxidation conditions and coating times). The samples are coded as listed in Table 
8.1 based on the addition of LPO enzyme catalyst and the coating time the samples 
underwent. 
 
In Table 8.1, the “Sample Code (before GO grafting)” describe the parameters used 
for coating the samples as performed in Chapter 7. For example, TPU-PDA-0-3 
refers to the sample with no LPO added with the samples immersed in the oxidizing 
DOPA solution for 3 hours. TPU-PDA-1.4-3 refers to the sample with 1.4 U/mL 
LPO added to increase the oxidation rate and immersed in the DOPA solution for 3 
hours as well. Once these samples were grafted with glucose oxidase enzyme, the 
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“-GO” was added in to their material name as listen in “Sample Code (after GO 
grafting)”. Additionally, when a sample is mentioned such as TPU-PDA-0, this 
refers to the collective set of TPUs coated without LPO both at 3 hours and 7 hours. 
 
Table 8.1. The glucose oxidase grafted sample codes 
Sample Code (before 
GO grafting) 
LPO added 
(U/mL) 
Coating 
time (h) 
Sample Code (after 
GO grafting) 
TPU-PDA-0-3 0 3 TPU-PDA-GO-0-3 
TPU-PDA-0-7 0 7 TPU-PDA-GO-0-7 
TPU-PDA-1.4-3 1.4 3 TPU-PDA-GO-1.4-3 
TPU-PDA-1.4-7 1.4 7 TPU-PDA-GO-1.4-7 
 
 
8.3.1. Gelatin methacrylate 
 
Gelatin methacrylate (GelMA) was synthesized to serve as the glucose loaded 
hydrogel as it requires non-expensive reagents and  an easy synthesis protocol as 
established by Nichol, JW, et al., 20101. Briefly, 3 g of porcine skin gelatin was 
dissolved in 30 mL phosphate buffer solution (PBS) pH 7.4 at 60°C. Once gelatin 
was completely dissolved, the temperature was lowered to 50°C and 6 mL of 
methacrylic anhydride was added dropwise and the solution was reacted for 1 hour. 
After the acrylation step, 120 mL PBS 7.4 was added to the solution to dilute it. The 
solution was placed in a dialysis tube with a molecular weight cut-off of 3500 Da 
and it was dialyzed in deionized water for 5 days to remove any unreacted 
methacrylic anhydride. The solution was then freeze-dried and the recovered 
samples were stored in a waterproof container in a refrigerator with a temperature 
of 4°C. 
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Figure 8.1 shows the functionalization of gelatin with methacrylic anhydride to 
form gelatin methacrylate. The presence of the vinyl groups in GelMA allow it to 
be crosslinked with the addition of a photoinitiator and irradiated under UV light or 
to react with a thiol group like HA-SH, as was performed with other acrylate 
functionalized polymers such as HB PEGDA and HB PEGDA-co-GMA (see 
Chapter 2 and 4) 
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Figure 8.1: Chemical structure of gelatin functionalized to gelatin methacrylate (GelMA)  
with methacrylic anhydride. 
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8.3.1.1. Preparation of glucose-loaded GelMA hydrogel 
 
GelMA was selected as the glucose-loaded hydrogel for several reasons: 1) the 
synthesis process and purification were relatively simple (especially compared to 
the preparation of HB PEGDA and HA-SH), 2) the material is stable in oxygen and 
does not self-crosslink (HA-SH requires to be prepared and stored with Argon), 3) 
only two reagents were required (gelatin and methacrylic anhydride), 4) it was able 
to crosslink under UV light with the addition of a photoinitiator, 5) it has been used 
in biomedical engineering applications and has been tested to be cytocompatible1–
3. 
 
To prepare the glucose-loaded hydrogel samples,  300 mg of GelMA was dissolved 
in 2 mL of modified PBS pH 7.4 solution (containing 0.5 w/v% Irgacure and 10 
w/v% glucose) at 50°C. After the samples were dissolved, 100 μL of the prepared 
solutions were pipetted into the hydrogel moulds previously used in Chapter 2 and 
3 for preparation of HB PEGDA/HA-SH samples. Hydrogels within moulds were 
placed under a UV LED lamp and crosslinked for 10 minutes with an intensity of 4 
mW/cm2  at a wavelength of 365 nm with a LED lamp to surface distance of 10 cm. 
Figure 8.2 shows the different steps done in the preparation of the hydrogel samples. 
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Figure 8.2: a) 15 w/v% GelMA solution in “modified” PBS (with 10 w/v% glucose and 
0.5 w/v% Irgacure 2959 in PBS pH 7.4). b) UV-crosslinked 100 μL glucose-loaded 
GelMA hydrogel (diameter 7.5 mm). c) UV-crosslinking set-up of the GelMA hydrogels  
with intensity of 4 mW/cm2 at 365 nm wavelength. 
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8.3.2. Surface grafting of glucose oxidase on PDA-TPU patch 
 
A 10,000 U/L solution of glucose oxidase in PBS pH 7.4 was prepared in a 250 mL 
beaker. While grafting of compounds in polyDOPA is usually done in TRIS buffer 
solution pH 8.5 (this solution was also used for PDA-coating of the fibre samples) 
PBS pH 7.4 was used to avoid denaturation or inactivation of the GO enzyme in a 
basic solution. Strips of TPU-PDA fibres (of different oxidizing and coating 
parameters, see Table 8.1) were immersed in the solution for 24 hours with constant 
stirring at 300 rpm. Afterwards, the strips were removed and washed twice in PBS 
to remove any traces of unattached GO enzymes. 
 
 
8.3.3. Tests for analyzing the presence of immobilized glucose 
oxidase 
 
8.3.3.1. SEM analysis 
 
Scanning Electron Microscopy was performed using a LEO 1420 microscope 
(Zeiss, Germany) at 20 kV and a working distance of 15 mm. The diameters of the 
fibres in electrospun membranes were measured on SEM images using ImageJ 
software. Any difference in the morphology of the coated fibrous patches compared 
to the uncoated fibrous patches was analyzed. The maximum magnification that can 
be obtained from this instrument was 5000x. 
 
Coated and uncoated samples were analyzed by SEM. To prepare the samples for 
SEM analysis, samples of the modified fibre patch were cut into 2 mm x 2 mm 
squares and mounted onto SEM sample holder using conductive tape. The samples 
were coated with a thin layer of gold using a sputter-coating machine (30 mA, 50 
seconds) to improve conductivity for imaging. 
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8.3.3.2. FTIR-ATR analysis 
 
Attenuated Total Reflectance Fourier Transform InfraRed Spectra (ATR-FTIR) of 
PDA-coated TPU was obtained at room temperature in the spectral range from 4000 
to 400     cm-1 using a Perkin–Elmer Spectrum 100 equipped with an ATR accessory 
(UATR KRS5) with diamond crystal. The spectra, obtained as a result of 16 scans 
with a resolution of 4 cm-1, were analyzed using the Perkin–Elmer Spectrum 
Software. Spectra were recorded on the PDA-coated TPUs (TPU-PDA samples), 
GO-grafted TPU-PDA-samples (TPU-PDA-GO), gelatin powder, and dried gelatin 
methacrylate (GelMA). 
 
 
8.3.3.3. ROS production of GO-immobilized TPU patch 
 
8.3.3.3.1. Enzyme activity in the material 
 
In this experiment, the activity of the active glucose oxidase was measured by 
measuring the H2O2 produced after 5 hours using a pertitanic acid  assay4. 1 cm by 
1 cm strips of TPU-PDA-GO samples were cut, weighed, and placed in bijoux vials 
and 5 mL glucose solution (10 w/v% glucose in PBS pH 7.4) was added. The 
samples we incubated at 37°C for 5 hours and then their H2O2 concentrations were 
measured using the pertitanic assay discussed in Section 3.3.3. The equation used 
for calculating their enzyme activity in terms of U/g material (with 1 U = μmol 
H2O2 converted/minute) was: 
 
𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 =
[𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 (𝐿)] [𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (
𝜇𝑚𝑜𝑙
𝐿 )]
[𝑡𝑖𝑚𝑒 (min)][𝑚𝑎𝑠𝑠 𝑠𝑎𝑚𝑝𝑙𝑒 (𝑔)]
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8.3.3.3.2. ROS production with a glucose-loaded hydrogel source 
 
This part of the study examines the ability of a glucose-loaded hydrogel to diffuse 
into the GO-grafted TPU and produce hydrogen peroxide. 1 cm by 1 cm strips of 
TPU-PDA-GO samples were cut and placed in bijoux vials along with 100 μL 
glucose-loaded GelMA hydrogels prepared from Section 8.3.1.1. Figure 8.3 shows 
the two materials as arranged within the vial. Afterwards, 5 mL of PBS pH 7.4 was 
added into the vials and the samples were incubated at 37°C for 24 hours. The 
hydrogen peroxide concentration of the samples were then measured using the 
pertitanic acid assay. The difference between this procedure and that of Section 
8.3.3.3.1 is that glucose in the hydrogel has to be released and diffuse outwards to 
the surrounding media before coming into contact with the TPU-PDA-GO material. 
 
 
 
Figure 8.3: TPU-PDA-GO-1.4-7 (1 cm x 1 cm) with 100 μL glucose-loaded 
 GelMA hydrogel. 
 
 
 
207 
 
8.4. Results and discussion 
 
8.4.1. Morphological analysis for GO-immobilized TPU patch 
 
Figures 8.4 and 8.5 depict the SEM images of electrospun TPU fibre patch samples 
which were coated with PDA in varying conditions (see Table 8.1) before and after 
GO was grafted into their matrix. In both images, spherical particles (indicated by 
red arrows in the figures), previously not observed in TPU and TPU-PDA SEM 
images from Chapter 7, were detected on certain areas of the fibres, forming a 
rougher look than the uncoated fibres. These particles could be aggregations of GO 
enzyme grafted on TPU-PDA surface that is abundant in quinone groups. Figure 
8.4 shows the TPU-PDA material with no GO enzyme and the corresponding 
samples grafted with GO enzyme. PDA was found to deposit itself preferably in 
areas of fibre intersection based on results from Chapter 7. For the TPU material 
immersed in GO solution, particles were also found on other parts of the fibre 
matrix, and not just at the junctions. Fibre porous structure was kept after GO 
functionalization. 
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Figure 8.4: SEM images of TPU-PDA-LPO-0 coated for 3h and 7h (see the code), then 
immersed in GO enzyme solution for 24 hours. 
 
 
Figure 8.4 shows the TPU-PDA material coated with PDA in the presence of 1.4 
U/mL LPO for 3 hours and 7 hours compared to the same samples with grafted GO. 
In analogy to Figure 8.3, small spherical particles could be observed on the GO-
grafted fibres, which could indicate the presence of glucose oxidase enzyme that 
was immobilized on the PDA-coated fibres. Fibre porous structure was kept after 
GO functionalization.  
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Figure 8.5: SEM images of TPU-PDA-GO-1.4 coated at 3h or 7h (see code), then 
immersed in GO enzyme solution for 24 hours. 
 
 
8.4.2. FTIR-ATR analysis 
 
TPU (Lubrizol Tecophilic SP60D60) was purchased as a biomedical grade 
thermoplastic polyurethane. The chemical structure of the material is unknown: the 
only available information is that TPU is an aliphatic polyether. 
 
Figure 7.12 in Chapter 7 showed the FTIR-ATR spectra of the original TPU and 
TPU coated with PDA without the use of lactoperoxidase, and with the use of 1.4 
U/mL LPO during a 7 hour coating period. On the other hand, Figures 8.6 to 8.10 
show the FTIR spectra of the GO-immobilized PDA-coated TPU fibre samples.  
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There was no discernible difference in the spectra of GO-immobilized materials 
respect to spectra reported in Chapter 7 for TPU-PDA-0-7 and TPU-PDA-1.4-7 
(Figure 7.12). It is possible that the absorption bands of used enzymes (both GO 
and LPO), being present at low quantities, are masked by the absorption bands of 
TPU-PDA spectrum 
 
In more details, spectra in Figure 8.6 to Figure 8.10 showed: 
 
(i) The characteristic bands of the aliphatic polyether TPU, such as the 
strong absorbance band at 1098 cm-1 assigned to the C-O stretching and 
confirming the presence of ether bonds in the polymer backbone, C=O 
stretching of urethane bonds (1691 cm-1) and N-H bending of urethane 
bonds (1524 cm-1). The low absorption band at around 2900 cm-1 was 
assigned to the C-H stretching. 
 
(ii) The characteristic bands of PDA coating, such as the absorption at 3322 
cm-1 attributed to the O-H stretching of the catechol groups, the band at 
3000 cm-1 assigned to the stretching of C-H, the absorption band at 1524 
cm-1 and 1490 cm-1 due to the C=C stretching of aromatic rings, an 
increased intensity of the C=O stretching band at 1110 cm-1 associated 
with quinone groups. 
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Figure 8.6: FTIR spectra of TPU-PDA-GO-0-3 
 
Figure 8.7: FTIR spectra of TPU-PDA-GO-0-7 
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Figure 8.8: FTIR spectra of TPU-PDA-GO-1.4-3 
 
 
Figure 8.9: FTIR spectra of TPU-PDA-GO-1.4-7 
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In a previous study that characterized the FTIR spectrum of glucose oxidase, the 
following bands of note were reported: 1650 cm−1 (amide І band); 1540 cm-1 (amide 
II band); 1400 cm-1 (carboxylate groups)5. In the FTIR-ATR spectra of the TPU-
PDA-GO fibre patches, main absorbance bands were in a close wavelength range 
respect to GO FTIR spectrum. Hence FTIR-ATR analysis could not detect GO 
grafting. The presence of GO in the TPU-PDA-GO fibre patches could be 
confirmed based on the ability of the functionalised material to produce hydrogen 
peroxide (enzyme activity) which will be discussed later. 
 
Figure 8.10 and 8.11 show the FTIR spectra for gelatin methacrylate. Figure 8.10 
is the FTIR spectrum obtained by the Ph.D student (presented as % transmission to 
be more easily compared with Figure 8.11) and Figure 8.11 is the FTIR spectrum 
of gelatin and GelMA from a study done by Zhou, X., et al. (2016) that also utilized 
the same protocol used by Nichol, et al. (2010)2,6. Figure 8.11 was reprinted with 
permission. 
 
The spectrum of GelMA (Figure 8.10) was similar to that of gelatin (Fig. 8.11). A 
strong peak was present at 1650 cm−1 related to amide I (C=O stretching). The band 
at 1500–1570 cm−1 was due to amide N–H bending while the band at 3200–3400 
cm−1 was attributed to N–H and O-H stretching. The peak at 3062 cm−1 was due to 
C–H stretching. The peak due to carbon double bond in GelMA should be detected 
at 1640 cm−1 indicating the grafting of methacrylate anhydride, however it 
overlapped with the amide I peak. Hence FTIR-ATR analysis could not evidence 
the presence of MA functionalities which should be analyzed with different 
techniques (e.g. NMR analysis). 
 
214 
 
 
Figure 8.10: FTIR spectra of gelatin methacrylate reported as a function of percent 
transmittance.  
 
 
Figure 8.11. FTIR spectra of gelatin and GelMA from a study by Zhou, X., et al 
(2016)6. Reprinted Figure 3.A, reproduced with permission: Copyright (2019) 
American Chemical Society. 
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8.4.3. ROS production of GO-immobilized TPU patch 
 
8.4.3.1. GO enzyme in TPU-PDA-GO materials 
 
In order to confirm the presence of GO in the TPU, the materials were tested for 
their ability to produce H2O2 by reacting the material with glucose and then 
quantifying the H2O2 formed. The GO enzyme activity is quantified as the µmol 
H2O2 produced per minute by a gram of TPU-PDA-GO fibre patch. The simplified 
equation used to obtain this was: 
𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 =
[0.005 𝐿] [𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (
𝜇𝑚𝑜𝑙
𝐿 )]
[300 𝑚𝑖𝑛][𝑚𝑎𝑠𝑠 𝑠𝑎𝑚𝑝𝑙𝑒 (𝑔)]
 
 
Since the experiment measured the H2O2 concentration produced over a span on 
300 minutes (5 hours) by the TPU-PDA-GO sample of a certain mass immersed in 
a 5 mL PBS pH 7.4 solution containing 10 w/v% glucose, the remaining data to 
obtain was the H2O2 concentration and mass. Figure 8.12 present the processed data 
from this enzyme activity analysis based on the ability of GO grafted into TPU-
PDA to produce hydrogen peroxide in the presence of glucose. 
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Figure 8.12: GO enzyme activity in TPU-PDA-GO fibre patches. 
 
In comparing the effect of coating time (3 hours versus 7 hours) on GO enzyme 
activity for TPU-PDA-GO-0 samples, it was found that differences in enzyme 
activity of the materials were statistically significant (t(4) = 2.9342, p = 0.0426) 
from each other. For TPU-PDA-GO-1.4, the role of coating times was also 
considered to be a significant factor (t(4) = 3.7662, p = 0.0197) on GO enzymatic 
activity of the material. This means that PDA coating time plays a key role on the 
amount of immobilized active glucose oxidase enzyme. 
 
Statistical analysis showed that the difference of GO enzyme activity between TPU-
PDA-GO-0-3 and TPU-PDA-GO-1.4-3 was not statistically significant (p = 0.78). 
This means that even with greater oxidation in TPU-PDA-GO-1.4-3, the amount of 
GO deposited into the fibre patch for materials with a PDA coating time of 3 hours 
were approximately identical. The difference between TPU-PDA-GO-0-7 and 
TPU-PDA-GO-1.4-7 was also not statistically significant (p = 0.20). It is also a 
possibility that the amount of quinone groups where enzymes could be immobilized 
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in TPU-PDA-GO-1.4 was greater than the control setting, but had been partially 
grafted with lactoperoxidase enzyme reducing the possibility to graft more glucose 
oxidase.  
 
Since it was found that coating time plays a more significant role on GO enzyme 
activity immobilized into the fibre patch, future studies ought to try the addition of 
a concentration lower than 1.4 U/mL LPO (such as 0.7 U/mL LPO) with a coating 
time of 5 hours as a compromise between the two parameters (while still reducing 
the time required for target oxidation). 
 
 
8.4.3.2. ROS production of TPU-PDA-GO with a glucose-
loaded hydrogel 
 
Figure 8.13 shows the H2O2 concentration of the TPU-PDA-GO materials when 
used with a glucose-loaded GelMA hydrogel after 24 hours. From previous studies, 
10-20 mM H2O2 has been selected as the set production target per day that was 
reported to stimulate angiogenesis in wounds7. TPU-PDA-GO plus GelMA 
hydrogel has been developed to be used in conjunction with HB PEGDA/HA-SH 
10-1.0 hydrogel selected to attain this target concentration. However, if TPU-PDA-
GO plus GelMA hydrogel two-layer system might produce alone the target ROS 
concentration, it could be used as an alternative device for wound healing. On the 
other hand, the three-layer system should be carefully evaluated for its cytotoxicity 
effects if producing much more hydrogen peroxide than the target concentration.  
 
In comparing the effect of coating time (3 hours versus 7 hours) on H2O2 produced 
for TPU-PDA-GO-0 + glucose-loaded GelMA hydrogel samples, differences were 
not statistically significant (p = 0.60). On the contrary, for TPU-PDA-GO-1.4, 
differences in the results obtained at different coating times were statistically 
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significant (p =0.02). This means that the role of PDA coating time is probably 
more significant for samples that have an added amount of lactoperoxidase to 
enhance the rate of DOPA oxidation. 
 
Statistical analysis showed that the difference of H2O2 produced between TPU-
PDA-GO-0-3 and TPU-PDA-GO-1.4-3 was not statistically significant (p = 0.17). 
The difference between TPU-PDA-GO-0-7 and TPU-PDA-GO-1.4-7 was also not 
statistically significant (p = 0.10).  As with the statistical analysis from Section 
8.4.3.1, the effect of added lactoperoxidase did not improve the activity of GO 
enzyme within the material. 
 
 
Figure 8.13: ROS production (after 24 hours) of TPU-PDA-GO patches with 
glucose-loaded GelMA hydrogel. 
 
This experiment has proven that TPU-PDA-GOs can produce hydrogen peroxide 
when provided with a glucose source that can diffuse into the electrospun fibre and 
react with the immobilized glucose oxidase. This means that the GO-grafted PDA-
coated TPU device can provide more ROS to the wound site if necessary, such as 
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for vulnerable patients that require an extra concentration of ROS and the protection 
from exposure provided by the TPU material. However, this also means that the 
LPO enhancement performed in Chapter 7 did not provide an added amount of 
grafted GO enzyme that could be immobilized, even if the measured degrees of 
oxidation in the DOPA solution and TPU material were significantly higher. 
 
 
8.5. Conclusions 
 
Glucose oxidase was successfully grafted into a PDA-coated electrospun TPU fibre 
patch. The material that produced the highest activity was TPU-PDA-GO-1.4-7 
with an activity of 16.36 ± 3.76 U/g glucose oxidase. When used with a 100 μL 
glucose-loaded GelMA hydrogel, 3.69 ± 0.50 mM H2O2 was produced after 24 
hours. PDA coating time played a more significant role on the amount of grafted 
GO respect to the use of LPO enzyme catalyst. For this application, the use of LPO 
did not bring any improvements to this specific application of GO-grafting despite 
the observed enhanced oxidation as reported in Chapter 7. It is recommended for 
further studies to explore lower concentrations of LPO with coating times of around 
5 hours (still lower than 7 hours required for coating with no enzyme) since there 
is a chance that the presence of LPO causes an interference with the grafting of 
glucose oxidase into the PDA-coated TPU fibre patches. However, TPU-PDA-GO-
1.4-3 and TPU-PDA-GO 1.4-7 were used for cytocompatibility assays in Chapter 
9 as single substrates, bilayer wound healing devices with glucose-loaded GelMA, 
and trilayer wound healing devices with honey-mimetic HB PEGDA/HA-SH and 
glucose-loaded GelMA hydrogels. 
 
In this chapter, gelatin methacrylate was synthesized and crosslinked into a 
hydrogel under UV radiation with the addition of a photoinitiator. This material 
served to be a viable option for being loaded with glucose. More data and the 
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characterizations performed on this polymer can be found in the appendices, 
including its use in other applications. 
 
It is also recommended that images of the fibre patches can be obtained at 
magnifications of 20,000x and higher before and after GO enzyme grafting by using 
more advanced SEM instruments that can accomplish this. This would give a more 
comprehensive view of confirming whether or not there are smaller enzyme 
particles that can be found grafted into the fibres other than the clusters found in the 
SEM images. 
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Chapter 9 Assembly of 
Multilayer Wound Healing Patch 
 
9.1. Abstract 
 
In this chapter, the cytocompatibility of four types of TPU-PDA-GO fibre patches 
and glucose-loaded GelMA hydrogel were evaluated in NIH/3T3 mouse fibroblast 
cells for 24 hours using an indirect method. These materials were tested first 
individually and then conbined together. After selecting set-ups which kept cell 
viability, these were assembled together with the honey mimetic HB PEGDA/HA-
SH 10-1.0 hydrogel (250 U/L GO and 2.5 w/w% glucose) to form a multilayer 
wound healing device. The final trilayer set-up which gave the highest cell viability 
of 58.2 ± 8.5% was HB PEGDA/HA-SH 10-1.0 hydrogel (250 U/L GO and 2.5 
w/w% glucose) + TPU-PDA-GO-0-3 fibre patch + 10 w/v% glucose-loaded 
GelMA hydrogel. The obtained cytocompatibility for the multilayer was not 
considerably ideal, hence the GO/glucose concentrations in HB PEGDA/HA-SH 
10-1.0 should be tailored when used in combination with TPU-PDA-GO fibre patch 
and glucose-loaded GelMA. An alternative application would be to apply the TPU-
PDA-GO system to protect the in situ HB PEGDA/HA-SH 10-1.0 hydrogel 
dressing from exposure to external environment and, once the glucose from the HB 
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PEGDA/HA-SH 10.1 hydrogel has almost depleted itself, the glucose-loaded 
GelMA hydrogel could be applied as an alternative glucose source. 
 
 
9.2. Introduction 
 
Multilayer wound dressings (sometimes termed as composite wound dressings) are 
generally organized into three parts: bacterial barrier, absorption layer, and the 
adhesive1. The most common types are variations of a pad, cloth, and film with an 
adhesive applied to the bottom layer for the dressing to adhere to skin.   
 
For hydrogels, a bilayer hydrogel wound dressing under the name Oxyzyme was 
developed, which has been previously mentioned in Chapter 12,3. In this material, 
the bottom hydrogel was loaded with glucose oxidase and the second layer of 
hydrogel loaded with glucose was applied on top of it. This was one of the honey-
based wound healing materials along with Surgihoney4. 
 
To combat the rising problem of antibacterial resistance, a multilayer wound 
healing device was designed utilizing the concept of antibacterial ROS produced 
by glucose oxidase and glucose within honey. This “honey mimetic” multilayer 
wound healing device required to fulfill other objectives as well: 
 
• Produce a minimum concentration of 10 mM H2O2 per day to stimulate 
angiogenesis in wound tissue5 
• Provide sufficient coverage of the wound tissue including irregular surfaces 
and crevices (obtained with HB PEGDA/HA-SH 10-1.0 hydrogel having in situ 
gelling properties) 
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• Have extra protection from possible contamination and exposure (this 
function is intended to be fulfilled by the TPU-PDA-GO fiber patch which has 
mussel-like adhesive properties that allow adhesion to the hydrogel) 
• Additionally, these materials should be in general: hydrophilic, porous, 
oxygen-permeable to allow the wound to breathe and drain off wound exudates, 
and biocompatible6 
 
Together, these components are combined and shown in Figure 9.1 to show the 
assembly using the materials produced in previous chapters. 
 
 
Figure 9.1: Assembly of multilayer wound healing device and their individual 
components. 
 
In this chapter, the cytocompatibility of TPU-PDA-GO fibres with NIH/3T3 mouse 
fibroblasts was evaluated before their assembly in the multilayer wound healing 
device. This analysis was needed to select a biocompatible fibrous layer for the 
multilayer device in the perspective of further studies. Afterwards, TPU-PDA-GO 
patch cytocompatibility was evaluated when it was used in combination with a 
glucose-loaded GelMA hydrogel, similarly to the procedure in Section 3.3.4. 
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Finally, the components were assembled to form the multilayered wound healing 
device as shown in Figure 9.1 and evaluated for their cytocompatibility. 
 
9.3. Materials and methods 
 
Phosphate buffer solution tablets (PBS 7.4), High-Glucose Dulbecco's Modified 
Eagle Medium (DMEM), Fetal Bovine Serum (FBS), Resazurin sodium salt were 
provided by Sigma Aldrich, Italy. NIH/3T3 mouse fibroblast cells (ATCC® CRL-
1658™) were obtained from ATCC, Italy. 
 
 
9.3.1. HB PEGDA/HA-SH hydrogel 
 
The process for producing this material was described in Chapter 3. The glucose 
oxidase/glucose concentration used throughout in this study was 250 U/L GO and 
2.5 w/w% glucose. 
 
 
9.3.2. GO-immobilized TPU patch and glucose hydrogel source 
 
The processes for producing these materials were described in Chapter 8. Four types 
of glucose oxidase enzyme-grafted, polyDOPA-coated electrospun thermoplastic 
polyurethane fibres (TPU-PDA-GO) were used as previously listed in Table 8.1. 
UV-crosslinked gelatin methacrylate hydrogel was used as the glucose-laden 
medium where glucose diffused downwards to the TPU fibers and hydrogen 
peroxide was produced able to diffuse through the HB PEGDA/HA-SH 10-1.0 
hydrogel. 
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9.3.3. Cytocompatibility of electrospun TPU fibre materials 
 
Cytocompatibility of the materials was evaluated with the assistance of Andrea 
Gallina, a post-graduate student from Politecnico di Torino.  
 
Pure electrospun TPU fibre mat and TPU-PDA-GO fibre mats were prepared by 
cutting the fibre patches into 5 mm by 5 mm pieces. They were tested for 
cytocompatibility using a non-contact method by placing them in a transwell insert 
in a 24-well plate. Samples were sterilized by UV radiation within a biological hood 
for 2 hours.  
 
Cytotoxicity of the patches was evaluated using NIH/3T3 mouse fibroblast cells 
(ATCC® CRL-1658™). Briefly, cell suspension containing 50,000 cells/mL was 
prepared in full cell medium (High-Glucose Dulbecco's Modified Eagle Mixture, 
containing 10 v/v% Fetal Bovine Serum) from cells cultured approximately 24 
hours previously.  
 
Then, 1 mL of the prepared full cell medium was added to each well in the sterilized 
plate and incubated at 37°C for 24 hours. After this, the Alamar Blue assay was 
performed. The transwell inserts were removed and the cells were washed twice 
with sterile PBS pH 7.4. Then 1 mL of 1X Alamar Blue solution was added to each 
well, and the plate was returned to incubate for 6 hours at 37°C. Alamar Blue 
solution was prepared by dissolving 3 mL of resazurin blue in 27 mL PBS pH 7.4 
to obtain a 1X or 10 v/v% Alamar Blue solution. Readings were obtained from the 
Perkin Elmer Victor X3 multimode plate reader. The fluoresence intensity of the 
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solutions was measured at 595 nm wavelength under excitation at 535 nm 
wavelength. The percentage of cell viability was calculated as: 
 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%)
=  
𝑅𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝑆𝑎𝑚𝑝𝑙𝑒 𝑊𝑒𝑙𝑙 −  𝑅𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝐴𝑙𝑎𝑚𝑎𝑟 𝐵𝑙𝑢𝑒
𝑅𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝑁𝑜 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑊𝑒𝑙𝑙 − 𝑅𝑒𝑎𝑑𝑖𝑛𝑔 𝑜𝑓 𝐴𝑙𝑎𝑚𝑎𝑟 𝐵𝑙𝑢𝑒
∗ 100%   (𝑒𝑞. 6) 
 
Samples were analysed in quadruplicates. Control samples were also tested 
consisting of cells cultured in tissue culture polystyrene plates without the presence 
of electrospun mats. 
 
 
9.3.4. Assembly of bilayer wound healing patch 
 
The TPU-PDA-GO fibre patch plus glucose-loaded GelMA samples were 
assembled for cytocompatibility testing as follows: firstly, 5 mm by 5 mm fiber 
patches of TPU-PDA-GO were prepared as described in Section 9.3.3.  
 
The next step was the preparation of the glucose-loaded GelMA hydrogel beads. 
To prepare the glucose-loaded hydrogel samples, 300 mg of GelMA was dissolved 
in 2 mL of PBS solution at pH 7.4 and at 50°C, containing 0.5 w/v% Irgacure and 
10 w/v% glucose. After the samples were dissolved, 30 μL of the prepared solutions 
were pipetted into a flat hydrophobic Teflon-coated surface previously used in 
Chapter 3 for preparation of HB PEGDA/HA-SH beads. Such beads (still liquid but 
held in form by surface tension) were placed under an UV LED lamp (at 10 cm 
distance) and crosslinked for 10 minutes at a power of 4 mW/cm2 and a wavelength 
of 365 nm. These beads are shown in Figure 9.2. 
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These two components were assembled by spreading out the TPU-PDA-GO fiber 
patch and gently placing the glucose-loaded GelMA hydrogel bead on top of it. This 
assembled system is shown in Figure 9.2. 
 
 
Figure 9.2: Photos of glucose-loaded GelMA hydrogel bead alone, and on the top of a 
TPU-PDA-GO fibre patch to assemble a bilayer wound healing device. 
 
 
 
9.3.5. Cytocompatibility evaluation of bilayer wound healing 
patch 
 
Cytocompatibility of the materials was evaluated with the assistance of Andrea 
Gallina, a post-graduate researcher from Politecnico di Torino.  
 
Samples of electrospun TPU and TPU-PDA-GO fibre mats were prepared by 
cutting the patches into 5 mm by 5 mm pieces. They were tested for 
cytocompatibility using a non-contact method by placing them on transwell inserts 
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in a 24-well plate. Samples were sterilized by UV radiation within a biological hood 
for 2 hours.  
 
Glucose-loaded GelMA hydrogels were prepared as described in Section 9.3.4, 
separated from the TPU-PDA-GO fibre patches to avoid ROS formation before the 
evaluation started. 
 
Once both components were sterilized, the GelMA hydrogels were placed within 
the transwell inserts as shown in Figure 9.3. An extra row of transwell inserts was 
prepared to test the cytocompatibility of glucose-loaded GelMA hydrogel alone. 
 
 
Figure 9.3: Bilayer TPU-PDA-GO + glucose loaded GelMA hydrogel set-ups for 
cytocompatibility testing. 
 
Cytotoxicity of the patches were evaluated using NIH/3T3 mouse fibroblast cells 
(ATCC® CRL-1658™). Briefly, cell suspension containing 50,000 cells/mL was 
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prepared in full cell medium (High-Glucose Dulbecco's Modified Eagle Mixture, 
containing 10 v/v% Fetal Bovine Serum) from cells cultured approximately 24 
hours previously.  
 
Then, 1 mL of the prepared full cell medium was added to each well in the sterilized 
plate and incubated at 37°C for 24 hours. After this, the Alamar Blue assay was 
performed. The transwell inserts were removed and the cells were washed twice 
with sterile PBS at pH 7.4. Then 1 mL of 1X Alamar Blue solution was added to 
each well, and the plate was returned to incubate for 6 hours at 37°C. Alamar Blue 
solution was prepared by dissolving 3 mL of resazurin blue in 27 mL PBS pH 7.4 
to obtain a 1X or 10 v/v% Alamar Blue solution. Readings were obtained from the 
Perkin Elmer Victor X3 multimode plate reader. The fluorescence intensity of the 
wells was measured at 595 nm emission wavelength by excitation at 535 nm 
wavelength.  
 
In this cytocompatibility assay, the viability of the cells was tested while H2O2 was 
continuously produced by the two components and released into the cell medium. 
Other experiments included the evaluation of cell viability when the cells were in 
indirect contact with glucose-loaded GelMA hydrogel and in control conditions 
(cells cultured in tissue culture polystyrene plates without any sample). 
 
 
9.3.6. Assembly of trilayer wound healing patch 
 
The final multilayer wound healing device was prepared as follows: Using a 24 well 
plate as a hydrogel mould, 200 µL HB PEGDA/HA-SH 10-1.0 was poured into 
each well to form in situ and crosslink into a hydrogel. Next, a 1 cm by 1 cm TPU-
PDA-GO fibre patch was placed on top of this hydrogel. It was observed that this 
fibre patch immediately adhered to the hydrogel and was difficult to pull out, which 
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could be attributed to its mussel-like adhesive property. Finally, 100 µL cylindrical 
glucose-loaded GelMA hydrogel pieces (as described in Section 8.3.1.1.) were 
placed on the top of the TPU-PDA-GO fibre patch. The final assembled device is 
shown in Figure 9.4 
 
 
Figure 9.4: Trilayer ROS-producing wound healing device. 
 
 
9.3.7. Cytocompatibility of trilayer wound healing device 
 
Cytocompatibility of the materials was evaluated with the assistance of Andrea 
Gallina, a post-graduate researcher from Politecnico di Torino. Since this material 
was more complex than the previous materials analyzed, the procedure was 
modified following the ISO 10993 standards for the testing of the biocompatibility 
of medical devices. 
 
After the multilayer wound dressing was assembled as described in Section 9.3.6, 
the plate containing the samples was sterilized under UV light for two hours. Then, 
1 mL of DMEM was added to each well to collect eluates from the wound healing 
system after 24 hours. These eluates were filtered through a 0.22 µm syringe filter 
for further sterilization.  
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Separately, another 24 well plate was prepared that had been cultured to contain 
50,000 cells per well. The original cell media within these wells were removed and 
the cell media containing the eluates was introduced into the wells. The plate 
containing the cells and eluate-extracted cell media was incubated at 37°C for 24 
hours.  
 
After this, the Alamar Blue assay was performed. The cell media in each well were 
pipetted and discarded and the cells were washed in sterile PBS pH 7.4 twice. Then 
1 mL of 1X Alamar Blue solution was added to each well, and the plate was 
returned to incubate for 6 hours at 37°C. Alamar Blue solution was prepared by 
dissolving 3 mL of resazurin blue in 27 mL PBS pH 7.4 to obtain a 1X or 10 v/v% 
Alamar Blue solution. Readings were obtained from the Perkin Elmer Victor X3 
multimode plate reader. The fluorescence intensity of the wells was measured at 
595 nm emission wavelength by excitation at 535 nm wavelength.  
 
In this cytocompatibility assay, the viability of the cells was tested from the eluates 
in the cell media which contained H2O2 produced after 24 hours and possibly some 
polymer residue from the multilayer components.  
 
 
9.4. Results and discussion 
 
9.4.1. Cytocompatibility of TPUs 
 
Figure 9.5 presents the non-contact cytocompatibility results of the electrospun 
TPU fibre patches (modified and unmodified) using NIH/3T3 mouse fibroblast 
cells after 24 hours.  
NT in the figure refers to the set of wells with no treatment introduced as the cells 
were cultured (positive control). The unmodified TPU fibre patch was also tested 
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to serve as a control reference to compare its cytocompatibility with the GO-grafted 
PDA-coated TPU fibres. The TPU fibre gave a positive result in terms of percent 
cell viability, which was expected as the material used was a commercially 
available medical grade TPU. 
 
The four GO-grafted TPUs resulted in positive cytocompatibility as they showed 
percent cell viabilities greater than 80%. This means that the four configurations 
can be tested for further cytocompatibility testing where it actively produces H2O2 
with the glucose-loaded GelMA hydrogel. 
 
 
Figure 9.5: Viability of NIH/3T3 cells in indirect contact with electrospun TPU fibre 
mats (unmodified and GO enzyme grafted) after 24 hours. 
 
 
9.4.2. Cytocompatibility of bilayer wound healing device 
 
Figure 9.6 presents the non-contact cytocompatibility results of TPU-PDA-GO 
fiber patches used in conjunction with glucose-loaded GelMA hydrogel, using 
NIH/3T3 mouse fibroblast cells after 24 hours. NT in the figure refers to the set of 
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wells with no treatment introduced as the cells were cultured (positive control). The 
glucose-loaded GelMA was also tested to ascertain whether it was cytocompatible. 
 
Results showed that the glucose-loaded GelMA hydrogel had a cytocompatibility 
of 86.7 ± 8.4%. A cell viability value above 80% indicates that the material is 
cytocompatible. However, GelMA hydrogel cytocompatibility was lower than for 
TPU-PDA-GO fibre  patches. The percentage of cell viability of the bilayer samples 
ranged from 93.8% to 99.0% with not significant differences among tested samples. 
The slight increase of cell viability percentage in the bilayer device compared to 
GelMA hydrogel could be attributed to the release of H2O2 at low rates, as 
demonstrated in a previous study which showed H2O2 genotoxic and proapoptotic 
or antiapoptotic effects depending on release kinetics7.  
 
As the four sets of materials were cytocompatible when tested in indirect contact 
with NIH/3T3 fibroblasts after 24 hours, they all could be used for assembly into a 
trilayer wound healing device for evaluating their cytocompatibility, when used 
with honey mimetic HB PEGDA/HA-SH hydrogels. 
 
 
Figure 9.6: Viability of NIH/3T3 cells in indirect contact with electrospun TPU-PDA-
GO mats combined with glucose-loaded GelMA hydrogel beads after 24 hours. 
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9.4.3. Cytocompatibility of trilayer wound healing device 
 
Figure 9.7 presents the cytocompatibility results of NIH/3T3 mouse fibroblast cells 
after 24 hours using the eluates deriving from the multilayer device (extracted after 
24 hours). NT in the figure refers to the set of wells with no treatment introduced 
as the cells were cultured (positive control). As the composition of HB 
PEGDA/HA-SH 10-1.0 and GelMA hydrogels were set constant, the materials were 
differentiated from the TPU-PDA-GO type used. These fibre materials have 
varying GO enzyme activities (reported as Units GO/gram TPU) thus they produce 
varying amounts of H2O2 depending on their GO activity. 
 
Cytocompatibility values of the trilayer materials were considerably low, with the 
highest percentage of cell viability when TPU-PDA-GO-0-3, TPU-PDA-GO-0-7 
and TPU-PDA-GO-1.4-3 patches were used with a value of 58.2 ± 8.5%, 59.7 ± 
1.0%, and 54.2 ± 6.0%, respectively. Samples containing TPU-PDA-GO-1.4-7 
patches were not cytocompatible (17.7 ±. 5.2 %). GO enzyme assay results showed 
that TPU-PDA-GO-0-3 patch had the lowest GO amount in terms of U GO/g 
(7.9±1.9 U GO/g fibre), followed by TPU-PDA-1.4-3 (7.5±1.6 U  GO/g fibre), next 
TPU-PDA-GO-0-7 (12.6±2.0 U GO/g fibre), and TPU-PDA-GO-1.4-7 had the 
highest GO amount (16.4±3.8 GO U /g fibre),  which means that TPU-PDA-GO-
1.4-7 patch has approximately twice the activity and the potential to produce twice 
as much hydrogen peroxide than TPU-PDA-GO-0-3 patch. Hence cytotoxicity in 
TPU-PDA-GO-1.4-7  containing materials could be due to high production of H2O2, 
deriving from a combined mechanism. As a solution, the GO/glucose 
concentrations in HB PEGDA/HA-SH hydrogel could be reduced when used in 
combination with the TPU-PDA-GO fibre  patch and glucose-loaded GelMA. An 
alternative would be to apply the TPU-PDA-GO system to protect the in situ HB 
PEGDA/HA-SH 10-1.0 wound dressing from exposure and once the glucose from 
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the HB PEGDA/HA-SH 10.1 hydrogel has almost depleted itself, the glucose-
loaded GelMA hydrogel could be applied as an alternative glucose source. 
 
 
 
Figure 9.7: Cell viability of NIH/3T3 cells tested with the eluates of the trilayer wound 
healing device after 24 hours. 
 
Another possible explanation for the low cytocompatibility is possibly due to the 
amount of H2O2 accumulated in 24 hours immediately introduced into the system 
as opposed to being produced and released throughout the 24 hour time-span. By 
revising the method to test for the cytocompatibility, a more accurate estimation of 
the cytocompatibility could be obtained. 
 
 
9.5. Conclusions 
 
Individually, glucose-loaded GelMA, TPU-PDA-GO-0-3, TPU-PDA-GO-0-7, 
TPU-PDA-GO-1.4-3, and TPU-PDA-GO-1.4-7 were tested to be cytocompatible 
in NIH/3T3 mouse fibroblasts after 24 hours culture time, in indirect contact tests. 
The TPU fibre patches were also cytocompatible when paired together with the 
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glucose-loaded GelMA, in indirect contact tests. However, when they were used 
together with HB PEGDA/HA-SH 10-1.0 hydrogels (with 250 U/L glucose oxidase 
and 2.5 w/w% glucose) cytcompatibility decreased for all sample types. The trilayer 
set-up which gave the highest cell viability of 58.2 ± 8.5% was HB PEGDA/HA-
SH 10-1.0 hydrogel (250 U/L GO and 2.5 w/w% glucose) + TPU-PDA-GO-0-3 
fibre patch + 10 w/v% glucose-loaded GelMA hydrogel. This was closely followed 
by the trilayer containing TPU-PDA-GO-0-7 (59.7 ± 1.0%)  and TPU PDA-GO-
1.4-3 (54.2 ± 6.0%). For future studies, it is recommended to devise a protocol on 
simulating the ROS production of the trilayer material for accurate measurement of 
H2O2 concentrations that are released into the media. Additionally optimization 
studies on the GO concentration of the base HB PEGDA/HA-SH 10-1.0 hydrogel 
are highly recommended. After these tests have been done, the three trilayer types 
can then be tested to determine what are their antibacterial properties. 
 
The obtained cytocompatibility for the multilayer was not considerably ideal, thus 
it is likely that the GO/glucose concentrations in HB PEGDA/HA-SH hydrogel 
should be reduced when used with the TPU-PDA-GO fibre patch with glucose-
loaded GelMA. An alternative would be to apply the TPU-PDA-GO system to 
protect the in situ HB PEGDA/HA-SH 10-1.0 wound dressing from exposure and 
once the glucose from the HB PEGDA/HA-SH 10.1 hydrogel has almost depleted 
itself, the glucose-loaded GelMA hydrogel could be applied as an alternative 
glucose source. 
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Chapter 10 General discussion 
and conclusion 
 
10.1. General discussion 
 
In order to address the problem of the rise of antibacterial resistance to current and 
future drugs, one solution is to make use of drug free antibacterial methods. In this 
thesis the proposed method is to exploit one of the antibacterial characteristics of 
honey, which is the production of antibacterial reactive oxygen species (ROS) such 
as hydrogen peroxide (H2O2) from glucose oxidase enzyme and glucose. Over the 
course of this research, three types of ROS producing materials have been 
produced: 1) an in situ forming hydrogel that physically encapsulates glucose 
oxidase and glucose together (HB PEGDA/HA-SH), 2) an in situ  forming hydrogel 
that has covalently immobilized glucose oxidase and physically encapsulates 
glucose (HB PEGDA-co-GMA/HA-SH), 3) a surface modified polyDOPA-coated 
electrospun thermoplastic polyurethane fibre patch with glucose oxidase 
immobilized via binding with the poly-DOPA (TPU-PDA-GO) which can convert 
the glucose (coming from a glucose loaded GelMA hydrogel) it interacts with into 
H2O2. 
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Use of GO enzyme/glucose to produce antibacterial ROS (hydrogen peroxide, 
H2O2)  
 
In general, the concept of using glucose oxidase and glucose in order to produce 
antibacterial H2O2 provides many opportunities. This system can be physically 
encapsulated within a hydrogel or chemically immobilized on a solid substrate (e.g. 
by binding to a polyDOPA coating) or into a hydrogel (by binding to hydrogel 
chains containing epoxide groups). The amount of ROS produced by the system 
and its rate of release can be fine-tuned by manipulating the amounts of glucose 
oxidase and glucose concentrations. This allows control of the concentrations of the 
wound healing device to be specific to different kinds of patients. The target range 
of production was 10-20 mM H2O2 per day in order to facilitate angiogenesis as 
previously reported1.  
 
HB PEGDA/HA-SH 10-1.0 with 250 U/L glucose oxidase and 2.5 w/w% glucose 
was able to achieve this range of H2O2 production, with 16.0±4.2 mM H2O2 after 
24 hours. HB PEGDA-co-GMA/HA-SH 10-1.0 with 250 U/L and 2.5 w/w% 
glucose produced 8.3±0.9 mM H2O2 after 24 hours. This reduced production of 
H2O2 in HBPcG/HA-SH is likely to to the reduced movement the enzyme had 
around the hydrogel system as it was fixed to a certain location whereas in HB 
PEGDA/HA-SH GO and glucose moved freely within the interstices of the 
hydrogel matrix, with their interactions resulting in more H2O2 produced. 
 
TPU-PDA-GO 1.4-7 fibre patch (i.e. with polyDOPA coating deposed in 7 hours 
using 1.4 U/mL LPO and grafted with GO to yield 16.4±3.8 U GO/g activity) in 
combination with 10 w/v% glucose-loaded GelMA hydrogel produced 3.7±0.5 mM 
H2O2 after 24 hours. The average sample weight of the 1 cm by 1 cm TPU patch is 
0.0039 grams, which means it has an activity of 0.0063±0.0015 U GO that diffuses 
the produced H2O2 into the 5 mL PBS solution. This means that a maximum of 
18.1±4.5  mM H2O2 can be produced at the maximum during the 24 hour period. 
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However, the obtained concentration was only 20% was produced and released into 
the system as the material was limited by the glucose in GelMA that diffused 
towards the TPU-PDA-GO layer and reacted with the enzyme. This means that the 
rate of H2O2 production in this bilayer system can be controlled to some degree by 
manipulating the glucose concentration in GelMA, area of contact between TPU-
PDA-GO/GelMA (giving the 100 µL hydrogel a larger diameter), and GelMA 
hydrogel composition (this study used 15 w/v% but it is possible a higher glucose 
diffusion can be achieved at lower polymer concentrations). 
Information about this ROS-producing system is discussed more in depth in 
Chapter 3, 4, and 8. 
 
 
Hyperbranched Polymer Synthesis 
 
For producing novel hydrogels with in situ forming characteristics, two types of 
PEG-based hyperbranched polymers were synthesized: hyperbranched 
polyethylene glycol diacrylate (HB PEGDA) and hyperbranched polyethylene 
glycol diacrylate-co-glycidyl methacrylate (HB PEGDA-co-GMA or HB PcG). 
These polymers contain vinyl groups that can be crosslinked into hydrogels in two 
ways: by UV-crosslinking when a photoinitiator is added into the system (this was 
performed on HB PEGDA but not discussed in this research thesis) or by Michael 
addition thiol-ene crosslinking with a thiolated polymer such as thiolated 
hyaluronic acid with a defined thiolation degree  (HA-SH). The speed at which the 
hydrogel is formed is proportionally dependent on the amount of hyperbranched 
polymer and its vinyl group content and can be tailored by changing these two 
characteristics. 
 
Crosslinking degree affects several hydrogel properties such as gelation time (the 
more vinyl and thiol groups available for crosslinking, the lesser the gelation time),  
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water absorption and degradation rate, (a more crosslinked material has a lower 
water absorption values but also takes longer to degrade).  
 
Their respective chemical data are summarized in the abstracts of Chapter 2 for HB 
PEGDA and Chapter 4 for HB PEGDA-co-GMA. 
 
 
Polymer Processing, Surface Modification, and Functionalization 
 
Commercially available biomedical grade thermoplastic polyurethane (TPU) 
Lubrizol Tecophilic SP-60D-60 was selected to be processed into a fibre mat by 
electrospinning according to the processing conditions described in Chapter 5.The 
material was selected due to its established biocompatibility, hydrophilic properties 
where it has a static contact angle of 72.0±2.9°; water absorbance percentage of 
44.7±4.9% after 24 hours and 60.6±3.0% after 4 weeks (ideal for contact with 
hydrogels); Young’s modulus of 25.1±1.5 MPa, ultimate tensile strength of 
10.4±0.7 MPa, and ultimate elongation percentage of 386±63% (mechanical 
properties are in the accepted range of commercial wound dressings). 
 
 This fibre patch was then coated with PDA, with and without the aid of 
lactoperoxidase (LPO) enzyme to boost the oxidation process and potentially lower 
the coating time required (described in depth in Chapter 7). These modified fibre 
patches (TPU-PDA-LPO) were immersed in a glucose oxidase solution for 24 hours 
in order to let the enzyme molecules bind and be immobilized into the PDA layer. 
Various tests in Chapter 8 confirmed the presence of GO and its ability to produce 
hydrogen peroxide with glucose .  
 
TPU-PDA-0-7-GO (PDA coating for 7 hours without LPO) had an enzymatic 
activity of 12.6±2.0 U GO/g while TPU-PDA-1.4-7 (PDA coating for 7 hours with 
1.4 U/mL LPO) had an enzymatic activity of 16.4±3.8 U GO/g activity. 
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Synthesis of Glucose Loaded Top Hydrogel 
 
Gelatin methacrylate (GelMA) was synthesized from porcine skin gelatin and 
functionalized with glycidyl methacrylate following the same procedure proposed 
by Nichol, JW, et al., 20102. This hydrogel was selected for the following reasons: 
1) the synthesis process and purification were relatively simple (especially 
compared to the preparation of HB PEGDA and HA-SH), 2) the material is stable 
in oxygen and does not self-crosslink (HA-SH requires to be prepared and stored 
with Argon), 3) only two reagents were required (gelatin and methacrylic 
anhydride), 4) it was able to crosslink under UV light with the addition of a 
photoinitiator, 5) it has been used in biomedical engineering applications and has 
been tested to be cytocompatible2–4. This glucose-loaded material was intended to 
be applied to wounds already crosslinked when placed on top of the TPU-PDA-GO 
patch similar to the bilayer hydrogel wound dressing system of Oxyzyme5–7. 
 
 GelMA hydrogel formed from a 15 w/v% solution with the addition of 0.5 w/v% 
Irgacure 2959 and exposure to UV radiation for 10 min. Glucose was loaded into 
the hydrogel at 10 w/v% concentration. Chemical characterization by FTIR-ATR 
analysis confirmed the functionalization of gelatin with methacrylate 
functionalities. Characterization of this material can be found in Chapter 8. 
 
 
ROS Production in Polymer Biomaterials 
 
A colorimetric assay was applied to detect the formation of hydrogen peroxide from 
the various types of material (thiol-ene hydrogel, TPU patch, or TPU patch with 
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glucose-laden hydrogel on the top) 8. Details of the ROS measurement results can 
be found in Chapter 3, 4, and 8 with the data summarized below in Table 10.1.  
 
Table 10.1. Summary of materials with their highest H2O2-yielding parameters 
Material 
GO/glucose 
content 
H2O2 concentration after 24 
hours (mM) 
200 µL HB PEGDA/ HA-
SH 10-1.0 in 10 mL PBS 
pH 7.4 
250 U/L GO, 2.5 
w/w% 
In static conditions: 9.1±0.9 mM 
H2O2 
With shaking: 16.0±4.2 mM H2O2 
200 µL HB PEGDA-co-
GMA/ HA-SH 10-1. 0 in 
10 mL PBS pH 7.4 
250 U/L GO, 2.5 
w/w% 
With shaking: 8.3±0.9 mM H2O2 
1 cm x 1 cm (0.0039 g) 
TPU-PDA-GO-1.4-7 + 100 
µL glucose-loaded GelMA 
in 5 mL PBS pH 7.4 
16.4±3.8 U GO/g 
fibre patch, 
10 w/v% glucose 
in GelMA 
In static conditions: 3.7±0.5 mM 
H2O2 
Maximum concentration based on 
activity (static conditions): 18.1±4.5 
mM H2O2 
 
 
Cytocompatibility of ROS-producing Biomaterials 
 
Cytocompatibility of the materials were tested using NIH/3T3 mouse fibroblast 
cells for 24 hours. The base materials (not producing ROS) such as HB 
PEGDA/HA-SH 10-1.0, TPU, and TPU-PDA, TPU-PDA-GO, and UV-crosslinked 
GelMA showed cytocompatibility when analysed individually. 
 
When loaded with GO enzyme and glucose, HB PEGDA/HA-SH 10-1.0 was 
cytocompatible for GO concentrations between 0 to 250 U/L with 2.5 w/w% 
glucose. From the material data sheet, glucose oxidase has an activity of 19,290 
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U/g, thus when converting the enzyme activity concentration to mass concentration 
for the enzyme solutions used, the prepared solutions were between 0 to 13 mg/L. 
 
5 mm by 5 mm TPU-PDA-GOs used with 30 µL 10 w/v% glucose-loaded GelMA 
hydrogel gave cytocompatible results with percentage of cell viability higher than 
80%. The cytocompatibility of the bilayer material was designed to keep the testing 
conditions as similar to the ones used for HB PEGDA/HA-SH 10-1.0 and HB 
PEGDA-co-GMA/HA-SH 10-1.0 where hydrogels were set to sample sizes of 30 
µL  and tested with 30,000 NIH/3T4 cells/mL for 24 hours. 
 
The material HB PEGDA-co-GMA demonstrated low cytocompatibility due to 
glycidyl methacrylate’s unconjugated epoxide bonds that did not graft with an 
enzyme and was not suitable for wound healing applications however it has the 
potential to be used in other enzyme immobilization applications, such as 
immobilizing enzymes for sensor applications and used in enzyme reactor vessels 
as a catalyst for reactions without requiring separation from the bulk fluid9,10. 
 
 
Antibacterial Activity of ROS-producing Biomaterials 
 
Antibacterial tests were performed in collaboration with PhD Ayesha Idrees 
(Politecnico di Torino). HB PEGDA/HA-SH 10-1.0 hydrogels showed zones of 
inhibition for several bacterial strains at a concentration of 250 U/L GO and 2.5 
w/w% glucose: S. aureus, S. epidermidis, E. coli, Methicillin-resistant S. aureus 
(MRSA), Methicillin-resistant S. epidermidis (MRSE), P. aeruginosa, A. 
baumannii. At an increased concentration of 500 U/L GO and 2.5 w/w% glucose, 
this hydrogel showed zones of inhibition for all strains mentioned previously and 
for KPC-2 producing drug resistant E. coli. 
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The antibacterial activity of TPU-PDA-GO material plus glucose loaded GelMA 
hydrogel was not performed in this thesis but it will be performed in  later studies.  
ROS produced from these materials are additional to those produced by the HB 
PEGDA/HA-SH hydrogel and aims to prolong the antimicrobial activity of the final 
device.  
 
 
Assembly of Multilayer Wound Healing Device 
 
Figure 10.1 shows the assembled multilayer wound healing device with the specific 
materials used for each layer. 
 
 
Figure 10.1: Multilayer wound healing device 
 
A multilayer wound material loaded with drug-free ROS producing GO enzyme 
was developed. The bottom HB PEGDA/HA-SH hydrogel had 250 U/L GO 
concentration and 2.5 w/w% glucose and this was the base setting of the device, 
showing cytocompatibility when tested with NIH/3T3 mouse fibroblasts and 
displaying antibacterial activity. 
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For the trilayer device, the highest overall cytocompatibility was 58.3±8.5% when 
using TPU-PDA-GO-0-3 and glucose-loaded (10 w/v%) UV-crosslinked GelMA 
hydrogel. The other trilayer materials with similar cytcompatibility were the ones 
that used TPU-PDA-GO-0-7 (59.7±1.0%) and TPU-PDA-GO-1.4-3 (54.2±6.0%). 
The obtained cytocompatibility for the multilayers were not considerably ideal, thus 
it is likely that a higher amount of ROS was produced leading to cytotoxicity, with 
the combined concentration being at least 12.1±1.4 mM H2O2 for TPU-PDA-GO-
0-3, for example. Due to the lack of HB PEGDA, overall ROS measurements in the 
trilayer system were not able to be performed but it is possible that the overall 
concentration is higher with some glucose molecules that have permeated through 
the TPU-PDA-GO membrane without reacting with the grafted GO to reacting 
instead with the unimmobilized (thus more mobile) GO in the HB PEGDA/HA-SH 
10-1.0 hydrogels.  
 
Hence, GO/glucose concentrations in bottom HB PEGDA/HA-SH 10-1.0 hydrogel 
should be reduced when used in combination with the TPU-PDA-GO fiber patch 
with glucose-loaded GelMA top hydrogel. An alternative would be to apply the 
TPU-PDA-GO system to protect the in situ HB PEGDA/HA-SH 10-1.0 wound 
dressing from exposure and once the glucose from the HB PEGDA/HA-SH 10.1 
hydrogel has almost depleted itself, the glucose-loaded GelMA hydrogel could be 
applied as an alternative glucose source.  
 
The other possible alternative configurations of this wound healing device can be 
seen in Figure 10.2, using the materials developed in this study. For example, by 
using Layer 1 and 2, this combination uses the advantage of Layer 1 being a primary 
antibacterial material-producing wound dressing and Layer 2 as an extra protective 
film as well as being a secondary source of ROS-producing glucose oxidase 
enzymes. Layer 2 and Layer 3 used together is another potential combination with 
in situations where lower ROS concentrations are more desirable. 
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Figure 10.2: Possible configurations for assembling the materials developed in this thesis 
for an antibacterial wound healing patch using Layers 1 to 3. 
 
 
 
10.2. Conclusions and future development 
 
HB PEGDA/HA-SH 10-1.0 hydrogels have proven to be a potentially effective 
drug-free antibacterial wound healing device that mimic the ROS-producing 
property of honey. Its quick-forming in situ  properties allow it to be applied into a 
wound surface as a liquid, fill irregular crevices in the wound, and rapidly turn into 
a hydrogel in approximately one minute. The optimal composition of this hydrogel 
for producing ROS is 250 U/L glucose oxidase and 2.5 w/w% glucose. 
 
Further research should be conducted for the use of a lower GO concentration when 
the hydrogel is combined with a TPU-PDA-GO fibre patch + glucose-loaded 
GelMA top hydrogel. Independently, these two sets of medical devices produce 
good cytocompatibility in NIH/3T3 mouse fibroblasts (after 24 hours) but when 
used together, ROS concentration reaches a high level causing cytotoxicity. 
Another possible explanation for the low cytocompatibility is that in this work the 
whole amount of H2O2 accumulated in 24 hours was tested, rather than the amount 
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produced throughout the 24 hour time-span. By revising the method to test ROS 
production, a more accurate estimation of the cytocompatibility could be obtained. 
 
It is also recommended that antibacterial testing can be also performed on the TPU-
PDA-GO patches in combination with glucose-loaded GelMA hydrogels to analyse 
whether they produce antibacterial activity at an equal level respect to HB 
PEGDA/HA-SH 10-1.0 hydrogels alone. 
 
In imaging studies performed on GO enzyme grafted PDA-TPU-LPO and PDA-
TPU systems, higher magnifications than 20,000x should be performed. Due to the 
limitations of the equipment used, in this study maximum magnification was 
5,000x. At a higher magnification, the individual enzyme clusters onto the TPU 
fibre surface could be easily detected11,12.  
 
For future studies regarding honey-mimetic, drug free antibacterial materials, the 
system of producing ROS with glucose oxidase and glucose may be tested in other 
hydrogel matrices, such as thermoresponsive polymers. One of the polymer 
syntheses performed by the PhD candidate was PLGA(polylactic-co-glycolic acid)-
PEG (polyethylene glycol)-PLGA in supercritical carbon dioxide (see Thesis 
Appendix A and B). The copolymer was water soluble at room temperature and 
turned into a gel at around body temperature  (35℃) when solution concentration 
was 20 w/w% PLGA-PEG-PLGA. Data on copolymer synthesis, hydrogel 
rheological properties, and ROS formation from GO and glucose can be found in 
the PhD thesis appendices. This preliminary study on thermosensitive hydrogels 
underlines that the GO/glucose system can be applied over a wide range of 
hydrogels having different gelation mechanisms. 
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Appendix A – Synthesis and 
characterization of thermosensitive 
PLGA-PEG-PLGA hydrogel 
 
 
 
A1. Abstract 
 
A triblock polylactic-co-polyglycolic acid-polyethylene glycol- polylactic-co-
polyglycolic acid (PLGA-PEG-PLGA or PPP) polymer was synthesized by the 
researcher while performing her secondment in the Vornia Ltd., research laboratory 
utilizing their innovative production technology that allows for production of 
cleaner biomaterials (medical grade polymers). This material has been 
commercialized and launched into the market.  When dissolved in PBS pH 7.4 or 
water from 20 w/w% to 30 w/w%, the material behaved as a thermoresponsive 
hydrogel where the solutions were in liquid state in room temperature but transition 
into a hydrogel at a temperature of 32℃ or higher. When a 20 w/w% PPP polymer 
solution containing glucose oxidase was mixed with a 20 w/w% PPP polymer 
solution containing glucose, this hydrogel mixture produced hydrogen peroxide as 
a result. For PPP hydrogels: 250 U/L GO with 2.5 w/w% glucose produced 6.3±1.6 
mM H2O2 after 24 hours and 500 U/L GO with 5.0 w/w% glucose produced 
10.9±0.5 mM H2O2 after 24 hours. The intended application was to use this material 
as an injectable hydrogel for wound healing purposes where the liquid solution 
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transforms into a hydrogel upon contact of the solution with human body heat (at a 
temperature of around 37℃) where this hydrogel behaves as a honey mimetic 
wound healing device similar to HB PEGDA/HA-SH 10-1.0. What can be gained 
from this synthesis and hydrogel preparation is that the glucose oxidase/glucose 
system can be applied to a wide range of hydrogel materials where their behavioural 
properties (such as gelation time, method of crosslinking, etc.) can be tailored to 
specific wound healing applications. 
 
 
 
A2. Introduction 
 
 
The researcher aimed to synthesize a triblock polylactic-co-polyglycolic acid-
polyethylene glycol- polylactic-co-polyglycolic acid (PLGA-PEG-PLGA) polymer  
making it an environmentally friendly process. The original process was performed 
by Gao, Y. et al. (2010)1. Figures A1 to A3 show the polymerization reaction for 
lactide, glycolide, and polyethylene glycol (PEG) forming a triblock polymer. 
 
 
Figure A1: Polyethylene glycol (red) reacting with stannous octanoate (orange) 
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Figure A2:. Ring opening reaction for PLGA-PEG-PLGA 
 
 
 
Figure A3. Final PLGA-PEG-PLGA (PPP) product 
 
 
 
A3. Materials and methods 
 
Phosphate buffer solution (PBS) pH 7.4 tablets, glucose, glucose oxidase (GO, E.C. 
1.1.3.4.), sulfuric acid, titanium oxysulfate were bought from Sigma Aldrich, UK. 
The reagents for the polymer synthesis were also provided by them. 
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A3.1. Polymer Synthesis 
 
A copy of the PLGA-PEG-PLGA product brochure, prepared by the PhD candidate 
during her secondment is shown in Appendix B. Product synthesis is not disclosed 
for commercial reasons. 
 
 
A3.2. Chemical characterization by 1H NMR and Gel Phase 
Chromatography 
 
See Chapter 2, Section 2.3.4 for the procedure on 1H NMR and GPC sample 
preparation and analysis. 
 
 
A3.3. Determination of gelation temperature 
 
PLGA-PEG-PLGA (PPP) hydrogels were prepared by dissolving PPP at 20, 25, 
and 30 w/w% in PBS pH 7.4. The temperature where gelation occurs was measured 
by using a TA Discovery Hybrid Rheometer-2 (DHR-2).  
 
A hydrogel sample was placed in an 8 mm flat disc plate rheometer. The storage 
modulus profiles were measured from 30°C to 40°C with a step increase of 0.1°C 
(10% strain, 10 Hz frequency). An increasing storage modulus means that the 
hydrogel becomes more solid-like. 
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A3.4. ROS measurement assays 
 
The main purpose of this section is to test the applicability of antibacterial ROS 
glucose oxidase/glucose hydrogels in non thiol-ene crosslinking polymer system. 
PLGA-PEG-PLGA was selected to see if the ROS system was applicable to a 
thermoresponsive hydrogel. 
 
Briefly, two ROS systems were prepared in 20 w/w% PPP: 250 U/L GO and 2.5 
w/w% glucose; 500 U/L and 5.0 w/w% glucose. The hydrogels were prepared by 
mixing 100 µL Solution A and 100 µL Solution B. These polymer solutions became 
hydrogels while incubated at 37℃ as shown in Table A.1. 
 
Table A.1. Concentration of GO and glucose used for preparing thermoresponsive 
PPP hydrogels. 
Final hydrogel 
composition (20 w/w% 
PLGA-PEG-PLGA) 
Solution A (Glucose 
oxidase containing 
solution) 
Solution B (Glucose 
containing solution) 
250 U/L GO and 2.5 w/w% 
glucose 
PPP composition: 20 
w/w% 
Glucose oxidase 
concentration: 500 U/L 
PPP composition: 20 w/w% 
Glucose concentration: 5 
w/w% 
500 U/L and 5.0 w/w% 
glucose 
PPP composition: 20 w/w% 
Glucose oxidase 
concentration: 1000 U/L 
PPP composition: 
Glucose concentration: 10 
w/w% 
 
Using the procedure described in Chapter 3, Section 3.3.3. the H2O2 content of these 
hydrogels were measured at different time points: 2 hours, 4 hours, 24 hours, and 
48 hours. 
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A4. Results and Discussion 
 
A4.1. Chemical characterization 
 
Figure A.4. outlines the NMR results showing the presence of the polylactide, 
polyglycolide and PEG groups. Calculations from NMR data gave a 
lactide:glycolide molar ratio of 7.7:1, a 24.42 wt% PEG, and a molecular weight of 
6,143 Da. Meanwhile the GPC results show that Mw was 9,786 Da and Mn was 
6,960 Da. The reaction had a molar yield of 98%, which means that 98% of the 
reagents were reacted in the polymer synthesis. 
 
 
Figure A4: 1H NMR results of PLGA-PEG-PLGA with the GPC results for the Mn 
and Mw reported for 2, 4, and 6 hours. 
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A4.2. Gelation temperature 
 
From Figure A.5, it can be seen that storage modulus increases with respect to 
temperature up to a certain point before decreasing once again. It was observed that 
increasing the amount of polymer in the solution decreases the gelation 
temperature. For concentrations 25 w/w% PPP and 30 w/w% PPP, they became 
hydrogels at approximately 32℃ while 20 w/w% PPP had a gelation temperature 
of 35℃.  This means that for all concentrations, a hydrogel would be formed at 
body temperature, 37℃. For practical reasons such as ease of dissolving and 
conserving material, 20 wt% will be used for future studies such as measuring the 
amount of H2O2 produced. 
 
 
 
Figure A.5: Storage of 2PLGA-PEG-PLGA hydrogels as a function of temperature. 
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A4.3. ROS production in thermoresponsive hydrogels 
 
Hydrogen peroxide was successfully produced in the two GO/glucose 
concentrations used. However, when compared to the HB PEGDA/HA-SH 10-1.0 
hydrogels of the same GO/glucose concentrations, the PLGA-PEG-PLGA 
hydrogels produced H2O2 concentrations which were significantly lower than their 
counterparts. The target H2O2 production for ROS-producing hydrogels was 10-20 
mM H2O2 per day, which was only achieved by the PPP hydrogel with 500 U/L GO 
and 5.0 w/w% glucose2. 
 
 
Figure A.6. H2O2 production in PLGA-PEG-PLGA at different time points. 
 
 
The intended application was to use this material as an injectable hydrogel for 
wound healing purposes where the liquid solution transforms into a hydrogel from 
the contact of the solution to human body heat (at a temperature of approximately 
37℃) where this hydrogel behaves as a honey mimetic wound healing device 
similar to HB PEGDA/HA-SH 10-1.0. 
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A.5. Conclusions 
  
 
The honey-mimetic system (glucose oxidase enzyme/glucose reacting to form 
hydrogen peroxide) used in the main thesis was also applicable to a 
thermoresponsive hydrogel of 20 w/w% PLGA-PEG-PLGA with 500 U/L GO and 
5.0 w/w% glucose. This material produced 9.6±0.5 mM H2O2 in 24 hours. This 
polymer was developed and synthesized by the PhD candidate during her 
secondment in Vornia Ltd., Ireland. This material was advertised in the Vornia 
website briefly before the company was sold to Ashland Specialties Ltd., Ireland. 
 
What can be gained from this synthesis and hydrogel preparation is that the glucose 
oxidase/glucose system can be applied to a wide range of hydrogel materials where 
their behavioural properties (such as gelation time, method of crosslinking, etc.) 
can be tailored to specific wound healing applications. 
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Appendix B: Brochure copy of Vornia Ltd.s’ PLGA-
PEG-PLGA  
This was written by the PhD candidate and featured in briefly in Vornia website 
(before the company was purchased by Ashland Specialties, Ltd.) 
